<SEC-DOCUMENT>0001493152-22-029342.txt : 20221021
<SEC-HEADER>0001493152-22-029342.hdr.sgml : 20221021
<ACCEPTANCE-DATETIME>20221021162543
ACCESSION NUMBER:		0001493152-22-029342
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20221021
DATE AS OF CHANGE:		20221021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Soluna Holdings, Inc
		CENTRAL INDEX KEY:			0000064463
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				141462255
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-261427
		FILM NUMBER:		221324014

	BUSINESS ADDRESS:	
		STREET 1:		325 WASHINGTON AVENUE EXTENSION
		CITY:			ALBANY
		STATE:			NY
		ZIP:			12205
		BUSINESS PHONE:		518-218-2500

	MAIL ADDRESS:	
		STREET 1:		325 WASHINGTON AVENUE EXTENSION
		CITY:			ALBANY
		STATE:			NY
		ZIP:			12205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MECHANICAL TECHNOLOGY INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>form424b5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
Pursuant to Rule 424(b)(5)<BR>
Registration Statement No. 333-261427</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this preliminary prospectus supplement is not complete and may be changed. We may not sell these securities until the
registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus supplement and the
accompanying base prospectus are not an offer to sell these securities, nor are they a solicitation of offers to buy these securities
in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>PRELIMINARY
PROSPECTUS SUPPLEMENT&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(To
    Prospectus dated December 16, 2021)</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>SUBJECT
    TO COMPLETION</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>DATED
    OCTOBER 21, 2022</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SOLUNA
HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock, par value $0.001, pursuant to
this prospectus supplement and the accompanying base prospectus, at a public offering price of $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share of common stock. A description of the determination of the public offering price is included in
&ldquo;Underwriting&mdash;Pricing of the Offering.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
offering is being underwritten on a firm commitment basis. We have retained Univest Securities, LLC, or Univest or the Representative,
to act as our underwriter in connection with this offering. See &ldquo;Underwriting&rdquo; beginning on page S-21  of this prospectus
supplement for more information regarding these arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Concurrently with this offering, we intend to sell
up to an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock directly to Soluna SLC
Fund I Projects Holdco LLC, or Spring Lane, in a private placement at the same price per share as the public offering price per share
set forth above, for aggregate gross proceeds to us of approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; . The closing of this
offering is not contingent upon closing of the concurrent private placement. The shares of common stock being offered in the concurrent
private placement are being offered pursuant to the exemptions provided in Section 4(a)(2) under the Securities Act of 1933, as amended,
or the Securities Act, and Rule 506(b) promulgated thereunder, and they are not being offered pursuant to this prospectus supplement
and the accompanying prospectus. In addition, upon closing of this offering, certain convertible promissory note with an aggregate principal
amount of $850,000 held by Spring Lane will automatically convert into shares of common stock at a conversion price equal to the
public offering price per share set forth above.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our common stock involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page S-5  of this prospectus supplement,
page 4 of the accompanying base prospectus and the risks discussed in the documents incorporated by reference in this prospectus supplement
and the accompanying base prospectus, as they may be amended, updated or modified periodically in our reports filed with the Securities
and Exchange Commission. You should carefully read and consider these risk factors before you invest in our securities. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Share</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: justify">Public offering price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts and commissions<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds to us before expenses<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
    that we sell all of the common stock offered by this prospectus supplement. We have agreed to issue the underwriter or its designees
    warrants to purchase a number of shares of common stock equal to 5.0% of the aggregate number of shares of common stock sold in this
    offering, or the Representative&rsquo;s Warrants, and to reimburse the underwriter for certain offering-related expenses. See &ldquo;Underwriting&mdash;Potential
    Conflicts of Interest&rdquo; on page S-21  of this prospectus supplement for a description of all underwriting compensation payable
    in connection with this offering. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount of offering proceeds to us presented in this table does not give effect to any exercise of the over-allotment option (if any)
    we have granted to the underwriter as described below.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the underwriter an option to purchase from us at any time and from time to time up to additional shares of our common
stock at the public offering price of $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , less underwriting discounts
and commissions, within 45 days from the date of this prospectus supplement. If the underwriter exercises this option in full, the
total underwriting discounts and commissions will be approximately $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
and the total proceeds, before expenses, to us will be approximately $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock and 9.0% Series A Cumulative Perpetual Preferred Stock, par value $0.001 per share, or Series A Preferred Stock, are currently
listed on Nasdaq under the symbols &ldquo;SLNH&rdquo; and &ldquo;SLNHP&rdquo;, respectively. On October 20, 2022, the last reported sale
price of our common stock was $1.86 per share and the last reported sale price of our Series A Preferred Stock was $6.32 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter expects to deliver the shares of common stock to investors on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2022, subject to satisfaction of customary closing
conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission, or the SEC, nor any state securities commission has approved or disapproved of the securities
offered hereby or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Book-Running
Manager</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="form424b5_001.jpg" ALT="Logo, company name&#10;&#10;Description automatically generated" STYLE="height: 141px; width: 255px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus supplement is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ,
2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus
Supplement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_001">ABOUT THIS PROSPECTUS SUPPLEMENT</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-ii</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_002">ABOUT THIS OFFERING</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-3</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_003">RISK FACTORS</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-5</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_004">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-16</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_005">USE OF PROCEEDS</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-17</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_006">DIVIDEND POLICY</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-18</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_007">DILUTION</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-19</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_008">DESCRIPTION OF SECURITIES WE ARE OFFERING</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-20</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_009">UNDERWRITING</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-21</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_010">LEGAL MATTERS</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_011">EXPERTS</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_012">WHERE YOU CAN FIND MORE INFORMATION</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#ah_013">INCORPORATION OF DOCUMENTS BY REFERENCE</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a001_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABOUT
    THIS PROSPECTUS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ii</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a002_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RISK
    FACTORS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a003_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a004_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>USE
    OF PROCEEDS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a005_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
    SECURITIES THAT WE MAY OFFER</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a006_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
    OF CAPITAL STOCK</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a007_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
    OF WARRANTS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>33</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a008_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
    OF DEBT SECURITIES</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>35</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a009_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
    OF SUBSCRIPTION RIGHTS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>45</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a010_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
    OF UNITS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>46</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a011_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
    STOCKHOLDERS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>47</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a012_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLAN
    OF DISTRIBUTION</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>48</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a013_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LEGAL
    MATTERS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>51</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a014_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPERTS</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>51</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a015_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHERE
    YOU CAN FIND MORE INFORMATION</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>51</B></FONT></td></tr>
<TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#a016_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCORPORATION
    OF DOCUMENTS BY REFERENCE</B></FONT></a></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>51</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_001"></A>ABOUT
THIS PROSPECTUS SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is in two parts, this prospectus supplement and the accompanying base prospectus, both of which are part of a registration statement
on Form S-3 (File No. 333-261427) (as amended, the &ldquo;Registration Statement&rdquo;), that we filed with the SEC using a &ldquo;shelf&rdquo;
registration process and which was declared effective by the SEC on December 16, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
two parts of this document include: (1) this prospectus supplement, which describes the specific details regarding the securities offered
by this prospectus supplement; and (2) the accompanying base prospectus included in the Registration Statement, which provides a general
description of the securities that we may offer, some of which may not apply to this offering. Generally, when we refer to this &ldquo;prospectus,&rdquo;
we are referring to both documents combined. If information in this prospectus supplement is inconsistent with the accompanying base
prospectus, you should rely on this prospectus supplement. You should read this prospectus supplement together with the additional information
described below under the heading &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Documents by Reference.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
statement made in this prospectus supplement or in any document incorporated or deemed to be incorporated by reference into this prospectus
supplement, the accompanying base prospectus and the Registration Statement will be deemed to be modified or superseded for purposes
of this prospectus supplement to the extent that a statement contained in this prospectus supplement or in any other subsequently filed
document that is also incorporated by reference into this prospectus supplement modifies or supersedes that statement. Any statements
so modified or superseded will be deemed not to constitute a part of this prospectus supplement except as so modified or superseded.
In addition, to the extent of any inconsistencies between the statements in this prospectus supplement and similar statements in any
previously filed report incorporated by reference into this prospectus supplement, the accompanying base prospectus and the Registration
Statement, the statements in this prospectus supplement will be deemed to modify and supersede such prior statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registration Statement that contains the accompanying base prospectus and this prospectus supplement, including the exhibits to the Registration
Statement and the information incorporated by reference herein and therein, contains additional information about the securities offered
by this prospectus supplement. The Registration Statement can be read on the SEC&rsquo;s website or at the SEC&rsquo;s offices mentioned
below under the heading &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are responsible for the information contained and incorporated by reference in this prospectus supplement, the accompanying base prospectus
and any related free writing prospectus that we prepare or authorize. Neither we nor the underwriter has authorized anyone to provide
you with different or additional information, and we take no responsibility for any other information that others may give you. If you
receive any other information, you should not rely on it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement and the accompanying base prospectus do not constitute an offer to sell or the solicitation of an offer to buy
any securities other than the securities to which this prospectus supplement relates, nor do this prospectus supplement and the accompanying
base prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom
it is unlawful to make such offer or solicitation in such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not assume that the information in this prospectus supplement and the accompanying base prospectus is accurate at any date other
than the date indicated on the cover page of this prospectus supplement or that any information that we have incorporated by reference
in this prospectus supplement and the accompanying base prospectus is correct on any date subsequent to the date of the document incorporated
by reference. Our business, financial condition, results of operations or prospects may have changed since that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not rely on or assume the accuracy of any representation or warranty in any agreement that we have filed in connection with this
offering or that we may otherwise publicly file in the future because any such representation or warranty may be subject to exceptions
and qualifications contained in separate disclosure schedules, may represent the applicable parties&rsquo; risk allocation in the particular
transaction, may be qualified by materiality standards that differ from what may be viewed as material for securities law purposes or
may no longer continue to be true as of any given date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context requires otherwise, references in this prospectus supplement to &ldquo;SHI&rdquo;, the &ldquo;Company&rdquo;, &ldquo;we&rdquo;,
&ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Soluna Holdings, Inc. together with its consolidated subsidiaries. SHI, our logo and
our other registered or common law trademarks, trade names or service marks, to the extent any such marks have been registered, appearing
in this prospectus supplement and the accompanying base prospectus are owned by us. Solely for convenience, trademarks and trade names
referred to in this prospectus supplement and the accompanying base prospectus, including logos, artwork and other visual displays, may
appear without the &reg; or &trade; symbols, but such references are not intended to indicate in any way that we will not assert, to
the fullest extent under applicable law, our rights of the applicable licensor to these trademarks and trade names. Unless otherwise
stated in this prospectus supplement and the accompanying base prospectus, we do not intend our use or display of other companies&rsquo;
trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding: 1pt 4pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
SUPPLEMENT SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following summary of our business highlights some of the information contained elsewhere in, or incorporated by reference into, this
prospectus supplement. Because this is only a summary, however, it does not contain all of the information that may be important to you.
You should carefully read this prospectus supplement and the accompanying base prospectus, including the documents incorporated by reference,
which are described under &ldquo;Incorporation of Documents by Reference&rdquo; in this prospectus supplement. You should also carefully
consider the matters discussed in the section of this prospectus supplement titled &ldquo;Risk Factors&rdquo; and under similar sections
of the accompanying base prospectus and other periodic reports incorporated herein and therein by reference.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Unless
the context requires otherwise in this prospectus supplement, the terms &ldquo;SHI&rdquo;, the &ldquo;Company&rdquo;, &ldquo;we&rdquo;,
&ldquo;us&rdquo;, or &ldquo;our&rdquo; refer to Soluna Holdings, Inc. together with its consolidated subsidiaries, and &ldquo;SCI&rdquo;
refers to Soluna Computing, Inc., formerly known as EcoChain, Inc.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHI
currently conducts our business through our wholly-owned subsidiary, SCI. SCI is engaged in the mining of cryptocurrency through data
centers that can be powered by renewable energy sources. Recently, SCI has built, and intends to continue to develop and build, modular
data centers that are currently used for cryptocurrency mining and that in the future can be used for computing intensive, batchable
applications, such as artificial intelligence and machine learning, with the goal of providing a cost-effective alternative to battery
storage or transmission lines. Headquartered in Albany, New York, the Company uses technology and intentional design to solve complex,
real-world challenges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCI
was incorporated in Delaware on January 8, 2020 as EcoChain, Inc., which operates a cryptocurrency mining facility that integrates with
the cryptocurrency blockchain network. Through the October 2021 acquisition by EcoChain, Inc. of an entity at the time named Soluna Computing,
Inc., SCI also has a pipeline of certain cryptocurrency mining projects previously owned by Harmattan Energy, Ltd. (&ldquo;HEL&rdquo;)
(formerly known as Soluna Technologies, Ltd.), a Canadian corporation incorporated under the laws of the Province of British Colombia
that develops vertically-integrated, utility-scale computing facilities focused on cryptocurrency mining and cutting-edge blockchain
applications. Following such acquisition, on November 15, 2021, SCI completed its conversion and redomicile to Nevada and changed its
name from &ldquo;EcoChain, Inc.&rdquo; to &ldquo;Soluna Computing, Inc.&rdquo;. The following day, the acquired entity, Soluna Computing,
Inc., changed its name to &ldquo;Soluna Callisto Holdings Inc.&rdquo; (&ldquo;Soluna Callisto&rdquo;). We earn revenue from this business
as the mined cryptocurrencies are converted into U.S. dollars. SCI has also began mining operations in fiscal year 2021 in Murray, Kentucky
and Calvert City, Kentucky. The mining facility in Calvert City currently performs hosting services and prop mining in which 10 megawatts
is used for hosting services and 10 megawatts is used for prop mining. The mining facility in Murray, Kentucky operates fully on prop
mining with a capacity of 25 megawatts. On September 17, 2022, SCI sold specified assets consisting mainly of mining equipment and other
general equipment items to a buyer at their Wenatchee, Washington location. In addition, SCI entered into a management and hosting services
agreement with the buyer to host several mining equipment now owned by the buyer. We have a development site in Texas (&ldquo;Project
Dorothy&rdquo;) for a potential of up to 100 megawatts to be built at a wind farm with initial energization of 50 megawatts anticipated
to begin in the fourth quarter of 2022, subject to ERCOT approval and with ramp up likely to continue into fiscal year 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Concurrent
Private Placement of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In a concurrent private placement, we intend to
                                                                                        sell up to an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock directly to Spring Lane in a
                                                                                        private placement at the same price per share as the public offering price per share set forth above, for aggregate gross proceeds
                                                                                        to us of approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; . The closing of this offering is not contingent upon
                                                                                        closing of the concurrent private placement. The shares of common stock being offered in the concurrent private placement are being
                                                                                        offered pursuant to the exemptions provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder, and
                                                                                        they are not being offered pursuant to this prospectus supplement and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<DIV STYLE="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 1pt 4pt; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuance
of Convertible Promissory Note and Automatic Conversion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2022, we issued to Spring Lane a convertible promissory note (as subsequently amended, the &ldquo;Note&rdquo;) in the principal
amount of $850,000, which bears interest thereon accruing at a rate of 10% per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal amount and all unpaid accrued interest on the Note are to become due and payable on September 30, 2024. The Note may not be
prepaid without the prior written consent of Spring Lane, except upon written notice to Spring Lane upon change of control, pursuant
to the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
offering will be deemed a &ldquo;Qualified Financing&rdquo; pursuant to the Note, upon consummation of which the outstanding principal
amount of the Note and any unpaid accrued interest are to automatically convert into the securities sold in the Qualified Financing at
a conversion price equal to the price paid per share for securities by the investors in the Qualified Financing, except to the extent
that such conversion would result in Spring Lane beneficially owning greater than 19.9% of the Company. In accordance with the Note,
upon closing of this offering, the Note will automatically convert into an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>October
2021 Convertible Secured Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 20, 2021, we entered into a securities purchase agreement (as amended and supplemented by the addendums, the &ldquo;October 2021
Purchase Agreement&rdquo;) with certain accredited investors (the &ldquo;Noteholders&rdquo;), and issued, upon closing of the offering
on October 25, 2021, convertible secured notes (the &ldquo;October Secured Notes&rdquo;) in the aggregate principal amount of $16,304,348
for an aggregate purchase price of $15 million to the Noteholders. The October 2021 Purchase Agreement, contains, among others, a &ldquo;most
favored nation&rdquo; provision (the &ldquo;MFN Provision&rdquo;) which provides that as long as any Noteholder holds any of the October
Secured Notes with a principal amount in excess of $1,500,000, in the event that we issue or sell any common stock or common stock equivalents,
if the Noteholder holding outstanding securities issued pursuant to the October 2021 Purchase Agreement reasonably believes that any
of the terms and conditions of such issuance or sales are more favorable than the terms and conditions granted to the Noteholder pursuant
to the October 2021 Purchase Agreement, upon notice to us within five trading days after disclosure of such issuance or sale, we will
amend the terms of the October 2021 Purchaser Agreement as to such Noteholder, only so as to give such Noteholder the benefit of such
more favorable terms or conditions. Pursuant to the MFN Provision, we may be required to issue to the Noteholders additional shares of
common stock or other securities convertible into shares of common stock upon conversion of the October Secured Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2022, we entered into an addendum (the &ldquo;Addendum&rdquo;), pursuant to which a portion of the October Secured Notes would
be converted and may be redeemed in three tranches, with each tranche of $1,100,000 required to be converted into common stock in each
case at the then in effect conversion price, with such price, prior to each conversion, to be reduced (but not increased) to a 20% discount
to the 5-day volume weighted average price (&ldquo;VWAP&rdquo;) of our common stock. In addition, the Noteholders may require us to redeem
up to $2,200,000 worth of October Secured Notes in connection with each tranche at a rate of $1.20 for every $1.00 owed, less the amount
of October Secured Notes converted during such tranche, not including the required conversion amount if the Noteholders are unable to
convert out of such amount of the October Secured Notes in each tranche. We are required to deposit up to $1,950,000 in an escrow account
in connection with each tranche to satisfy any redemptions, except with respect to the first tranche as provided in the Addendum Amendment
(as defined below). The Addendum also provides the right for us to pause the commencement of the conversion of the second and third tranches
each for 45 days in the event we pursue an equity financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2022, we and the Noteholders entered into an agreement further amending the Addendum (the &ldquo;Addendum Amendment&rdquo;),
which among others, extended the maturity date of the October Secured Notes by six months to April 25, 2023, and increased the principal
amount of the October Secured Notes by an aggregate of $520,241 for a total outstanding principal amount of $13,006,022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Addendum, between July 21, 2022 to August 3, 2022, the October Secured Notes with an aggregate principal amount of $1,100,000
converted into 293,350 shares of common stock, at the conversion price of $3.75. In connection with this offering, we have paused the
second and the third tranches pursuant to the Addendum. As of October 20, 2022, October Secured Notes with an aggregate principal amount
of $13,006,022 are outstanding. The October Secured Notes that are not converted or redeemed pursuant to the Addendum will a conversion
price of $9.18, subject to adjustments set forth in the October Secured Notes and the October 2021 Purchase Agreement, including the
MFN Provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soluna
Holdings, Inc., formerly known as Mechanical Technology, Incorporated, was incorporated in Nevada on March 24, 2021, and is the successor
to Mechanical Technology, Inc., which was incorporated in the State of New York in 1961, as a result of a merger which became effective
on March 29, 2021, and is headquartered in Albany, New York. Effective November 2, 2021, the Company changed its name from &ldquo;Mechanical
Technology, Incorporated&rdquo; to &ldquo;Soluna Holdings, Inc.&rdquo; Our principal executive offices are located at 325 Washington
Avenue Extension, Albany, NY 12205 and our website is http://www.solunacomputing.com. Our telephone number is 518-218-6051. Information
contained on our website does not constitute part of and is not incorporated into this prospectus supplement, the accompanying base prospectus
or the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="text-align: center; border: Black 1.5pt solid; padding: 0pt 0.1in">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_002"></A>ABOUT THIS OFFERING</B></FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock offered by us</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
    to purchase additional shares </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have granted the underwriter an option to purchase from us at any time and from time to time up to
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares of our common stock at the public offering price of $
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , less underwriting discounts and commissions, within 45 days
    from the date of this prospectus supplement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    stock outstanding after this offering, the concurrent private placement, and the automatic conversion of the Note upon closing of
    this offering <SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
    (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares if the underwriter exercises in full its
    over-allotment option to purchase additional shares of common stock).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Concurrent Private Placement</B></P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Concurrently with this offering, we intend to sell
up to an aggregate of shares of common stock directly to Spring Lane in a private placement at the same price per share as the public
offering price per share, for aggregate gross proceeds to us of approximately $ . The closing of this offering is not contingent upon
closing of the concurrent private placement. The shares of common stock being offered in the concurrent private placement are being offered
pursuant to the exemptions provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder, and they are not
being offered pursuant to this prospectus supplement and the accompanying prospectus.</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
    of proceeds</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                                                              estimate that we will receive net proceeds of approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; from this offering,
                                                                              assuming no exercise of the underwriter&rsquo;s over-allotment option, and approximately $ , assuming full exercise of the
                                                                              over-allotment option, after deducting estimated underwriting discounts and commissions and estimated expenses payable by
                                                                              us.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    gross proceeds to us in this offering and the concurrent private placement, in the aggregate, will be $ .</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to use the net proceeds of this the offering and the concurrent private placement for the acquisition, development and growth
    of data centers, including cryptocurrency mining processors, other computer processing equipment, data storage, electrical infrastructure,
    software and real property (<I>i.e., </I>land and buildings) and business, including but not limited to the Project Dorothy facility,
    and for working capital and general corporate purposes, which include, but are not limited to, operating expenses. See &ldquo;Use
    of Proceeds&rdquo; on page S-17  for more information.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    factors</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our common stock involves a high degree of risk. As an investor you should be prepared to lose your entire investment See &ldquo;Risk
    Factors&rdquo; beginning on page S-5, page 4 of the accompanying base prospectus, and the risks discussed in the documents incorporated
    by reference in this prospectus supplement and the accompanying base prospectus, as they may be amended, updated or modified periodically
    in our reports filed with the SEC and other information herein and therein. Additional risks and uncertainties not presently known
    to us or that we currently deem to be immaterial may also impair our business and operations.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq
    symbol</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            common stock and Series A Preferred Stock are listed on Nasdaq under the symbols &ldquo;SLNH&rdquo;
                                            and &ldquo;SLNHP&rdquo;, respectively.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Except as otherwise indicated, the number of shares of common stock to be outstanding immediately after this offering is based on 15,395,068
shares of our common stock outstanding as of October 11, 2022, and excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,061,245
    shares of Series A Preferred Stock issued and outstanding;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,500
    shares of Series B Convertible Preferred Stock (the &ldquo;Series B Preferred Stock&rdquo;) issued and outstanding;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock issuable upon conversion of the outstanding October Secured Notes, pursuant to the conversion terms described under
    &ldquo;Prospectus Supplement Summary&mdash;Convertible Secured Notes&rdquo;;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">812,325
    shares of common stock issuable upon the exercise of stock options outstanding at a weighted average exercise price of $6.46 per
    share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,582,788
    shares of common stock issuable upon the exercise of warrants outstanding at a weighted average exercise price of $7.03 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">832,598
    shares of common stock issuable upon the vesting of restricted stock units; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,916
    shares of common stock reserved for future issuance under the 2021 Equity Incentive Plan (the &ldquo;2021 Plan&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated, all information in this prospectus supplement assumes (i) no exercise, conversion, or settlement of the outstanding
preferred stock, notes, options, restricted stock units or warrants described above, other than the automatic conversion of the Note
upon closing of this offering, (ii) no exercise of the Representative&rsquo;s Warrants to be issued to the underwriter or its designees
in connection with this offering and (iii) no exercise of the underwriter&rsquo;s option to purchase additional shares of common stock
from us. In addition, all information in this prospectus supplement excludes (a) additional shares of common stock or other securities
convertible into shares of common stock that may be issued to the Noteholders pursuant to the MFN Provision, and (b) the shares of
common stock equal to 10% of the capital raised from this offering, the Note and the concurrent private placement to be issued to the
holder of the Series B Preferred Stock pursuant to Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible
Preferred Stock (the &ldquo;Series B Certificate of Designations&rdquo;) with respect to certain consent requirements, upon closing of
this offering and the concurrent private placement.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_003"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully
the risks and uncertainties described under the heading &ldquo;Risk Factors&rdquo; contained in this prospectus supplement and in the
accompanying base prospectus, described under the section entitled &ldquo;Risk Factors&rdquo; contained in our Annual Report on Form
10-K and the subsequent Quarterly Reports on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC,
which are incorporated by reference into this prospectus supplement, together with other information in this prospectus supplement and
the accompanying base prospectus (including the documents incorporated by reference herein and therein). The risks described in these
documents are not the only ones we face, but are those that we consider to be material. There may be other unknown or unpredictable economic,
business, competitive, regulatory or other factors that could have material adverse effects on our future results. Past financial performance
may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future
periods. If any of these risks actually occurs, our business, financial condition, results of operations, cash flow or prospects could
be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment.
Please also carefully read the section below entitled &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
inability or failure to access power sources to provide adequate energy to our facilities and operations would materially impact our
operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cryptocurrency mining operations require significant amounts of energy, and the lack of a power supply agreement and inability to access
power sources could result in our inability to obtain adequate power needed for our cryptocurrency mining operations. Unless and until
we were able to obtain such power directly from power suppliers, such would result in a significant interruption to our business. We
may also incur significant costs associated with negotiating and entering into power supply agreements to provide power to our facilities,
and with setting up corresponding infrastructure to receive such power directly. Further, there can be no assurances that we would be
able to enter into power supply agreements with power suppliers, or negotiate power supply agreements on favorable terms to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may undertake cost-reduction initiatives to reduce our expenses and to better align our expenses with our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to reduce our expenses and better align our expenses with our business, we may take one or more measures, including but not limited
to, a reduction in personnel, restructuring initiatives and a reduction in other expenditures. These expense reduction measures may yield
unintended consequences and costs, such as the loss of institutional knowledge and expertise, attrition beyond our intended reduction-in-force,
lowered morale among our remaining employees, and the risk that we may not achieve the anticipated benefits of such cost-saving measures,
all of which may have an adverse effect on our results of operations or financial condition. We may also discover that the reductions
in workforce and other cost-cutting measures may make it difficult for us to pursue new opportunities and initiatives and require us
to hire qualified replacement personnel, which may require us to incur additional and unanticipated costs and expenses. There can be
no assurances that any cost-saving initiatives we may take will be successful in reducing our expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Indebtedness</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
obligations under the October Secured Notes are secured by substantially all of our assets, and if we default on those obligations, the
holders of the October Secured Notes could foreclose on our assets. As a result of these security interests, such assets would only be
available to satisfy claims of our general creditors or to holders of our equity securities if we were to become insolvent at a time
when the value of such assets exceeded the amount of our indebtedness and other obligations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Noteholders have a security interest in substantially all of our assets pursuant to the October Secured Notes. As a result, if we default
under our obligations to the Noteholders, the Noteholders could foreclose on their security interests and liquidate some or all of these
assets, which would harm our business, financial condition and results of operations. The outstanding principal amount of the October
Secured Notes as of October 19, 2022, was $13,006,022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a default, the Noteholders would have a prior right to substantially all of our assets to the exclusion of our general creditors.
In that event, our assets would first be used to repay in full all indebtedness and other obligations secured by the Noteholders, resulting
in all or a portion of our assets being unavailable to satisfy the claims of any unsecured indebtedness. Only after satisfying the claims
of any unsecured creditors would any amount be available for our equity holders. These events of default include, among other things,
our failure to pay any amounts due under the October Secured Notes and the October 2021 Purchase Agreement, including any amendments
thereto, a breach of covenants or obligations under the October Secured Notes and the October 2021 Purchase Agreement, our insolvency,
a material adverse effect occurring, the occurrence of certain defaults under certain other indebtedness or certain final judgments against
us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pledge of these assets and other restrictions may limit our flexibility in raising capital for other purposes. Because substantially
all of our assets are pledged under October Secured Notes, our ability to incur additional secured indebtedness or to sell or dispose
of assets to raise capital may be impaired, which could have an adverse effect on our financial flexibility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, following an event of default under the October Secured Notes, the Noteholders will have the right to declare all outstanding
borrowings under the October Secured Notes, together with accrued interest and other amounts payable thereunder, to be immediately due
and payable in cash. If the debt under the October Secured Notes was to be accelerated, we cannot assure you that our assets would be
sufficient to repay in full our debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
outstanding debt obligations may adversely affect our cash flow and our ability to operate our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of October 11, 2022, we had the principal balance remaining of approximately
$13.0 million on the October Secured Notes, approximately $9.9 million under the Master Equipment Finance Agreement, dated as of December
30, 2021, as amended, by and between Soluna MC Borrowing 2021-1 LLC, our indirect wholly owned subsidiary, and NYDIG ABL LLC (&ldquo;NYDIG&rdquo;)
as lender, servicer and collateral agent (the &ldquo;NYDIG facility&rdquo;), and $575,000 under an unsecured line of credit we entered
into with KeyBank National Association on September 13, 2021 (the &ldquo;KeyBank facility&rdquo;), of which accrued interest is due monthly,
and principal is due in full following the lender&rsquo;s demand. We have agreed to repay $25,000 of principal under the KeyBank facility
each week. Under the NYDIG facility, we, through Soluna MC Borrowing 2021-1 LLC, are required to make average monthly principal and interest
payments of approximately $730,000 on initial drawdown in aggregate principal amount of approximately $4.6 million bearing interest at
14%, and a subsequent drawdown of $9.6 million. Although we are currently in discussions with NYDIG to potentially modify the repayment
schedule under the NYDIG Facility, and for the month of September 2022, made interest-only payments which has delayed our future monthly
principal and interest payments by one month each, there is no assurance that we will be able to modify the repayment schedule under the
NYDIG Facility. Pursuant to the terms of October Secured Notes, on April 25, 2023, the maturity date of the October Secured Notes, to
the extent the October Secured Notes are not converted, the October Secured Notes are payable in full. Additionally, pursuant to the Addendum
and the Addendum Amendment, we are required to hold certain funds in escrow for conversion or redemption of the October Secured Notes
in tranches. We may be unable to repay the outstanding debt obligations. Such failure to repay the outstanding debt obligations could
have a material adverse effect on our financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The terms of our October Secured, the NYDIG facility
and the KeyBank facility could have negative consequences to us, including but not limited to limiting our to obtain additional financing
to fund working capital, operating losses, capital expenditures or acquisitions on terms acceptable to us, or at all, limiting the amount
of cash we have to operate our business, reducing the number of authorized and unissued shares of our common stock available for issuance,
including in subsequent equity financings, in the event the Noteholders elect to convert the October Secured Notes into common stock,
and increasing our vulnerability to economic downturns and adverse developments in our industry or the economy in general.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial, business,
economic, regulatory and other factors. We will be unable to control many of these factors, such as economic conditions. We cannot be
certain that we will continue to have sufficient capital to allow us to pay the principal and interest on our debt and meet any other
obligations. If we do not have enough money to service our debt, we may be required, but unable to refinance all or part of our existing
debt, sell assets, borrow money or raise equity on terms acceptable to us, if at all, and the lender could foreclose on its security
interests and liquidate some or all of our assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Financial Position, Capital Requirements and Financings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is substantial doubt about our ability to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
shown in the accompanying financial statements as of June 30, 2022, we did not generate sufficient revenue to generate net income, and
have negative working capital as of June 30, 2022. In addition, we have seen a decline in the price of Bitcoin due its volatility, which
could have material and negative impact to our operations. These factors, among others including, but not limited to the changes in inflation,
interest rates and overall economic conditions, may indicate that there is substantial doubt about our ability to continue as a going
concern within one year after issuance of the financial statements for the three months ended June 30, 2022, or August 15, 2022. If we
are unable to meet our financial obligations, we could be forced to restructure or refinance, seek additional equity capital or sell
our assets. We might then be unable to obtain such financing or capital or sell our assets on satisfactory terms. There can be no assurance
that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms.
If we are not able to obtain the additional financing on a timely basis, if and when it is needed, we will be forced to delay or scale
down some or all of our development activities or perhaps even cease the operation of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
outstanding notes, the terms of our preferred stock and certain of our warrants contain provisions that could limit our financing options
and liquidity position or make it difficult to consummate public or private equity offerings, debt financings or corporate collaboration
and licensing arrangements, which would limit our ability to grow our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions in our outstanding notes, the certificates of designation for our Series A Preferred Stock and Series B Preferred Stock and
certain of our warrants impose operating and financial restrictions on us. These restrictions prohibit, make difficult, or limit our
ability to, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
pay cash dividends to our stockholders, subject to various conditions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
redeem or repurchase or otherwise acquire our common stock or other equity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
sell, lease, license, lend or otherwise convey an interest in a material portion of our assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
sell or otherwise issue shares of our common stock or other capital stock, including in equity offerings, subject to certain limited
exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the October 2021 Purchase Agreement pursuant to which we issued the October Secured Notes, until the obligations are paid in full,
the only financings we may pursue are certain equity financings, subject to pricing limitations and conditions. In addition, the securities
purchase agreement contains a &ldquo;most favored nation&rdquo; provision. <I>See &ldquo;&mdash;Risks Related to Our Securities&mdash;Certain
provisions in our debt instruments and Series B Certificate of Designations may require us to issue additional securities to the holders
of such debt instruments and Series B Preferred Stock, which would dilute the interests of other security holders and may depress
the market price of our securities.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Moreover, the Series B Certificate of Designations
and certain of our outstanding warrants contain conversion price or exercise price adjustments upon subsequent public offering of
our securities, subject to certain conditions.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
failure to comply with the restrictions in our debt instruments could result in events of default, which, if not cured or waived, could
result in us being required to repay the borrowings before their due date. If we are forced to refinance these borrowings on less favorable
terms, our results of operations and financial condition could be adversely affected by increased costs and rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
restrictions, as well as certain conversion price adjustments and other anti-dilution features of the Series B Preferred Stock, October
Secured Notes and certain of our warrants, including but not limited to, the potential reset of conversion or exercise prices, as applicable,
and &ldquo;most favored nation&rdquo; provisions, may limit our ability to obtain additional financing on favorable terms to us, or at
all, or make it difficult to consummate public or private equity offerings, debt financings or corporate collaboration and licensing
arrangements, which would limit our ability to grow our business or take advantage of certain business opportunities, all of which could
have an adverse impact on our business and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will require additional capital to fund our operations. Failure to obtain this necessary capital if needed may force us to delay, limit,
or terminate our business plans or our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are considering further increasing the processing power of our cryptocurrency mining operations as we seek to leverage our experience
and expertise in this area of operations. To do so, however, we will need to raise additional capital by debt and/or equity financing,
which may not be available to us on acceptable terms or at all. If we experience a significant and sustained drop in operating profits,
or if there are unanticipated reductions in cash inflows or increases in cash outlays, we may be subject to cash shortfalls. Failure
to generate adequate cash from our operations or find sources of funding would require us to scale back or curtail our operations or
expansion efforts, including limiting our ability to expand the SCI cryptocurrency business to a larger-scale cryptocurrency mining operation,
and would have an adverse impact on our business and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Raising
additional capital through equity or convertible debt securities may cause dilution to your ownership interest in our securities. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may continue to seek funds through equity or debt financings, collaborative or other arrangements with corporate sources, or through
other sources of financing, and the price per share at which we sell additional shares of our common stock or other securities convertible
into or exchangeable into our common stock in future transactions may be higher or lower than the price per share in this offering. To
the extent that we raise additional capital through the issuance and sale of equity or convertible debt securities, your ownership interest
in our securities may be diluted. The exercise or conversion of such securities into shares of common stock, or further shares issued,
may result in further dilution to your ownership interest. Further, we may choose to raise additional capital due to market conditions
or strategic considerations even if we believe we have sufficient funds for our current or future operating plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price per share at which we sell additional shares of our common stock or other securities convertible into or exchangeable into our
common stock in future transactions may be higher or lower than the price per share in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
terms of any financing arrangements we enter into may adversely affect the holdings or the rights of our stockholders and the issuance
of additional securities by us, or the possibility of such issuance, may cause the market price of our shares to decline. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our agreements with investors and our outstanding warrants contain provisions that impose limitations on our ability to participate
in certain variable rate transactions, including at-the-market transactions, which may limit our opportunities to obtain financing in
sufficient amounts or on acceptable terms. The sale of additional equity or convertible debt securities would dilute all of our stockholders,
and if such sales occur at a deemed issuance price that is lower than the current exercise price of certain of our outstanding warrants,
the exercise price for those warrants would adjust downward to the deemed issuance price pursuant to price adjustment protection contained
within those warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
incurrence of indebtedness through credit facilities would result in increased fixed payment obligations and, potentially, the imposition
of restrictive covenants. Those covenants may include limitations on our ability to incur additional debt, making capital expenditures
or declaring dividends, and may impose limitations on our ability to acquire, sell, or license intellectual property rights and other
operating restrictions that could adversely impact our ability to conduct our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we raise additional funds through collaborations, strategic alliances, or licensing arrangements or other marketing or distribution arrangements
with third parties, we may have to relinquish valuable rights to our technologies or future revenue streams on terms that may not be
favorable to us. If we are unable to expand our operations or otherwise capitalize on our business opportunities, our business, financial
condition and results of operations could be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or
terminate our product development or commercialization efforts, or grant others rights to develop and market product candidates that
we would otherwise prefer to develop and market ourselves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not have sufficient cash from our operations to enable us to pay dividends on the Series A Preferred Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
dividends on the Series A Preferred Stock are cumulative, our board of directors must approve the actual payment of the dividends. We
will pay monthly dividends on the Series A Preferred Stock from funds legally available for such purpose when, as and if declared by
the board of directors or any authorized committee thereof. The board of directors can elect at any time or from time to time, and for
an indefinite duration, not to pay any or all accumulated dividends. The board of directors could do so for any reason. The amount of
dividends we can pay depends upon the amount of cash we generate from and use in our operations, which may fluctuate significantly based
on, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    level of our revenues and our results of operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prevailing
    global and regional economic and political conditions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effect of domestic and foreign governmental regulations on the conduct of our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to service and refinance our current and future indebtedness;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to raise additional funds through future offerings of securities to satisfy our capital needs; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to draw on our existing credit facilities and the ability of our lenders to perform their obligations under their agreements
    with us.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if payment of dividends on the Series A Preferred Stock for any dividend period would cause us to fail to comply with any applicable
law, including the requirement under the Nevada Revised Statutes (&ldquo;NRS&rdquo;) that dividends be paid out of surplus or net profits,
we will not declare or pay a dividend for such dividend period. Our ability to pay dividends on the Series A Preferred Stock may also
be restricted or prohibited by the terms of any senior equity securities or indebtedness. The instruments governing the terms or future
financings or refinancing of any borrowings may contain covenants that restrict our ability to pay dividends on the Series A Preferred
Stock. The Series A Preferred Stock places no restrictions on our ability to incur indebtedness with such restrictive covenants. In the
event that the payment of a dividend on the Series A Preferred Stock would cause us to fail to comply with any applicable law or would
be restricted or prohibited by the terms of any senior equity securities or indebtedness, holders of the Series A Preferred Stock will
not be entitled to receive any dividend for that dividend period, and the unpaid dividend will cease to accrue or be payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any shares of Series A Preferred Stock remain outstanding, unless we have also either paid or declared and set part in full the
payment for cumulative dividends on our Series A Preferred Stock for all past completed dividend periods, we may not declare or set apart
for payment any dividends or make any distribution of cash or other property on our common stock or other capital stock ranking junior
or on parity with the Series A Preferred Stock, including our Series B Preferred Stock. We may not have sufficient cash available to
pay dividends on the Series A Preferred Stock or Series B Preferred Stock when such dividends become payable which will in turn prohibit
us from declaring or paying any cash dividend or other distribution to holders of shares of our Series B Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
amount of cash that we will have available for dividends on the Series A Preferred Stock will not depend solely on our profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual amount of cash that we will have available for dividends on the Series A Preferred Stock also depends on many factors, including,
among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our operating cash flow, capital expenditure requirements, working capital requirements and other cash needs; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    under our existing or future credit, capital lease and operating lease facilities or any future debt securities; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount of any reserves established by our board.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of cash that we generate from our operations may differ materially from our net income or loss for the period, which is affected
by non-cash items, and the board in its discretion may elect not to declare any dividends. As a result of these and the other factors
mentioned above, we may pay dividends during periods when we record losses and may not pay dividends during periods when we record net
income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
ability to meet our obligations under the Series A Preferred Stock depends on the earnings and cash flows of our subsidiaries and the
ability of our subsidiaries to pay dividends or advance or repay funds to us.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct all of our business operations through our subsidiaries. In servicing dividend payments to be made on the Series A Preferred
Stock, we will rely on cash flows from these subsidiaries, mainly dividend payments and other distributions. The ability of these subsidiaries
to make dividend payments to us will be affected by, among other factors, the obligations of these entities to their creditors, requirements
of corporate and other law, and restrictions contained in agreements entered into by or relating to these entities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may incur additional indebtedness, which may impact our financial position, cash flow and ability to pay dividends on the Series A Preferred
Stock and Series B Preferred Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 11, 2022, we had total indebtedness of approximately $23.5 million. We may incur additional indebtedness and become more highly
leveraged, which may negatively impact our financial position, cash flow and ability to pay dividends on the Series A Preferred Stock.
Increases in our borrowing could affect our financial condition and make it more difficult for us to comply with the financial covenants
governing our indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
there are no restrictions under our current indebtedness on our ability to pay dividends to the holders of our preferred stock, our future
indebtedness may restrict payments of dividends on the Series A Preferred Stock or Series B Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Series A Preferred Stock and Series B Preferred Stock represent perpetual equity interests.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Preferred Stock and Series B Preferred Stock represent perpetual equity interests in us and, unlike our indebtedness, will not
give rise to a claim for payment of a principal amount at a particular date. As a result, holders of such shares of our preferred
stock may be required to bear the financial risks of an investment in the shares of preferred stock for an indefinite period of time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if the Series A Preferred Stock is delisted from Nasdaq, the ability to transfer or sell shares of the Series A Preferred Stock may be
limited and the market value of the Series A Preferred Stock will likely be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividends
or other payments with respect to the Series A Preferred Stock and Series B Preferred Stock may be subject to withholding taxes in circumstances
where we are not obliged to make gross up payments, and this could result in holders receiving less than expected in such circumstances.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of certain changes to current tax law that require tax to be withheld from dividends or other payments on the Series A Preferred
Stock and Series B Preferred Stock, we are not required to make gross up payments in respect of such taxes. This would result in holders
of Series A Preferred Stock and Series B Preferred Stock receiving less than expected and could materially adversely affect the return
on such holders&rsquo; investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Provisions
of our corporate charter documents, bylaws and certain of our debt instruments may make an acquisition of us or a change in our management
more difficult.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
in our articles of incorporation, as amended (the &ldquo;Articles of Incorporation&rdquo;) and our bylaws (the &ldquo;Bylaws&rdquo;)
may discourage, delay or prevent a merger, acquisition or other change in control of us that our stockholders may consider favorable,
including transactions in which stockholders might otherwise receive a premium for their shares. These provisions could also limit the
price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our
common stock. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current
management by making it more difficult for stockholders to replace members of our board of directors. Because our board of directors
is responsible for appointing the members of our management team, these provisions could in turn affect any attempt by our stockholders
to replace current members of our management team. Among others, these provisions include that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">allow
    the authorized number of directors to be changed by of our board of directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">alter
    our bylaws without obtaining stockholder approval;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorize
    the board of directors to amend the Bylaws;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limit
    who may call stockholder meetings; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    the approval of the holders of a majority of the outstanding shares of our capital stock entitled to vote in order to amend certain
    provisions of our Articles of Incorporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the October Secured Notes, a consolidation, merger or transfer of all or substantially all of our assets or to effect
a change in control of our ownership could constitute events of default, absent a waiver from the Noteholders. If such defaults were
to occur absent a waiver, the holders of the October Secured Notes may elect to declare the outstanding principal amount due under the
October Secured Notes, together with liquidated damages and other amounts payable thereunder, to become immediately due and payable in
cash. Under the Certificate of Designations, Preferences and Rights of our Series A Preferred Stock, filed with the Secretary of State
of the State of Nevada on August 18, 2021, as amended (the &ldquo;Series A Certificate of Designations&rdquo;), upon a change of control,
holders of our Series A Preferred Stock may also elect to convert all or some of their shares into shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the concentration of ownership of our outstanding voting stock held by our directors and officers may delay, defer or prevent a change
in control. As of October 11, 2022, our directors and executive officers held the current right to vote approximately 29.1% of the Company&rsquo;s
outstanding voting stock, and of this total, 24.4% was owned or controlled by Brookstone XXIV, for which Michael Toporek, our Chief Executive
Officer, also serves as Managing General Partner. Our directors and executive officers also have the right to acquire additional shares
of our common stock by exercising their equity awards under our equity compensation plans, which could increase their voting percentage
significantly. As a result, Mr. Toporek acting alone, and/or many of our officers and directors acting together may have the ability
to exert significant control over our decisions and control our management and affairs, including delaying, deferring or preventing a
change in control, impeding a merger, consolidation, takeover or other business combination involving us; or discouraging a potential
acquirer from making a tender offer or otherwise attempting to obtain control of us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we have a classified board of directors, which means that at least two stockholder meetings, instead of one, will be required to effect
a change in the majority control of our board of directors. This applies to every election of directors, not just an election occurring
after a change in control. The classification of our board increases the amount of time it takes to change majority control of our board
of directors and may cause potential acquirers to lose interest in a potential purchase of us, regardless of whether our purchase would
be beneficial to us or our stockholders. The additional time and cost to change a majority of the members of our board of directors makes
it more difficult and may discourage our existing stockholders from seeking to change our existing management in order to change the
strategic direction or our operational performance. As a result of these provisions in our corporate charter documents, bylaws and certain
of our debt instruments, the price investors may be willing to pay in the future for shares of our common stock may be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
provisions in our debt instruments and Series B Certificate of Designations may require us to issue additional securities to the holders
of such debt instruments and Series B Preferred Stock, which would dilute the interests of other security holders and may depress
the market price of our securities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the October 2021 Purchase Agreement and the MFN Provision thereunder, as long as any Noteholder holds any of the October Secured Notes
with a principal amount in excess of $1,500,000, in the event that we issue or sell any common stock or common stock equivalents, if
the Noteholder holding outstanding securities issued pursuant to the October 2021 Purchase Agreement reasonably believes that any of
the terms and conditions of this offering are more favorable than the terms and conditions granted to the Noteholder pursuant to the
October 2021 Purchase Agreement, upon notice to us within five trading days after disclosure of such sale or issuance, we will amend
the terms of the October 2021 Purchaser Agreement as to such Noteholder, only so as to give such Noteholder the benefit of such more
favorable terms or conditions. In the event the Noteholder provides such notice and the terms of the October 2021 Purchase Agreement
are amended as to such Noteholder as a result of this offering, we may need to issue additional securities to such Noteholders, which
could result in further dilution to the investors in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
raise additional capital, we may in the future offer additional shares of common stock or other securities convertible exchangeable,
or exercisable for shares of our common stock at prices and other terms that may be more favorable than the terms offered to the holders
of the October Secured Notes. This may result in additional dilution to our stockholders and could afford our stockholders a smaller
percentage interest in our voting power, liquidation value and aggregate book value. The existence of the MFN Provision may also make
it more difficult for us to consummate future offerings of our securities at a time and a price that we deem appropriate and may trigger
our obligation to obtain stockholder approval in connection with our future offerings under certain Nasdaq Listing Rules and related
guidance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Series B Certificate of Designations contains an anti-dilution provision which, at any time after the October Secured Notes have
been fully redeemed, defeased or converted, subject to limited exceptions, would reduce the conversion price of the Series B Preferred
Stock (and increase the number of shares common stock issuable upon such conversion) to 90% of the VWAP as reported on Nasdaq for the
five consecutive trading days after the effective date of the registration statement registering the resale of the shares of common stock
issuable upon the conversion of the shares of Series B Preferred Stock has been declared effective, and in the event we undertake a public
offering of our common stock or common stock equivalents, upon the completion of the public offering, the conversion price shall be equal
to 90% of the average VWAP reported on Nasdaq for the five consecutive trading days after the completion date of public offering. The
shares of Series B Preferred Stock are initially convertible to 1,155,268 at a conversion price of $5.41 per share and the conversion
price shall in no event be lower than $1.08 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Series B Preferred Stock will not be convertible into shares of our common stock until the October Secured Notes have been
either redeemed in full, defeased or converted. In the event that the average price of our common stock is below the conversion price
of the Series B Preferred Stock at the time such shares may be converted, the number of shares of common stock issuable upon such conversion
would increase, which would dilute the percentage ownership interest of all stockholders, increase the number of our publicly traded
shares and may dilute the book value per share of our common stock, which could depress the market price of our securities regardless
of our business performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Series A Preferred Stock and Series B Preferred Stock have liquidation preferences that are senior to our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment due upon liquidation on the Series A Preferred Stock is fixed at the liquidation preference of $25.00 per share, plus an amount
equal to all accumulated and unpaid dividends thereon to the date of liquidation, whether or not declared. In addition, our Series B
Preferred Stock ranks pari passu with our Series A Preferred Stock and upon any liquidation, dissolution or winding-up is entitled to
the greater of the aggregate stated value of the Series B Preferred Stock or the amount the holder of the Series B Preferred Stock would
be entitled to receive if the Series B Preferred Stock were fully converted to common stock, which amounts shall be paid on par with
all shoulders of our common stock. In the event of our voluntary or involuntary liquidation, dissolution or winding up of our affairs,
the holders of the Series A Preferred Stock and Series B Preferred Stock shall be entitled to receive out of our assets that are legally
available for distribution, prior to and in preference to distributions to the holders of our common stock or classes and series of securities
of the Company which by their terms do not rank senior to the Series A Preferred Stock and Series B Preferred Stock, and either in preference
to or pari passu with the holders of any other series of preferred stock that may be issued in the future that is expressly made senior
or pari passu, as the case may be. After the payment of the liquidation preference to the holders of our Series A Preferred Stock and
payment of the greater of the aggregate stated value of the Series B Preferred Stock or the amount the holder of the Series B Preferred
Stock would be entitled to receive if such shares were converted into shares of common stock, holders of our common stock are entitled
to receive our remaining assets in proportion to the respective number of shares held after payment of and reservation for our liabilities.
There can be no assurance that we will have available assets to pay to the holders of common stock, or any amounts, upon such a liquidation,
dissolution or winding-up of our business and you could lose some or all of your investment. The existence of the liquidation preferences
may reduce the value of our common stock, make it harder for us to sell shares of common stock in offerings in the future, or prevent
or delay a change of control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
may be future sales of Series A Preferred Stock, Series B Preferred Stock or securities convertible into common stock, which may adversely
affect the market price of our common stock and Series A Preferred Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of the October Secured Notes, the certificates of designations of our Series A and Series B Preferred Stock, our Articles
of Incorporation and the NRS, we are not restricted from issuing additional shares of Series A Preferred Stock, Series B Preferred Stock
or securities convertible into common stock. The market price of our common stock and Series A Preferred Stock could decline as a result
of sales of Series A Preferred Stock, Series B Preferred Stock, or securities convertible into common stock made after this offering,
or as a result of the perception that such sales could occur. Because our decision to issue securities in any future offering will depend
on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of any future offerings.
Thus, holders of our common stock and our Series A Preferred Stock bear the risk of our future offerings or sales, or the perception
that such offerings or sales may occur, of our Series A Preferred Stock, Series B Preferred Stock or securities convertible into common
stock reducing the market price of our common stock and Series A Preferred Stock and diluting their holdings. Future sales of our Series
A Preferred Stock, Series B Preferred Stock, or securities convertible into common stock could additionally result in further dilution
to your shares of common stock or Series A Preferred Stock in the event such shares of preferred stock are converted into shares of common
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may incur additional indebtedness and obligations to pay dividends on our preferred stock, some of which may be senior to the rights
of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may, subject to certain limitations, incur additional indebtedness and obligations to pay cumulative dividends on preferred stock, some
of which may be senior to the rights of our common stock. Subject to certain limitations, the certificates of designations of our Series
A Preferred Stock and Series B Preferred Stock do not prohibit us or our subsidiaries from incurring additional indebtedness or issuing
additional series of preferred stock. Any such indebtedness will in all cases be senior to the rights of holders of our common stock.
We may also issue additional series of preferred stock that contain dividend rights and liquidation preferences that are senior to the
rights of holders of our common stock. If we issue any additional preferred stock that ranks senior or pari passu with the Series A Preferred
Stock and Series B Preferred Stock, the holders of those shares will be entitled to a senior or ratable share with the holders of the
Series A Preferred Stock and Series B Preferred Stock in any proceeds distributed in connection with our insolvency, liquidation, reorganization
or dissolution. This may have the effect of reducing the amount of proceeds paid to the holders of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the This Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
may experience immediate and substantial dilution.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
public offering price per share in this offering may exceed the net tangible book value per share of our common stock outstanding prior
to this offering, in which case you may incur an immediate and substantial dilution in the net tangible book value of the shares of common
stock you purchase in this offering. After giving effect to the sale by us of (i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares
of our common stock at the public offering price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, and after deducting
underwriting discounts and commissions and estimated offering expenses payable by us, (ii) the concurrent private placement of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of common stock at the offering price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, and (iii) conversion of
the Note at a conversion price equal to the public offering price per share, you will experience immediate dilution of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share, representing the difference between the public offering price per share and our pro forma as adjusted net tangible book value
per share as of June 30, 2022 after giving effect to the pro forma adjustments and this offering. The exercise of warrants, conversion
of convertible securities, including the October Secured Notes, the exercise of outstanding stock options, vesting of other stock
awards and the issuance of shares of common stock equal to 10% of the capital raised from this offering, the Note and the concurrent
private placement to the holder of the Series B Certificate of Designations with respect to certain consent requirements, upon closing
of this offering and the concurrent private placement, may result in further dilution of your investment. See the section titled
&ldquo;Dilution&rdquo; on page S-19 in this prospectus supplement for a more detailed illustration of the dilution you would incur if
you participate in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price of our securities are likely be volatile, which may cause investment losses for our shareholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our securities has been and is likely to continue to be volatile, and investors in our securities may experience a decrease,
which could be substantial, in the value of their securities or the loss of their entire investment in us for a number of reasons, including
reasons unrelated to our operating performance or prospects. The market price of our securities could be subject to wide fluctuations
in response to a broad and diverse range of factors, including those described elsewhere in this &ldquo;Risk Factors&rdquo; section as
well as the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us regarding liquidity, significant acquisitions, equity investments and divestitures, addition or loss of significant customers
    and contracts, capital expenditure commitments and litigation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    issuance of securities or debt, particularly if in connection with acquisition activities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sale of a significant number of shares of our common stock by shareholders;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recent
    changes in financial condition or results of operations, such as in earnings, revenues or other measure of company value;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">volatility
    resulting from the economic turmoil caused by, but not limited to, the ongoing COVID-19 pandemic, the continuing armed conflict between
    Russia and Ukraine crisis and rising global inflation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    success of existing or new competitive products or technologies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of technological innovations or new product introductions by us or our competitors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    or legal developments in the United States and other countries;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    or disputes concerning patent applications, issued patents or other proprietary rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    recruitment or departure of key personnel;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated changes in estimates as to financial results or development timelines;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcement
    or expectation of additional financing efforts;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of our common stock by us, our insiders or other stockholders;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
    in our financial results or those of companies that are perceived to be similar to us;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in estimates or recommendations by securities analysts, if any, that cover us; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic, industry and market conditions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
broad market and industry factors may have a material adverse effect on the market price of our securities regardless of our actual operating
performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, stock markets have experienced in the past and may in the future experience a high level of price and volume volatility, and
the market prices of equity securities of many companies have experienced in the past and may in the future experience wide price fluctuations
not necessarily related to the operating performance of such companies. These broad market fluctuations may adversely affect the market
price of our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
our relatively small public float and daily trading volume have in the past caused, and may in the future result in, significant volatility
in the price of our securities. On October 11, 2022, we had approximately 10,736,844 shares of our common stock outstanding held by non-affiliates
and 3,055,190 shares of our Series A Preferred Stock held by non-affiliates. Our daily trading volume as of October 11, 2022 averaged
approximately 97,147 shares of common stock and 18,510 shares of Series A Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of this volatility, you may not be able to sell your common stock at or above the public offering price and you may lose some
or all of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
we will have broad discretion and flexibility in how the net proceeds from this offering are used, we may use the net proceeds in ways
in which you disagree or which may not yield a significant result. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management will have broad discretion over the use of proceeds from this offering. We currently intend to use the net proceeds of this
offering as described in the section entitled &ldquo;Use of Proceeds&rdquo; on page S-17. However, our management will have broad discretion
in the application of the net proceeds from this offering and could use them for purposes other than those contemplated at the time of
this offering. Accordingly, you are relying on the judgment of our management with regard to the use of these net proceeds, and you will
not have the opportunity, as part of your investment decision, to assess whether the proceeds will be used appropriately. The failure
by management to apply these funds effectively could result in financial losses that could have a material adverse effect on our business
and cause the price of our common stock to decline. Pending their use, we may invest the net proceeds from this offering in short-term,
interest-bearing debt instruments or bank deposits. These investments may not yield a favorable return, or any return, to us or our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
may experience future dilution as a result of future equity offerings and other issuances of our securities. In addition, this offering
and future equity offerings and other issuances of our common stock or other securities may adversely affect the price of our common
stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to raise additional capital, we may in the future offer additional shares of common stock or other securities convertible into
or exchangeable for our common stock prices that may not be the same as the price per share in this offering. We may not be able to sell
shares or other securities in any other offering at a price per share that is equal to or greater than the price per share paid by investors
in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders.
The price per share at which we sell additional shares of common stock or securities convertible into shares of common stock in future
transactions may be higher or lower than the price per share in this offering. You will incur dilution upon exercise of any outstanding
stock options, warrants or other convertible securities or upon the issuance of shares of common stock under our stock incentive programs.
In addition, the sale of shares of common stock in this offering and any future sales of a substantial number of shares of common stock
in the public market, or the perception that such sales may occur, could adversely affect the price of our common stock. We cannot predict
the effect, if any, that market sales of those shares of common stock or the availability of those shares for sale will have on the market
price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to require additional capital in the future in order to finance our operations. If we do not obtain any such additional financing,
it may be difficult to effectively realize our long-term strategic goals and objectives and we may be forced to forego certain strategic
opportunities. Any additional capital raised through the sale of equity or equity-backed securities may dilute our stockholders&rsquo;
ownership percentages and could also result in a decrease in the market value of our equity securities. Conversion price adjustments
and other anti-dilution features of the Series B Preferred Stock, October Secured Notes and certain of our warrants, including but not
limited to, the potential reset of conversion or exercise prices, as applicable, and &ldquo;most favored nation&rdquo; provisions, may
trigger obligations for us to issue additional securities that may result in further dilution to your shares of common stock. See &ldquo;<I>&mdash;Risks
Related to Our Securities&mdash;Certain provisions in our debt instruments and Series B Certificate of Designations may require us to
issue additional securities to the holders of such debt instruments and securities, which would dilute the interests of other security
holders and may depress the market price of our securities.&rdquo;</I> on page S-11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of any securities issued by us in future capital transactions may be more favorable to new investors, and may include preferences,
superior voting rights and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders
of any of our securities then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting
fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash
expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial
condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not intend to pay dividends on our common stock, so any returns will be limited to the value of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid cash dividends on our common stock, and do not anticipate paying any cash dividends in the foreseeable future but intend
to retain our capital resources for reinvestment in our business. In addition, the October Secured Notes prohibit us from declaring or
paying any dividend or other distribution to holders of shares of common stock. Further, we are currently restricted in our ability to
pay dividends on common stock pursuant to the terms of the Series A Certificate of Designations, unless we have paid or declared full
cumulative dividends on the Series A Preferred Stock for all past completed dividend periods. If we do not pay dividends, our common
stock may be less valuable because stockholders must rely on sales of their common stock after price appreciation, which may never occur,
to realize any gains on their investment. See &ldquo;Dividend Policy&rdquo; on page S-18.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
sale of our common stock in this offering and any future sales of our common stock, or the perception that such sales could occur, may
depress our stock price and our ability to raise funds in new stock offerings.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may from time to time issue additional shares of common stock at a discount from the current trading price of our common stock. In addition,
as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance of debt
securities, preferred stock or common stock. Sales of shares of our common stock in this offering, or the perception that such sales
could occur, or the reset of any exercise or conversion prices in our outstanding warrants and convertible notes and subsequent exercise
or conversion of such securities for shares of our common stock, may lower the market price of our common stock and may make it more
difficult for us to sell equity securities or equity-related securities in the future at a time and price that our management deems acceptable,
or at all. See <I>&ldquo;&mdash;Risks Related to Our Securities&mdash; We will require additional capital to fund our operations. Failure
to obtain this necessary capital if needed may force us to delay, limit, or terminate our business plans or our operations&rdquo;</I>
on page S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_004"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement, the accompanying base prospectus and the documents incorporated by reference into this prospectus supplement and
the accompanying base prospectus, and the documents that we reference herein and therein and have filed as exhibits to the Registration
Statement, including the sections entitled &ldquo;Risk Factors,&rdquo; contain &ldquo;forward-looking statements&rdquo; within the meaning
of Section 21(E) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) and Section 27A of the Securities
Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). These forward-looking statements include, without limitation: statements
regarding proposed new products or services; statements concerning litigation or other matters; statements concerning projections, predictions,
expectations, estimates, or forecasts for our business, financial and operating results and future economic performance; statements of
management&rsquo;s goals and objectives; statements concerning our competitive environment, availability of resources and regulation;
trends affecting our financial condition, results of operations or future prospects; our financing plans or growth strategies; and other
similar expressions concerning matters that are not historical facts. Words such as &ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;should&rdquo;,
&ldquo;could&rdquo;, &ldquo;would&rdquo;, &ldquo;predicts&rdquo;, &ldquo;potential&rdquo;, &ldquo;continue&rdquo;, &ldquo;expects&rdquo;,
&ldquo;anticipates&rdquo;, &ldquo;future&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;, &ldquo;believes&rdquo; and &ldquo;estimates,&rdquo;
and variations of such terms or similar expressions, are intended to identify such forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the
times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available
at the time they are made and/or management&rsquo;s good faith belief as of that time with respect to future events and are subject to
risks and uncertainties that could cause actual performance or results to differ materially from what is expressed in or suggested by
the forward-looking statements. The sections in this prospectus supplement and the accompanying base prospectus entitled &ldquo;Risk
Factors&rdquo; and the sections in our periodic reports, including the sections entitled &ldquo;Business&rdquo; and &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; in our most recent Annual Report on Form 10-K and subsequent
Quarterly Reports on Form 10-Q filed with the SEC, as well as other sections in this prospectus supplement, the accompanying base prospectus
and the documents or reports incorporated by reference herein and therein, and any other prospectus supplement and the documents that
we reference herein and therein and have filed as exhibits to the Registration Statement, discuss some of the factors that could contribute
to these differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements speak only as of the date they are made. You should not put undue reliance on any forward-looking statements. We assume no
obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting
forward-looking information, except to the extent required by applicable securities laws. If we do update one or more forward-looking
statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
Investors should review our subsequent reports filed with the SEC described in the sections entitled &ldquo;Where You Can Find More Information&rdquo;
and &ldquo;Incorporation of Certain Information by Reference&rdquo; of this prospectus supplement and the accompanying base prospectus
and incorporated by reference into herein and therein, and the documents that we reference herein and therein and have filed as exhibits
to the Registration Statement, all of which are accessible on the SEC&rsquo;s website at <I>www.sec.gov</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_005"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
no exercise of the underwriter&rsquo;s over-allotment option, and the sale of all securities sold in this offering and the
concurrent private placement, we estimate that the net proceeds from this offering and the concurrent private placement will be
approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , after deducting estimated underwriting discounts and
commissions and estimated offering fees and expenses of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; payable
by us. Assuming the same, if the underwriter&rsquo;s over-allotment option is exercised in full, we estimate that our net proceeds
from this offering and the concurrent private placement will be approximately $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; . However, we can offer no assurance that the concurrent private placement
will close, and if it does not close, based on the same assumptions above, we estimate that the net proceeds from this offering will
be approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , after deducting estimated underwriting discounts and
commissions and estimated offering fees and expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds of this offering and the concurrent private placement for the acquisition, development and growth of data
centers, including cryptocurrency mining processors, other computer processing equipment, data storage, electrical infrastructure, software
and real property (<I>i.e. </I>land and buildings) and business, including but not limited to the Project Dorothy facility, and for working
capital and general corporate purposes, which include, but are not limited to, operating expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts and timing of any expenditures will vary depending on the amount of cash generated by our operations, and the rate of growth,
if any, of our business, and our plans and business conditions. The foregoing represents our intentions as of the date of this prospectus
supplement based upon our current plans and business conditions to use and allocate the net proceeds of the offering. However, our management
will have significant flexibility and discretion in the timing and application of the net proceeds of the offering. Unforeseen events
or changed business conditions may result in application of the proceeds of the offering in a manner other than as described in this
prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that the net proceeds we receive from the offering are not immediately applied for the above purposes, we plan to invest the
net proceeds in short-term, interest-bearing debt instruments or bank deposits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_006"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect to pay or declare any cash dividends on our common stock for the foreseeable future. We expect to retain our future earnings,
if any, for use in the operation of our business, including the repayment of our outstanding indebtedness. Consequently, investors must
rely on sales of their common stock after price appreciation, which may never occur, as the primary way to realize any future gains on
their investment. There is no guarantee that shares of our common stock will appreciate in value or even maintain the price at which
our stockholders have purchased their shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the October Secured Notes prohibit us from declaring or paying any dividend or other distribution to holders of shares of common stock.
Further, we are currently restricted in our ability to pay dividends on common stock pursuant to the terms of the Series A Certificate
of Designations unless we have paid or declared full cumulative dividends on the Series A Preferred Stock for all past completed dividend
periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to pay future dividends will depend upon, among other factors, our cash balances and potential future capital requirements, debt
service requirements, earnings, financial condition, the general economic and regulatory climate and other factors beyond our control
that our board of directors may deem relevant. Investors should not purchase our common stock with the expectation of receiving cash
dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="ah_007"></A>Dilution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our securities in this offering, your ownership interest will be diluted to the extent of the difference between the public
offering price per share of our common stock in this offering and the pro forma as adjusted net tangible book value per share of our
common stock immediately after this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net tangible book value as of June 30, 2022, was approximately $65.4 million, or $4.64 per share of our common stock, based upon 14,104,145
shares of our common stock outstanding as of that date. Net tangible book value per share is determined by dividing our total tangible
assets, less total liabilities, by the number of shares of our common stock outstanding as of June 30, 2022. Dilution in net tangible
book value per share represents the difference between the amount per share paid by purchasers of shares of common stock in this offering
and the net tangible book value per share of our common stock immediately after this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to: (i) the conversion of an aggregate of $1,100,000 of the October Secured Notes into 293,350 shares of common stock subsequent
to June 30, 2022, pursuant to the Addendum, (ii) the exchange of Class C warrants for 296,013 shares of common stock in July 2022, (iii)
the issuance of the Series B Preferred Stock and accompanying warrants for the aggregate purchase price of $5,000,000 in July 2022, (iv)
the increase in the aggregate principal amount of the October Secured Notes in September 2022 pursuant to the Addendum Amendment, (v)
the exchange of Class B warrants for 430,564 shares of common stock in September 2022, and (vi) the issuance of the Note to Spring Lane
in the principal amount of $850,000 (collectively, the &ldquo;Pro Forma Adjustments&rdquo;), our pro forma net tangible book value as
of June 30, 2022 would have been approximately$71.8 million, or approximately $5.10 per share of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving further effect to (i) the sale of shares of our common stock in this offering at a public offering price of $ per share, and after
deducting the underwriter&rsquo;s discounts and commissions and estimated offering expenses payable by us in this offering, (ii) the
concurrent private placement, and (iii) the issuance of an aggregate of shares of common stock pursuant to the automatic conversion of
the Note, our pro forma as adjusted net tangible book value as of June 30, 2022, would have been approximately $ million, or $ per share.
This represents an immediate increase in net tangible book value of $ per share to existing stockholders and immediate dilution of $
per share to new investors. The following table illustrates this dilution on a per share basis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%">Public offering price per share</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Historical net tangible book value per share as of June 30, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.64</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Increase in net tangible book value per share attributable to the Pro Forma Adjustments:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.46</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Pro forma net tangible book value per share as of June 30, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5.10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Increase in pro forma net tangible book value per share attributable to this offering, the concurrent private placement and the automatic conversion of the Note</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Pro forma as adjusted net tangible book value per share as of June 30, 2022 after giving effect to this offering, the concurrent private placement and the automatic conversion of the Note</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dilution in net tangible book value per share to new investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the underwriter exercises in full its option to purchase up to an additional shares of our common stock, the pro forma as adjusted
net tangible book value per share after this offering would be $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share,
representing an increase in pro forma net tangible book value of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share to our existing stockholders and immediate dilution in net tangible book value of $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to new investors purchasing securities in this
offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing discussion and the table does not give effect to the potential issuance of additional securities to the Noteholders pursuant
to the MFN Provision or issuance of the shares of common stock equal to 10% of the capital raised from this offering, the Note and
the concurrent private placement to the holder of the Series B Certificate of Designations with respect to certain consent requirements,
upon closing of this offering and the concurrent private placement, which could result in further dilution to the investors in this
offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that outstanding options or warrants are exercised, you may experience further dilution. In addition, we may choose to raise
additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or
future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the
issuance of these securities could result in further dilution to our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table and discussion above are based on 14,104,145 shares of common stock issued and outstanding as of June 30, 2022, and excludes, as
of that date, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,061,245
    shares of Series A Preferred Stock issued and outstanding; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,479,908
    shares of common stock issuable upon conversion of the October Secured Notes, pursuant to the conversion terms described under &ldquo;<I>Prospectus
    Supplement Summary&mdash;Convertible Secured Notes</I>&rdquo;; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">898,600
    shares of common stock issuable upon the exercise of stock options outstanding at a weighted average exercise price of $5.92 per
    share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,033,266
    shares of common stock issuable upon the exercise of warrants outstanding at a weighted average exercise price of $10.44 per share,
    excluding warrants exchanged into common stock after June 30, 2022, described as Pro Forma Adjustments above;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">773,554
    shares of common stock issuable upon the vesting of restricted stock units; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,324
    shares of common stock reserved for future issuance under the 2021 Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_008"></A>DESCRIPTION
OF SECURITIES WE ARE OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following summary of the rights of our capital stock is not complete and is subject to and qualified in its entirety by reference to
our Articles of Incorporation and Bylaws, copies of which are filed as exhibits to our Annual Report on Form 10-K for the year ended
December 31, 2021, filed with the SEC on March 31, 2022, and the Certificate of Designations and forms of securities, copies of which
are filed as exhibits to the Registration Statement of which this prospectus supplement forms a part, and which are incorporated by reference
herein.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Articles of Incorporation authorizes us to issue up to 85,000,000 shares of stock, consisting of 75,000,000 shares of common stock, par
value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share, of which 6,040,000 shares were classified
as shares of Series A Preferred Stock and 187,500 shares were classified as Series B Preferred Stock as of October 11, 2022. As of October
11, 2022, we had 15,214,617shares of common stock issued and outstanding, 3,061,245 shares of Series A Preferred Stock issued and outstanding
and 62,500 shares of Series B Preferred Stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material terms and provisions of our common stock are described under the caption &ldquo;Description of Capital Stock &ndash; Common
Stock&rdquo; in the accompanying base prospectus and are incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_009"></A>UNDERWRITING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Univest
Securities, LLC is acting as the representative of the underwriters of this offering. We intend to enter into an underwriting agreement,
dated , 2022, with the Representative in connection with this offering. Subject to the terms and conditions of the underwriting agreement,
we intend to agree to sell to each underwriter named below, and each underwriter named below intends to severally agree to purchase,
at the public offering price, less the underwriting discounts set forth on the cover page of this prospectus supplement, the number of
shares of common stock listed next to its name in the following table:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; text-align: justify">Univest Securities, LLC</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting agreement provides that the obligations of the underwriters to pay for and accept delivery of the shares of common stock
offered by this prospectus supplement are subject to various conditions and representations and warranties, including the approval of
certain legal matters by their counsel and other conditions specified in the underwriting agreement. The shares of common stock are offered
by the underwriters, subject to prior sale, when, as and if issued to and accepted by them. The underwriters reserve the right to withdraw,
cancel or modify the offer to the public and to reject orders in whole or in part. The underwriters are obligated to take and pay for
all of the shares of common stock offered by this prospectus supplement if any such shares of common stock are taken, other than those
shares of common stock covered by the over-allotment option described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the underwriting agreement, we will agree to indemnify each underwriter against certain liabilities, including certain liabilities
arising under the Securities Act or to contribute to payments that an underwriter may be required to make for these liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the form of underwriting agreement will be filed as an exhibit to a Current Report on Form 8-K to be filed by us with the SEC,
which is incorporated by reference into the registration statement of which this prospectus supplement and accompanying base prospectus
forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
of the Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will negotiate the offering price per share of common stock offered in this offering with the Representative. The factors to be considered
in determining the offering price per share of common stock offered in this offering will include the general condition of the securities
market at the time of this offering, the history of, and the prospects, for the industry in which we compete, our past and present operations,
and our prospects for future revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-Allotment
Option</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to grant an option to the Representative exercisable for forty-five (45) days after the date of the closing of this offering,
to purchase up to additional shares of common stock (representing 15% of the number of the shares of common stock sold in this offering),
on the same terms and conditions as the shares of common stock being offered in this offering, solely to cover over-allotments, if any.
The Representative is not required to take or pay for the shares of common stock covered by the Representative&rsquo;s option to purchase
additional shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriting
Discounts and Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding the amount of discounts to be paid to the underwriters by us, before expenses:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Per<BR> Share</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total<BR> without<BR> exercise of over-<BR> allotment<BR> option</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total<BR> with full<BR> exercise of<BR> over-<BR> allotment<BR> option</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%">Public offering price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds, before expenses, to us</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.6in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have agreed to sell the shares of common stock to the underwriters at a public offering price of $
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock, which represents the public offering price of such
    shares of common stock set forth on the cover page of this prospectus, less the applicable 8.0% underwriting discount.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
estimate that the total expenses payable by us for this offering, excluding the underwriting discounts, will be approximately $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , whether or not the over-allotment is exercised, in full, by the
underwriters, which amount includes (i) reimbursement of the out-of-pocket accountable expenses of the Representative up to $125,000
being paid by us and (ii) other estimated Company expenses of approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which includes legal accounting printing costs and
various fees associated with the registration of our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
stated above, we have agreed to reimburse the Representative up to a maximum of $125,000 for out-of-pocket accountable expenses, including,
but not limited to, travel, due diligence expenses, reasonable fees and expenses of its legal counsel, accountable roadshow expenses,
and background checks on our principal shareholders, directors and officers; provided that any expense over $ shall require our prior
written or email approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Representative has advised us that the underwriters propose to offer the shares of common stock to the public at the public offering
price per share set forth on the cover page of this prospectus supplement. The underwriters may offer shares to securities dealers at
that price less a concession of up to $ per share. After the offering to the public, the public offering price and other selling terms
may be changed by the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representative&rsquo;s
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to issue to the Representative, upon the closing of this offering, the Representative&rsquo;s Warrants to purchase up to
an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock, or
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock if the
over-allotment is exercised in full (5% of the aggregate number of shares of common stock sold in this offering). The
Representative&rsquo;s Warrants will have an exercise price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share of common stock, which is 110% of the public offering price per share of common stock in this offering. The
Representative&rsquo;s Warrants are exercisable at any time and from time to time, in whole or in part, during the four and one half
year period commencing 180 days from the commencement of sales of the shares of common stock in this offering and expire on the date
that is five years following the commencement of sales of the shares of common stock in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Representative&rsquo;s Warrants are deemed underwriter&rsquo;s compensation by the Financial Industry Regulation Authority (&ldquo;FINRA&rdquo;)
and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e). The Representative (or permitted assignees under Rule
5110(e)(2)(B)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the shares of common stock underlying these
warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic
disposition of the warrants or the underlying shares of common stock for a period of 180 days from the date of the commencement of sales
of the shares of common stock offered hereby. In addition, the Representative&rsquo;s Warrants provide for registration rights upon request,
in certain cases. The demand registration right provided will not be greater than five years from the date of the commencement of sales
of such shares of common stock in compliance with FINRA Rule 5110(g)(8)(C). We will bear all fees and expenses attendant to registering
the shares of common stock issuable on exercise of the Representative&rsquo;s Warrants other than underwriting commissions incurred and
payable by the holders. The exercise price and number of shares of common stock issuable upon exercise of the Representative&rsquo;s
Warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization,
merger, or consolidation. The Representative&rsquo;s Warrants will be exercisable for cash or on a cashless basis if no registration
statement is available for resale of the shares of common stock issuable pursuant to the Representative&rsquo;s Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
of First Refusal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to grant the Representative, for the 12-month period following the closing of this offering, a right of first refusal to
provide investment banking services to us on an exclusive basis in all matters for which investment banking services are sought by us
(the &ldquo;Right of First Refusal&rdquo;), which right is exercisable in the Representative&rsquo;s sole discretion. In accordance with
FINRA Rule 5110(g)(6)(A)(i), such <FONT STYLE="background-color: white">Right</FONT> of First Refusal does not have a duration of more
than three years from the commencement of sales of the public offering or the termination date of the engagement between the us and the
underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stabilization,
Short Positions and Penalty Bids</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters may engage in stabilizing transactions for the purpose of pegging, fixing or maintaining the price of our shares of common
stock. Stabilizing transactions permit bids to purchase the underlying shares of common stock so long as the stabilizing bids do not
exceed a specific maximum. These stabilizing transactions may have the effect of raising or maintaining the market price of our common
stock or preventing or retarding a decline in the market price of our shares of common stock. As a result, the price of our shares of
common stock may be higher than the price that might otherwise exist in the open market. Neither we nor the underwriters make any representation
or prediction as to the effect that stabilizing transactions may have on the price of our shares of common stock. These transactions
may be effected on Nasdaq, in the over-the-counter market or on any other trading market and, if commenced, may be discontinued at any
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, the underwriters also may engage in passive market making transactions in our shares of common stock in
accordance with SEC Regulation M. In general, a passive market maker must display its bid at a price not in excess of the highest independent
bid for that security. However, if all independent bids are lowered below the passive market maker&rsquo;s bid that bid must then be
lowered when specific purchase limits are exceeded. Passive market making may stabilize the market price of such securities at a level
above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the underwriters make any representations or predictions as to the direction or magnitude of any effect that the transactions
described above may have on the price of our shares of common stock. In addition, neither we nor the underwriters make any representations
that the underwriters will engage in these transactions or that any transactions, once commenced will not be discontinued without notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on Nasdaq under the symbol &ldquo;SLNH&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Offer, Sale and Distribution of Shares of common stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prospectus supplement and accompanying base prospectus in electronic format may be made available on the websites maintained by one or
more underwriters or selling group members, if any, participating in this offering. The underwriters may agree to allocate a number of
shares of common stock to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions
will be allocated by the representative to underwriters and selling group members that may make internet distributions on the same basis
as other allocations. Other than the prospectus supplement and accompanying base prospectus in electronic format, the information on
the underwriters&rsquo; websites and any information contained in any other website maintained by the underwriters is not part of this
prospectus supplement and accompanying base prospectus or the registration statement of which this prospectus supplement and accompanying
base prospectus form a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Conflicts of Interest</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters and their affiliates may, from time to time, engage in transactions with and perform services for us in the ordinary course
of their business for which they may receive customary fees and reimbursement of expenses. In the ordinary course of their various business
activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities
(or related derivative securities) and financial instruments (including bank loans) for their own accounts and for the accounts of their
customers and such investment and securities activities may involve our securities and/or instruments. The underwriters and their affiliates
may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments
and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 9, 2022, we entered into an At-the-Market Issuance Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with the Representative pursuant
to which we may sell, at our option, up to an aggregate of $10,000,000 in shares of our 9.0% Series A Cumulative Perpetual Preferred
Stock, par value $0.001 per share, with a $25.00 liquidation preference per share through the Representative, as sales agent. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of the Sales Agreement, the Representative may sell the shares, if any, only by methods deemed to be an &ldquo;at
the market&rdquo; offering as defined in Rule 415 promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Sales Agreement, we provided the Representative with customary indemnification rights, including indemnification
against certain liabilities under the Securities Act and agreed to pay the Representative a commission in cash equal to 3% of the gross
proceeds from the sale of the shares under the Sales Agreement, if any. Either party may terminate the Sales Agreement in its sole discretion
at any time upon written notice to the other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 26, 2022, we entered into an underwriting agreement with the Representative in connection with a firm commitment underwritten offering
(the &ldquo;April 2022 Offering&rdquo;). <FONT STYLE="background-color: white">On April 29, 2022, we initially closed the April 2022
Offering whereby we issued and sold 525,714 shares of our Series Preferred Stock for aggregate gross proceeds of approximately $9.2 million
less underwriting discounts of 7.0% (approximately $0.6 million) payable to the Representative and other offering fees and expenses,
resulting in aggregate net proceeds to us approximately $8.56 million. On May 24, 2022, we sold an additional 73,518 shares of Series
A Preferred Stock in the April 2022 Offering pursuant to the partial exercise of the underwriter&rsquo;s over-allotment option resulting
in additional gross proceeds of approximately $1.3 million less underwriting discounts of 7.0% (approximately $90,000) payable to the
Representative. In connection with this offering, we issued underwriter&rsquo;s warrants to the Representative to purchase shares of
our common stock equal to 5% of the shares issued in the April 2022 Offering. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we agreed to pay the Representative a structuring fee of $300,000 in connection with the closing of the April 2022 Offering,
which is in addition to any reimbursement of out-of-pocket accountable expenses stated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters and certain of their affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment,
hedging, financing and brokerage activities. Some of the underwriters and certain of their affiliates may in the future engage in investment
banking and other commercial dealings in the ordinary course of business with us and our affiliates, for which they may in the future
receive customary fees, commissions and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in the ordinary course of their business activities, the underwriters and their affiliates may make or hold a broad array of
investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank
loans) for their own account and for the accounts of their customers. Such investments and securities activities may involve securities
and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish
or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that
they acquire, long and/or short positions in such securities and instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling
Restrictions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
action has been taken in any jurisdiction (except in the United States) that would permit a public offering of our common stock, or the
possession, circulation or distribution of this prospectus supplement and accompanying base prospectus or any other material relating
to us or the common stock offered hereby, where action for that purpose is required. Accordingly, the common stock offered hereby may
not be offered or sold, directly or indirectly, and neither this prospectus supplement and accompanying base prospectus, nor any other
offering material or advertisements in connection with the common stock may be distributed or published, in or from any country or jurisdiction
except in compliance with any applicable rules and regulations of any such country or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Canada.
</I></B>The shares of common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited
investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and
are permitted clients, as defined in National Instrument 31-103 <I>Registration Requirements, Exemptions and Ongoing Registrant Obligations</I>.
Any resale of the common stock must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus
requirements of applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
(including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by
the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s province or territory. The purchaser
should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s province or territory for particulars
of these rights or consult with a legal advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section 3A.4) of
National Instrument 33-105 <I>Underwriting Conflicts</I> (&ldquo;NI 33-105&rdquo;), the underwriters are not required to comply with
the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>People&rsquo;s
Republic of China</I></B>. This prospectus supplement and accompanying base prospectus have not been and will not be circulated or distributed
in the PRC, and the shares of common stock may not be offered or sold, and will not be offered or sold to any person for re-offering
or resale, directly or indirectly, to any resident of the PRC except pursuant to applicable laws and regulations of the PRC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_010"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the issuance of the securities offered hereby will be passed upon for us by Haynes and Boone, LLP, New York, New York. Certain
legal matters will be passed upon for the underwriter by Blank Rome LLP, New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_011"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of Soluna Holdings, Inc. as of and for the year ended December 31, 2021 incorporated into this prospectus
supplement and the accompanying base prospectus by reference to our Annual Report on Form 10-K for the fiscal year ended December 31,
2021, have been audited by UHY LLP, an independent registered public accounting firm, as stated in their report thereon, which are incorporated
by reference herein in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of Soluna Holdings, Inc. as of and for the year ended December 31, 2020 incorporated into this prospectus
supplement and the accompanying base prospectus by reference to our Annual Report on Form 10-K for the fiscal year ended December 31,
2020, have been audited by Wojeski &amp; Company, CPAs, P.C., an independent registered public accounting firm, as stated in their report
thereon, which are incorporated by reference herein in reliance upon such report and upon the authority of such firm as experts in accounting
and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_012"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement and the accompanying base prospectus constitutes a part of the Registration Statement on Form S-3 filed under the
Securities Act. As permitted by the SEC&rsquo;s rules, this prospectus supplement and the accompanying base prospectus forming a part
of the Registration Statement, and any other supplements or amendments thereto, do not contain all of the information that is included
in the Registration Statement. You will find additional information about us in the Registration Statement. Any statements made in this
prospectus supplement concerning legal documents are not necessarily complete and you should read the documents that are filed as exhibits
to the Registration Statement or otherwise filed with the SEC for a more complete understanding of the document or matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the
public at no cost from the SEC&rsquo;s website at http://www.sec.gov. Our corporate website is <I>www.solunacomputing.com</I>. The information
on our corporate website is not incorporated by reference in this prospectus supplement and the accompanying base prospectus forming
a part of the Registration Statement, or any other supplements or amendments thereto, and the documents incorporated by reference herein
and therein, and you should not consider it a part of this prospectus supplement and the accompanying base prospectus, Registration Statement
or such other supplements, amendments or documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ah_013"></A>INCORPORATION
OF DOCUMENTS BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed a Registration Statement on Form S-3 with the SEC under the Securities Act. This prospectus supplement and the accompanying
base prospectus is part of the Registration Statement, but the Registration Statement includes and incorporates by reference additional
information and exhibits. The SEC permits us to &ldquo;incorporate by reference&rdquo; the information contained in documents that we
file with the SEC, which means that we can disclose important information to you by referring you to those documents rather than by including
them in this prospectus supplement and the accompanying base prospectus. Information that is incorporated by reference is considered
to be part of this prospectus supplement and the accompanying base prospectus and you should read it with the same care that you read
this prospectus supplement and the accompanying base prospectus. Information that we file later with the SEC will automatically update
and supersede the information that is either contained, or incorporated by reference, in this prospectus supplement and the accompanying
base prospectus, and will be considered to be a part of this prospectus supplement and the accompanying base prospectus from the date
those documents are filed. We have filed with the SEC, and incorporate by reference in this prospectus supplement and the accompanying
base prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on Form 10-K for the fiscal year ended <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000384/g082656_10k.htm" STYLE="-sec-extract: exhibit">December 31, 2021</A>, filed with the SEC on March 31, 2022;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Quarterly Report on Form 10-Q for the quarter ended <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000723/g083007_10q.htm" STYLE="-sec-extract: exhibit">March 31, 2022</A>, filed with the SEC on May 16, 2022;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Quarterly Report on Form 10-Q for the quarter ended <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622001071/g083127_10q.htm" STYLE="-sec-extract: exhibit">June 30, 2022</A>, filed with the SEC on August 15, 2022;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Current Reports on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000023/g082540_8k.htm" STYLE="-sec-extract: exhibit">January 5, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000066/g082544_8k.htm" STYLE="-sec-extract: exhibit">January 18, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000093/g082567_8k.htm" STYLE="-sec-extract: exhibit">January 21, 2022</A> (second of two reports filed
    on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000098/g082575_8k.htm" STYLE="-sec-extract: exhibit">January 21, 2022</A>), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000255/g0102459_8k.htm" STYLE="-sec-extract: exhibit">March 1, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000525/g082970_8k.htm" STYLE="-sec-extract: exhibit">April 15, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000551/g082979_8k.htm" STYLE="-sec-extract: exhibit">April 19, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000586/g082991_8k.htm" STYLE="-sec-extract: exhibit">April 27, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000602/g082999_8k.htm" STYLE="-sec-extract: exhibit">April 29, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000798/g083036_8k.htm" STYLE="-sec-extract: exhibit">May 25, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000835/g083045_8k.htm" STYLE="-sec-extract: exhibit">June 1, 2022</A>,
    <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000862/g083056_8k.htm" STYLE="-sec-extract: exhibit">June 9, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000939/g083093_8k.htm" STYLE="-sec-extract: exhibit">July 20, 2022</A> (second of two reports filed on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622000942/g083091_8k.htm" STYLE="-sec-extract: exhibit">July 20, 2022</A>), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622001004/g083120_8k.htm" STYLE="-sec-extract: exhibit">August 3, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622001052/g083132_8k.htm" STYLE="-sec-extract: exhibit">August 11, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622001098/g083145_8k.htm" STYLE="-sec-extract: exhibit">August 22, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622001256/g083193_8k.htm" STYLE="-sec-extract: exhibit">September 14, 2022</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/64463/000175392622001350/g083222_8k.htm" STYLE="-sec-extract: exhibit">October 4, 2022</A>;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    portions of our Definitive Proxy Statement on Schedule 14A incorporated by reference to our Annual Report on Form 10-K, filed with
    the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/64463/000175392622000498/g082694_def14a.htm" STYLE="-sec-extract: exhibit">April 13, 2022</A>; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    description of our common on Form 8-A filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/64463/000100329721000034/mkty8a12b.htm" STYLE="-sec-extract: exhibit">March 22, 2021</A>, as amended by <A HREF="https://www.sec.gov/Archives/edgar/data/64463/000175392622000384/g082656_ex4-13.htm" STYLE="-sec-extract: exhibit">Exhibit 4.13</A> to our Annual Report on Form
    10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 31, 2022, including any amendments thereto or reports
    filed for the purposes of updating this description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also incorporate by reference all additional documents that we file with the SEC under the terms of Section 13(a), 13(c), 14 or 15(d)
of the Exchange Act that are made after the initial filing of the Registration Statement of which this prospectus supplement and the
accompanying base prospectus forms a part and prior to effectiveness of the Registration Statement and after the initial filing date
of the Registration Statement of which this prospectus supplement and the accompanying base prospectus is a part until the offering of
securities covered by this prospectus supplement has been completed. We are not, however, incorporating, in each case, any documents
or information that we are deemed to furnish and not file in accordance with SEC rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide, without charge, to each person to whom a copy of this prospectus supplement and the accompanying base prospectus or any
other supplement or amendment forming a part of the Registration Statement is delivered, including any beneficial owner, upon the written
or oral request of such person, a copy of any or all of the documents incorporated by reference herein and therein, including exhibits.
Requests should be directed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soluna
Holdings, Inc.<BR>
325 Washington Avenue Extension<BR>
Albany, NY 12205<BR>
<U>hello@soluna.io</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">518-218-6051</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of these filings are also available on our website at <I>www.solunacomputing.com</I>. For other ways to obtain a copy of these filings,
please refer to &ldquo;Where You Can Find More Information&rdquo; above.<SUP></SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>PROSPECTUS</B></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt">SOLUNA
HOLDINGS, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>$150,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Debt
Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Subscription
Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Units
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>3,552,146
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Offered
by the Selling Stockholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soluna
Holdings, Inc. (the &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;us&rdquo; or &ldquo;our&rdquo;) may offer and sell, from time
to time in one or more offerings, any combination of our common stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;),
our preferred stock, par value $0.001 per share (the &ldquo;Preferred Stock&rdquo;), warrants to purchase shares of Common Stock
or Preferred Stock or other securities, debt securities, subscription rights or units having an aggregate initial offering price
not exceeding $150,000,000. Our warrants will be exercisable for Common Stock or Preferred Stock or other securities and our units
may be convertible or exchangeable for Common Stock, Preferred Stock or our warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the selling stockholders may offer and sell up to an aggregate of 3,552,146 shares of Common Stock from time to time
in one or more offerings as further described herein. We will not receive any of the proceeds from the sale of Common Stock by
the selling stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock, Preferred Stock, warrants, debt securities, subscription rights and units collectively are referred to in this prospectus
as the &ldquo;securities.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
time we or the selling stockholders sell these securities, we will provide specific terms of such securities offered in a supplement
to this prospectus. Such prospectus supplement may also add, update or change information in this prospectus. You should read
this prospectus supplement, as well as the documents incorporated by reference or deemed to be incorporated by reference into
this prospectus, carefully before you invest in any securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
prospectus may not be used to offer or sell our securities unless accompanied by a prospectus supplement relating to the offered
securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock and our 9.0% Series A Cumulative Perpetual Preferred Stock, par value $0.001 per share (&ldquo;Series A Preferred
Stock&rdquo;), are currently listed on The Nasdaq Stock Market LLC (&ldquo;Nasdaq&rdquo;) under the symbols &ldquo;SLNH&rdquo;
and &ldquo;SLNHP&rdquo;, respectively. On December 10, 2021, the last reported sale price of our Common Stock was $10.53 and the
last reported sale price of our Series A Preferred Stock was $21.75. None of our other securities have been approved for listing
on any market or exchange, and we have not made any application for such listing. Each prospectus supplement will indicate if
our securities offered thereby will be listed on any securities exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 87 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, the aggregate market value of our outstanding Common Stock held by non-affiliates was approximately
$83,029,121.23, based on 13,085,116 shares of issued and outstanding Common Stock, of which 8,086,373 shares were held by affiliates,
and a per share price of $16.61 which represents the closing sale price of our Common Stock on November 15, 2021. As of the date
of this prospectus, we are not subject to the sale limitations described in General Instruction I.B.6 to Form S-3 because the
&ldquo;public float&rdquo; (the market value of our Common Stock held by non-affiliates) is greater than $75,000,000. In the event
that any time during the effectiveness of this registration statement of which this prospectus and any prospectus supplement forms
a part, we become subject to such sale limitations, as a result of the public float becoming less than $75,000,000, during any
applicable 12-month period, we will not sell securities in a public primary offering with a value exceeding more than one-third
of our public float.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
securities may be sold directly by us or the selling stockholders, through dealers or agents designated from time to time, to
or through underwriters or dealers or through a combination of these methods on a continuous or delayed basis. See &ldquo;Plan
of Distribution&rdquo; in this prospectus. We may also describe the plan of distribution for any particular offering of our securities
in a prospectus supplement. If any agents, underwriters or dealers are involved in the sale of any of our securities in respect
of which this prospectus is being delivered, we will disclose their names and the nature of our arrangements with them in a prospectus
supplement. The net proceeds that we expect to receive from any such sale will also be included in a prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves various risks. See &ldquo;Risk Factors&rdquo; beginning on page 4 of this prospectus and in the applicable
prospectus supplement, and in the risks discussed in the documents incorporated by reference in this prospectus and in the applicable
prospectus supplement, as they may be amended, updated or modified periodically in our reports filed with the Securities and Exchange
Commission. You should carefully read and consider these risk factors before you invest in our securities. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is December 16, 2021</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 87 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: left"><A HREF="#a001_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
    THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a002_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK
    FACTORS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a003_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a004_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE
    OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a005_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    SECURITIES THAT WE MAY OFFER</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a006_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a007_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF WARRANTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a008_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a009_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF SUBSCRIPTION RIGHTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a010_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF UNITS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a011_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLING
    STOCKHOLDERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a012_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN
    OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a013_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL
    MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a014_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a015_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE
    YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a016_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION
    OF DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 33; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><B>A</B><A NAME="a001_v1"></A><B>BOUT
THIS PROSPECTUS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This prospectus is part of a
shelf registration statement on Form S-3 that we filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
using a &ldquo;shelf&rdquo; registration process. Under this shelf registration process, we may sell any combination of the securities
described in this prospectus in one or more offerings from time to time having an aggregate initial offering price of $150,000,000.
In addition, under this shelf registration process, the selling stockholders to be named in a supplement to this prospectus may,
from time to time, sell up to 3,552,146 shares of Common Stock, as described in this prospectus, in one or more offerings. This
prospectus provides you with a general description of the securities that we and the selling stockholders may offer. Each time
we or the selling stockholders offer securities, we will provide you with a prospectus supplement that describes the specific
amounts, prices and terms of the securities that we or the selling stockholders offer. The prospectus supplement also may add,
update or change information contained in this prospectus. You should read carefully both this prospectus and any prospectus supplement,
together with additional information described below under the caption &ldquo;Where You Can Find More Information.&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>THIS PROSPECTUS MAY NOT BE
USED TO CONSUMMATE A SALE OF SECURITIES UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">You should rely only on the information
contained or incorporated by reference in this prospectus or a prospectus supplement. Neither we nor the selling stockholders
have authorized any person to provide you with different information. If anyone provides you with different or inconsistent information,
you should not rely on it. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy securities,
in any jurisdiction where such offer or sale is not permitted. You should assume that the information appearing in this prospectus
or any prospectus supplement, as well as information that we have previously filed with the SEC and incorporated by reference,
is accurate as of the date on the front of those documents only. Our business, financial condition, results of operations and
prospects may have changed since those dates. You should read both this prospectus, including the section titled &ldquo;Risk Factors,&rdquo;
and the accompanying prospectus supplement, together with additional information under the heading &ldquo;Where You Can Find More
Information.&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This prospectus contains summaries
of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete
information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred
to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which
this prospectus is a part, and you may obtain copies of those documents as described below under the section entitled &ldquo;Where
You Can Find More Information.&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 34 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>SUMMARY</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>Unless the context requires
otherwise in this prospectus, the terms &ldquo;SHI&rdquo;, the &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;us&rdquo;, or &ldquo;our&rdquo;
refer to Soluna Holdings, Inc. together with its consolidated subsidiaries, &ldquo;SCI&rdquo; refers to Soluna Computing, Inc.,
formerly known as EcoChain, Inc., and &ldquo;MTI Instruments&rdquo; refers to MTI Instruments, Inc. </I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>The Company</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Soluna Holdings, Inc. is a developer of
green data centers that convert excess renewable energy into global computing resources. The Company builds modular, scalable
data centers for computing intensive, batchable applications such as cryptocurrency mining, Artificial Intelligence, and machine
learning. The Company provides a cost-effective alternative to battery storage or transmission lines. Headquartered in Albany,
New York, the Company uses technology and intentional design to solve complex, real-world challenges. We conduct our two core
businesses through our wholly-owned subsidiaries, SCI, which is engaged in cryptocurrency mining powered by renewable energy,
and MTI Instruments, which manufactures precision tools and testing equipment for electronics, aviation, automotive, power and
other industries at the Albany, New York location.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCI
was incorporated in Delaware on January 8, 2020 as EcoChain, Inc. and develops and monetizes cryptocurrency mining facilities
that can be powered by renewable energy. EcoChain has established a cryptocurrency mining facility that integrates with the cryptocurrency
blockchain network in Washington State and, through our recent acquisition of Soluna Computing, Inc. (&ldquo;Soluna Computing&rdquo;),
SCI also has a pipeline of certain cryptocurrency mining projects previously owned by Harmattan Energy, Ltd. (formerly Soluna
Technologies, Ltd.), a Canadian corporation incorporated under the laws of the Province of British Colombia that develops vertically-integrated,
utility-scale computing facilities focused on cryptocurrency mining and cutting-edge blockchain applications. SCI changed its
name from &ldquo;EcoChain, Inc.&rdquo; to &ldquo;Soluna Computing, Inc.&rdquo; on November 15, 2021, following the acquisition.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">MTI Instruments was
incorporated in New York on March 8, 2000 and is a supplier of vibration measurement and balancing systems, precision linear displacement
solutions, and wafer inspection tools. MTI Instruments&rsquo; products consist of engine vibration analysis systems for both military
and commercial aircraft and electronic gauging instruments for position, displacement and vibration application within the industrial
manufacturing markets, as well as in the research, design and process development markets. These systems, tools and solutions
are developed for markets and applications that require consistent operation of complex machinery and the precise measurements
and control of products, processes, the development and implementation of automated manufacturing and assembly.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Corporate Information</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Soluna Holdings, Inc., formerly
known as Mechanical Technology, Incorporated, was incorporated in Nevada on March 24, 2021, and is the successor to Mechanical
Technology, Inc., which was incorporated in the State of New York in 1961, as a result of a merger which became effective on March
29, 2021, and is headquartered in Albany, New York. Effective November 2, 2021, the Company changed its name from &ldquo;Mechanical
Technology, Incorporated&rdquo; to Soluna Holdings, Inc.&nbsp;Our principal executive offices are located at 325 Washington Avenue
Extension, Albany, NY 12205 and our website is http://www.solunacomputing.com. Information contained on our website does not constitute
part of and is not incorporated into this prospectus or the registration statement of which it forms a part.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 35 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Risk Factors Summary</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In evaluating the Company, its
business and any investment in the Company, readers should carefully consider the following factors:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Risks relating to the COVID-19
pandemic and global economic uncertainty</I></B>&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Adverse
                 changes in economic or other market conditions in the United States, including risks resulting from the continuing
                 impact of the COVID-19 pandemic, could have a material adverse effect on our business and results of operations
                 and curtail our ability to raise financing.</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The
                 long-term effects of the COVID-19 pandemic, or the impacts of any future pandemics or other health crises, are
                 unknown and may adversely affect our business, results of operations, financial condition, liquidity and cash
                 flow.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Risks related to our SCI
business and cryptocurrency</I></B></P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">SCI has a limited operating
                                         history and we may not recognize any operating income from the SCI line of business in
                                         the future.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Prices of cryptocurrencies
                                         are extremely volatile, and if our mined cryptocurrencies are converted into dollars
                                         when such values are low, we may not recognize the income from the conversion of the
                                         mined cryptocurrencies that we were expecting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">SCI has an evolving business
                                         model that is subject to various uncertainties.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">SCI may not be able to continue
                                         to develop its technology and keep pace with technological developments, expand its mining
                                         operations or otherwise compete with other companies.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">There are several new and
                                         existing competitors in our industry that are purchasing mining equipment at scale, which
                                         may cause delays or difficulty in us obtaining new miners, which could materially and
                                         adversely affect our business and results of operations.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">We may be unable to obtain
                                         additional funding to scale the SCI cryptocurrency business to a larger-scale cryptocurrency
                                         mining operation.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Regulatory changes or actions
                                         may alter the nature of an investment in us or restrict the use of cryptocurrencies in
                                         a manner that adversely affects our business, prospects, operations, and profitability.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Security breaches could result
                                         in a loss of our cryptocurrencies.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Incorrect or fraudulent cryptocurrency
                                         transactions may be irreversible.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The impact of geopolitical
                                         and economic events on the supply and demand for Bitcoin and other cryptocurrencies is
                                         uncertain.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The failure of cryptocurrencies
                                         to become widely accepted and/or used as a medium of exchange and method of payment could
                                         adversely affect our business, prospects, and financial condition.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The properties included in
                                         our mining network may experience damages, including damages that are not covered by
                                         insurance.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">SCI&rsquo;s reliance on a
                                         third-party mining pool service provider for our mining revenue payouts may have a negative
                                         impact on SCI&rsquo;s operations.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Over time, incentives for
                                         Bitcoin miners to continue to contribute processing power to the Bitcoin network may
                                         transition from a set reward to transaction fees. If the incentives for Bitcoin mining
                                         are not sufficiently high, we may not have an adequate incentive to continue to mine.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The Bitcoin reward for successfully
                                         uncovering a block will halve several times in the future, and Bitcoin value may not
                                         adjust to compensate us for the reduction in the rewards we receive from our Bitcoin
                                         mining efforts.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">We may not be able to realize
                                         the benefits of forks, and forks in a digital asset network may occur in the future which
                                         may affect the value of the cryptocurrencies that we mine held by us.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">As the aggregate amount of
                                         computing power, or hash rate, in the Bitcoin network increases, the amount of Bitcoin
                                         earned per unit of hash rate decreases; as a result, in order to maintain our market
                                         share, we may have to incur significant capital expenditures in order to expand our fleet
                                         of miners.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Climate change, and the regulatory
                                         and legislative developments related to climate change, may materially adversely affect
                                         our business and financial condition.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Our business plan is heavily
                                         dependent upon acquisitions and strategic alliances and our ability to identify, acquire
                                         or ally on appropriate terms, and successfully integrate and manage any acquired companies
                                         or alliances will impact our financial condition and operating results.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">In connection with the ground
                                         leases for our cryptocurrency mining operations, we rely on the landlord to sell us the
                                         power required for our operations, and any failure of the landlord to supply such power,
                                         whether as a result of its failure to pay the Tennessee Valley Authority (&ldquo;TVA&rdquo;)
                                         or otherwise, would materially impact our operations, and the properties on which certain
                                         of our ground leases are located are subject to possible forfeiture to the U.S. government,
                                         and, if seized, would, in all likelihood, require us to spend significant funds to maintain
                                         our cryptocurrency mining rights.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Risks relating to our MTI
Instruments business</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Our MTI Instruments business depends on a small number of customers, including
    the U.S. Air Force, and many of them are in industries of a cyclical nature.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">We do not have long-term purchase commitments from our customers, and our
    customers are also able to cancel, reduce, or delay orders for our products.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Our operating results may experience significant fluctuations, which could
    adversely impact our operations and financial results.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">We may not be able to keep pace with technological innovations, and our efforts
    may not result in commercial success and/or may result in delays in development.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of our existing and target
        customers are in industries of a cyclical nature.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&#9679;</TD>
    <TD>MTI Instruments&rsquo; business operations, financial performance and liquidity are occasionally reliant on a single supplier
    or vendor or a limited group of suppliers and vendors.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>Risks relating to our Company generally
</I></B></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Our confidentiality agreements with employees and others may not adequately
    prevent disclosure of our trade secrets and other proprietary information, which could limit our ability to compete.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">We rely on highly-skilled personnel and the continuing efforts of our executive
    officers and, if we are unable to retain, motivate, or hire qualified personnel, our business may be severely disrupted.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">In addition, increased labor costs and the unavailability of skilled workers
    could hurt our business, financial condition, and results of operations.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Insiders continue to have substantial control over the Company, and the ownership
    by Brookstone Partners Acquisition, XXIV, LLC (&ldquo;Brookstone XXIV&rdquo;) of the outstanding shares of our Common Stock
    gives it a controlling interest in the Company, and it may acquire interests and positions that could present potential conflicts
    with our and our shareholders&rsquo; interests.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&#9679;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to complex environmental,
        health, and safety laws and regulations that may expose us to significant liabilities for penalties, damages, or costs
        of remediations or compliance.</P></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 36 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B><I>Risks related
to the recent acquisition of Soluna Computing</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">We may fail to realize all of the anticipated benefits of our recent acquisition
    of Soluna Computing.</TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operating results will suffer
        if SHI and SCI do not effectively manage the increased scale of SCI&rsquo;s operations and its optimization and expansion
        opportunities.</P>
        </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>General Risks</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">If we are unable to protect our information systems against service interruption
    or failure, misappropriation of data or breaches of security, our operations could be disrupted, we could be subject to costly
    government enforcement actions and private litigation and our reputation may be damaged.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Please see &ldquo;Risk Factors&rdquo;
beginning on page 4 for more detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 37 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><B>R</B><A NAME="a002_v1"></A><B>ISK
FACTORS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>An investment in our securities
involves a high degree of risk. You should consider and read carefully all of the risks and uncertainties described below, together
with all of the other information contained or incorporated by reference into this prospectus and in any prospectus supplement
or free writing prospectus or in the documents incorporated by reference herein and therein before deciding to invest in such
securities. If any of the following risks, or any risk described elsewhere in this prospectus and in any prospectus supplement
or free writing prospectus or in the documents incorporated by reference herein and therein, occurs, our business, business prospects,
financial condition, results of operations or cash flows could be materially adversely affected. In any such case, the trading
prices of our Common Stock and Series A Preferred Stock could decline, and you could lose all or part of your investment. The
risks described below and in any prospectus supplement or free writing prospectus and in the documents incorporated by reference
herein and therein are not the only ones facing us. Additional risks not currently known to us or that we currently deem immaterial
may also adversely affect us. This prospectus also contains forward-looking statements, estimates and projections that involve
risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements because
of specific factors, including the risks described below and in the documents incorporated by reference herein. </I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>You should carefully consider
the following risk factors in evaluating our business and us. The factors listed below and in the prospectus and in any prospectus
supplement or free writing prospectus represent certain important factors that we believe could cause our business results to
differ. These factors are not intended to represent a complete list of the general or specific risks that may affect us. It should
be recognized that other risks may be significant, presently or in the future, and the risks set forth below may affect us to
a greater extent than indicated. If any of the following risks occur, our business, financial condition or results of operations
could be materially and adversely affected. You should also consider the other information included in our most recent Annual
Report on Form 10-K (the &ldquo;Form 10-K&rdquo;) and subsequent quarterly reports filed with the SEC, which are incorporated
herein by reference into this registration statement, as well as in any applicable prospectus supplement and contained or to be
contained in our filings with the SEC and incorporated by reference in this prospectus, together with all of the other information
contained in this prospectus, or any applicable prospectus supplement. For a description of these reports and documents, and information
about where you can find them, see &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Information
by Reference.&rdquo; If any of the risks or uncertainties described in our SEC filings or any prospectus supplement or any additional
risks and uncertainties actually occur, our business, financial condition and results of operations could be materially and adversely
affected. </I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Risks Relating to the COVID-19
Pandemic and Global Economic Uncertainty&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Adverse changes in economic
or other market conditions in the United States and globally may have serious implications for the growth and stability of our
business and could otherwise adversely affect our business, results of operations and financial condition.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our business is affected by general
economic conditions, both inside and outside of the United States. Adverse changes to and uncertainty in the global economy, particularly
in light of the continuing uncertainty regarding the duration and scope of the COVID-19 pandemic, including as a result of the
recently-discovered Omicron variant of the novel coronavirus as well as the potential for resurgences or the emergence of new
variants to set back the global economic recovery or trigger future economic slowdowns or recessions, may lead to decreased demand
for our products and for Bitcoin and other cryptocurrencies, revenue fluctuations, and increased price competition for our products,
and may increase the risk of excess and obsolete inventories and higher overhead costs as a percentage of revenue. It could also
result in a decline in business and economic forecasts, which could adversely affect our sales in future periods. Additionally,
the financial strength of our customers and suppliers and their ability to obtain and rely on credit financing may affect their
ability to fulfill their obligations to us and have an adverse effect on our financial results.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Revenue growth and continued
profitability of our MTI Instruments business will significantly depend on the overall demand for test and measurement instrumentations
in key markets including research and development, automotive, semiconductor, cryptocurrencies, and electronics. The U.S. and
global economies have been historically cyclical and market conditions continue to be challenging, which has resulted in companies
delaying or reducing expenditures. Although recent trends have pointed to continuing improvements, there is still lingering volatility
and uncertainty, particularly in light of recent resurgences of the spread of COVID-19 and the emergence of the Omicron variant.
A change or disruption in the national or global financial markets for any reason may cause consumers, businesses, and governments
to defer purchases in response to tighter credit, decreased cash availability, and declining consumer confidence. Accordingly,
demand for our products could decrease and differ materially from their current expectations. Further, some of our customers may
require substantial financing in order to fund their operations and make purchases from us. The inability of these customers to
obtain sufficient credit to finance purchases of our products and meet their payment obligations to us or possible insolvencies
of our customers could result in decreased customer demand, an impaired ability for us to collect on outstanding accounts receivable,
significant delays in accounts receivable payments, and significant write-offs of accounts receivable, each of which could adversely
impact our business and our financial results.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 38 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>The long-term effects of
the coronavirus pandemic, or the impacts of any future pandemics or other health crises, are unknown and may adversely affect
our business, results of operations, financial condition, liquidity and cash flow.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our overall performance generally
depends upon domestic and worldwide economic and political conditions. The global spread of COVID-19 has created volatility, uncertainty,
and economic disruption. The pandemic caused a slowdown, and, going forward may cause future slowdowns in worldwide economic activity,
decreased demand for products and services, and financial markets. Meanwhile, disruptions to global supply chains, including a
global semiconductor chip shortage, as a result of the pandemic has continued, and may increase if there are surges in transmission
and illness from the coronavirus going forward, including as a result of new variants.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">While the COVID-19 pandemic,
and the changes to our operations necessitated by governmental and societal actions to contain it, including social distancing
and the closing and/or limits on the business operations, required us to make certain changes to the way we conduct our business
and operations, we have been fortunate that, to date, the pandemic has had a limited impact on our supply chains, distribution
systems, and ability to continue to conduct our business and operations. We cannot, however, predict the longer-term impacts of
the pandemic, or future health emergencies, on our business, operations, revenues, results of operations, or financial condition.
The ultimate extent of the impact of the current coronavirus pandemic, or any future epidemic, pandemic, or other outbreak or
health emergency, will depend on future developments, including how fast effective (or with respect to the current pandemic, additional)
vaccines and treatments are developed, the length of time before such vaccines are sufficiently distributed (both in the United
States and worldwide), new or continued government actions in response, including with respect to successive waves or variants
of the virus (as well as the extent to which such variants are more contagious and/or lethal), the extent to which then-current
vaccines and treatments are less effective against any such variants, and whether delays in such vaccinations allow vaccine-resistant
variants to develop and spread, all of which will impact the current or any future pandemic&rsquo;s or similar outbreak&rsquo;s
ultimate duration and severity as well as and how fast the economy recovers afterwards. Actions we took to mitigate the impact
of the current pandemic may not be successful if the pandemic continues for a longer period than expected or in future pandemics
or similar emergencies. For example, beginning in March 2020 we replaced our in-person sales meetings with meetings held by videoconference,
telephone calls, webinars, and additional informational website content geared towards addressing our customers&rsquo; questions
and concerns for both domestic and overseas customers. Nevertheless, we believe that our inability to hold in-person meetings,
while not significant, did have a negative impact on our product sales during the year ended December 31, 2020 and the nine months
ended September 30, 2021, and our efforts to mitigate the effects of the pandemic restrictions on our sales model may not be a
viable alternative to in-person meetings on a longer-term basis or during any future health or other emergency that engenders
similar restrictions.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In addition, while
the supply-chain disruptions and semiconductor shortage noted above have not had a significant impact on our mining operations
to date, if these conditions continue we may not be able to obtain new cryptocurrency mining equipment (generally called &ldquo;miners&rdquo;)
to replace miners that are no longer functioning, expand our cryptocurrency mining operations, or keep up with technological developments,
or be able to obtain replacement parts for our existing miners, in a timely or cost-effective manner. This could negatively impact
our ability to expand our mining operations and compete in the cryptocurrency mining industry, and otherwise materially and adversely
affect our business and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Further, the long-term social
and economic impact of the pandemic, or the acceleration of pre-existing trends as a result thereof, are still uncertain, and
it is not possible at this time to estimate the full impact that the pandemic will have on our business, as the impact will depend
on future developments, which are highly uncertain and cannot be predicted. It is also unknowable what impacts future pandemics
or health emergencies may bring. In either case, any such developments could materially and adversely affect our customer base
or the demand for our products, which would have a negative effect on our business, prospects, results of operations, and financial
condition, all of which could have a negative effect on the market price of our securities.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Risks Related to our SCI Business
and Cryptocurrency</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>SCI has a limited operating
history and we may not recognize operating income from the SCI line of business in the future.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">SCI began operations in January
2020 and therefore is subject to all the risks inherent in a newly-established business venture in a rapidly developing and changing
industry. SCI&rsquo;s limited operating history also makes it difficult to evaluate SCI&rsquo;s current business and its future
prospects. SCI has not yet been able to confirm that its business model can or will be successful over the long term, and we may
not ever continue to recognize operating income from this business. Our projections for its growth have been developed internally
and may not prove to be accurate. SCI&rsquo;s operating results will likely fluctuate moving forward as we focus on increasing
its mining operations and as the market prices of Bitcoin and other cryptocurrencies fluctuate. We may need to make business decisions
that could adversely affect SCI&rsquo;s operating results, such as modifications to its business structure or operations. In addition,
we expect additional growth in this business, which could place significant demands on SCI&rsquo;s and the Company&rsquo;s management
and other resources and require us to continue developing and improving our operational, financial, and other internal controls.
SCI may not be able to address these challenges in a cost-effective manner or at all. If we do not effectively manage SCI&rsquo;s
growth, it may not be able to execute on its business plan, respond to competitive pressures, or take advantage of market opportunities,
and our business, financial condition, and results of operations could be materially harmed.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Given SCI&rsquo;s
start-up status with an unproven business model, there is a substantial risk regarding SCI&rsquo;s ability to succeed. You should
consider our business and prospects in light of these risks and the risks and difficulties that we will encounter as we continue
to develop our business model. We may not be able to address these risks and difficulties successfully, which would materially
harm our business and operating results, and we could be forced to terminate our business, liquidate our assets and dissolve,
and you could lose part or all of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 39 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Prices of cryptocurrencies
are extremely volatile, and if our mined cryptocurrencies are converted into dollars when such values are low, we may not recognize
the income from the conversion of the mined cryptocurrencies that we were expecting<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The fluctuating prices of cryptocurrencies
represent significant uncertainties for SCI&rsquo;s business. The price of Bitcoin, Ether and other cryptocurrencies are subject
to dramatic fluctuations. A variety of factors, known and unknown, may affect price and valuation, including, but not limited
to (i) the supply of such cryptocurrencies; (ii) global blockchain asset demand, which can be influenced by the growth of retail
merchants&rsquo; and commercial businesses&rsquo; acceptance of blockchain assets like cryptocurrencies as payment for goods and
services, the security of online cryptocurrency exchanges and networks and digital wallets that hold blockchain assets, the perception
that the use and holding of blockchain assets is safe and secure, and the regulatory restrictions on their use; (iii) investors&rsquo;
expectations with respect to the rate of inflation; (iv) changes in the software, software requirements or hardware requirements
underlying a blockchain network; (v) changes in the rights, obligations, incentives, or rewards for the various participants in
a blockchain network; (vi) currency exchange rates; (vii) fiat currency withdrawal and deposit policies of cryptocurrency exchanges
and networks and liquidity on such exchanges and networks; (viii) interruptions in service from or failures of major cryptocurrency
exchanges and networks; (ix) investment and trading activities of large subscribers, including private and registered investment
funds, that may directly or indirectly invest in blockchain assets; (x) monetary policies of governments, trade restrictions,
currency devaluations and revaluations; (xi) regulatory measures, if any, that affect the use of blockchain assets; (xii) the
maintenance and development of the open-source software protocol of the cryptocurrency networks; (xiii) global or regional political,
economic or financial events and situations; (xiv) expectations among blockchain participants that the value of blockchain assets
will soon change; and (xv) a decrease in the price of blockchain assets that may have a material adverse effect on SCI&rsquo;s
financial condition and operating results. If our mined cryptocurrencies are converted into dollars when their values are low,
we may not recognize the income from the conversion of the mined cryptocurrencies that we were expecting. Further, the extreme
swings in value can make it difficult for us to develop reasonable financial plans and projections with respect to SCI&rsquo;s
business.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>SCI has <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
evolving business model that is subject to various uncertainties.</FONT></I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">As cryptocurrency assets and
blockchain technologies become more widely available, we expect the services and products associated with them to evolve. In order
to stay current with the industry, our business model may need to evolve as well. From time to time, we may modify aspects of
SCI&rsquo;s business relating to our models and strategies. We cannot offer any assurance that these or any other modifications
will be successful or will not result in harm to our business. We may not be able to manage growth effectively, which could damage
our reputation, limit our growth and negatively affect our operating results. Further, we cannot provide any assurance that we
will successfully identify all emerging trends and growth opportunities in this business sector and we may lose out on those opportunities.
Such circumstances could have a material adverse effect on our business, prospects or operations.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>SCI may not <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
able to continue to develop its technology and keep pace with technological developments, expand its mining operations or otherwise
compete with other companies, some of whom have greater resources and experience.</FONT></I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We do not have the resources
to compete with larger cryptocurrency mining entities at this time and may not be able to compete successfully against present
or future competitors. The cryptocurrency industry has attracted various high-profile and well-established operators, some of
which have substantially greater liquidity and financial resources than we do. With the limited resources we have available, we
may experience great difficulties in expanding and improving our network of miners to remain competitive, and we may not be in
a position to construct additional operational cryptocurrency mines.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 40 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Rapid technological
change is a current feature of the cryptocurrency industry, including cryptocurrency mining, and we cannot provide assurance that
we will be able to achieve the technological advances, in a timely manner or at all, that may be necessary for us to remain competitive
or that certain of our equipment will not become obsolete. Our ability to anticipate and manage changes in technology standards
on a timely basis will be a significant factor in our ability to remain competitive. We may not be successful, generally or relative
to our competitors, in timely implementing new technology into our systems, or doing so in a cost-effective manner. During the
course of implementing any such new technology into our operations, we may experience system interruptions and failures. Further,
if due to technological developments we need to replace our miners entirely to remain competitive in the market, there can be
no assurance that we will be able to do so on a cost-effective basis or in a timely manner, particularly in light of the long
production period to manufacture and assemble cryptocurrency miners, potential large-scale purchases of miners from existing competitors
and new entrants into the industry, and the current semiconductor chip shortage. Furthermore, there can be no assurance that we
will recognize, in a timely manner or at all, the benefits that we may expect as a result of our implementing new technology into
our operations. As a result, our business, prospects, and operations may suffer, and there may be adverse effects on our financial
condition and on the market prices of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In addition, competition from
existing and future competitors, particularly the many other North American companies that have access to more competitively-priced
energy, could result in our inability to secure acquisitions and partnerships that we may need to expand our business in the future.
This competition from other entities with greater resources, experience, and reputations may result in our failure to maintain
or expand our business, as we may never be able to successfully execute our business plan. If we are unable to expand and remain
competitive, our business could be negatively affected which would have an adverse effect on the trading price of our securities,
which in turn would harm investors in our Company.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>There are several new and existing
competitors in our industry that are purchasing mining equipment at scale, which may cause delays or difficulty in us obtaining
new miners, which could materially and adversely affect our business and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of the competitors in our industry
have also been purchasing mining equipment at scale, which has caused a worldwide shortage of mining equipment and extended the
corresponding delivery schedules for new miner purchases. There can be no assurance that manufacturers will be able to keep pace
with the surge in demand for mining equipment. It is uncertain how manufacturers will respond to this increased global demand.
In the event manufacturers are not able to keep pace with demand, we may not be able to purchase miners in sufficient quantities
or on the delivery schedules that meet our business needs, which would have a material adverse effect on our business, operations,
prospects, operating income, and financial condition, which would likely result in a decrease in the market value of our Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>We may be unable to obtain
additional funding to scale the SCI cryptocurrency business to a larger-scale cryptocurrency mining operation.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We are considering further increasing
the processing power of our cryptocurrency mining operations as we seek to leverage our experience and expertise in this area
of operations. To do so, however, we will need to raise additional debt and/or equity financing, which may not be available to
us on acceptable terms or at all. Failure to generate adequate cash from our operations or find sources of funding would require
us to scale back or curtail our operations or expansion efforts, including limiting our ability to expand the SCI cryptocurrency
business to a larger-scale cryptocurrency mining operation, and would have an adverse impact on our business and financial condition.
If we raise additional equity financing, our stockholders may experience significant dilution of their ownership interests, and
the per-share value of our Common Stock could decline. Furthermore, if we engage in additional debt financing, the holders of
debt likely would have priority over the holders of Common Stock on order of payment preference. We may be required to accept
terms that restrict our ability to incur additional indebtedness or take other actions including terms that require us to maintain
specified liquidity or other ratios that could otherwise not be in the interests of our stockholders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Regulatory <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
or actions may alter the nature of an investment in us or restrict the use of cryptocurrencies in a manner that adversely affects
our business, prospects, or operations and profitability.</FONT></I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">As cryptocurrencies have grown
in both popularity and market size, governments around the world have reacted, and continue to react, differently to cryptocurrencies;
certain governments have deemed them illegal, and others have allowed their use and trade without restriction, while in some jurisdictions,
such as in the U.S., cryptocurrencies are subject to extensive, and in some cases overlapping, unclear, and evolving, regulatory
requirements. In the United States, Congress and various federal agencies have increased their focus on the cryptocurrency sector
during the past year. Increasing regulation and regulatory scrutiny may result in increased costs, management having to devote
increased time and attention to regulatory matters, having to change aspects of our cryptocurrency mining business, or result
in limits on the use cases of cryptocurrencies, which could decrease their value. Regulatory developments may require us to comply
with new regulatory requirements, which would increase our operating costs. In addition, ongoing and future regulatory actions
could significantly restrict or eliminate the market for or uses of cryptocurrencies and otherwise materially and adversely impact
our ability to continue to operate and to continue as a going concern, which could have a material adverse effect on our business,
prospects, operations and financial condition, as well as on the value and trading prices of our Common Stock.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Security breaches could
result in a loss of our cryptocurrencies.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Security breaches including computer
hacking or computer malware have been a consistent concern in the cryptocurrency industry. This could involve hacking in which
an unauthorized person obtains access to the systems or information and can cause harm by the transmission of virus or the corruption
of data. These breaches may occur due to an action by an outside party, or by the error and negligence of an employee. We primarily
rely on the Luxor mining pool and SCI&rsquo;s cryptocurrencies are stored with exchanges such as Coinbase prior to selling them.
If any breach were to occur of our security system, operations or third party platforms, the result could cause a loss of our
cryptocurrencies, loss of confidential or proprietary information, force the Company to cease operations, or could cause damage
to the reputation of the Company. If an actual or perceived attack were to occur, the market perception of the Company may be
damaged, which could adversely affect potential and current investments in the Company and reduce demand for our securities and
cause a reduction in our share price.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Incorrect or fraudulent cryptocurrency
transactions may be irreversible. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is possible that, through computer
or human error, theft, or criminal action, our cryptocurrency could be transferred in incorrect amounts or to unauthorized third
parties or accounts. In general, cryptocurrency transactions are irreversible, and stolen or incorrectly-transferred cryptocurrencies
may be irretrievable, and we may have extremely limited or no effective means of recovering any losses as a result of an incorrect
transfer or theft. As a result, any incorrectly executed or fraudulent cryptocurrency transactions could adversely affect our
business, operating results and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 41; Value: 1 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The impact of geopolitical and economic
events on the supply and demand for Bitcoin and other cryptocurrencies is uncertain.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Geopolitical crises may motivate large-scale
purchases of Bitcoin and other cryptocurrencies, which could rapidly increase the price of Bitcoin and other cryptocurrencies.
This may increase the likelihood of a subsequent price decrease as crisis-driven purchasing behavior dissipates, adversely affecting
the value of the cryptocurrencies that we mine. Alternatively, as an emerging asset class with limited acceptance as a payment
system or commodity, global crises and general economic downturn may discourage investment in cryptocurrencies as investors focus
their investment on less volatile asset classes as a means of hedging their investment risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cryptocurrencies, which are relatively
new, are subject to supply and demand forces. How such supply and demand will be impacted by geopolitical events is largely uncertain
but could be harmful to us and investors in our Common Stock. Political or economic crises may motivate large-scale acquisitions
or sales of cryptocurrencies either globally or locally. Such events could have a material adverse effect on our ability to continue
as a going concern or to pursue our strategy at all, which could have a material adverse effect on our business, prospects, or
operations and potentially the value of any cryptocurrencies that we mine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The failure of cryptocurrencies
to become widely accepted and/or used as a medium of exchange and method of payment could adversely affect our business, prospects,
and financial condition. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The use of cryptocurrencies in the retail
and commercial marketplace, despite sporadic adoption, is currently limited. A significant portion of cryptocurrency demand is
generated by investors seeking a long-term store of value or speculators seeking to profit from the short- or long-term holding
of the asset. Price volatility, slow processing speeds, and high transaction costs undermine Bitcoin&rsquo;s and other cryptocurrencies&rsquo;
ability to be used as a medium of exchange, as retailers are less likely to accept it as a direct form of payment. Large-scale
acceptance of cryptocurrencies as a means of payment has not, and may never, occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The relative lack of acceptance of cryptocurrencies
in the retail and commercial marketplace, or a reduction of such use, limits the ability of end users to use them to pay for goods
and services. Such lack of acceptance or a decline in acceptance could have a material adverse effect on the value of the cryptocurrencies
that we mine, the viability of cryptocurrency mining as a business, and our ability to continue as a going concern or to pursue
our business strategy, which could have a material adverse effect on our business, prospects, operations, and financial condition,
as well as on the market value of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Facebook&rsquo;s proposed
development of a cryptocurrency, as well as the eventual likely development of government-backed digital currencies and the development
of cryptocurrencies by other tech companies, may adversely affect the value of Bitcoin and other existing, or even future, cryptocurrencies.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In May 2019, Facebook announced
its plans for a cryptocurrency then called Libra, now Diem, which faced significant objections and concerns from governments,
legislators and regulators. The massive social network and a number of other partners are estimating that the Diem digital coin
and Facebook&rsquo;s corresponding digital wallet would be a way to make sending payments around the world as easy as it is to
send a photo. Facebook&rsquo;s significant resources and ability to engage the world via social media may enable it to bring Diem
to market rapidly and to deploy it across industries more rapidly and successfully than previous cryptocurrencies. Facebook&rsquo;s
size and market share may cause its cryptocurrency to succeed to the detriment and potential exclusion of existing cryptocurrencies.
Further, in the event that government-backed digital currencies, which regulators in several countries are already considering
or even developing, are developed and widely adopted, it is likely to have a negative impact on the existing currencies including
larger widespread adoption and potentially impacting the market share by non-government digital currency. Additional cryptocurrencies
are introduced to the market frequently, and although some have gained popularity as some features have been different than Bitcoin,
Bitcoin remains the market leader. As cryptocurrency adoption grows, the likelihood increases that additional cryptocurrencies
will be introduced and gain popularity against Bitcoin, potentially negatively impacting the value of Bitcoin and perhaps other
cryptocurrencies.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>The properties included
in our mining network may experience damages, including damages that are not covered by insurance.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our current mining operation
in East Wenatchee, Washington is, and any future mines we establish will be, subject to a variety of risks relating to physical
condition and operation, including:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">the
                 presence of construction or repair defects or other structural or building damage;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">any
                 noncompliance with or liabilities under applicable environmental, health or safety regulations or requirements
                 or building permit requirements; and</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">any
                 damage resulting from natural disasters, such as hurricanes, earthquakes, fires, floods and windstorms.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For example, our mine could be
rendered inoperable, temporarily or permanently, as a result of a fire or other natural disaster or by a terrorist or other attack
on the mine. The security and other measures we take to protect against these risks may not be sufficient. Additionally, our mine
could be materially adversely affected by a power outage, loss of access to the electrical grid, or loss by the grid of cost-effective
sources of electrical power generating capacity. Given the power requirement, it would not be feasible to run miners on back-up
power generators in the event of a power outage. Our insurance covers the replacement cost of any lost or damaged miners, but
does not cover any interruption of our mining activities; our insurance therefore may not be adequate to cover the losses we suffer
as a result of any of these events. In the event of an uninsured loss, including a loss in excess of insured limits, at any of
the mines in our network, such mines may not be adequately repaired in a timely manner or at all and we may lose some or all of
the future revenues anticipated to be derived from such mines. The potential impact on our business is currently magnified because
we are only operating a single mine.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>SCI&rsquo;s reliance on
a third-party mining pool service provider for our mining revenue payouts may have a negative impact on SCI&rsquo;s operations.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We use a third&ndash;party mining
pool to receive our mining rewards from the network. Cryptocurrency mining pools allow miners to combine their computing power,
increasing their chances of solving a block and getting paid by the network. The rewards are distributed by the pool operator,
proportionally to our contribution to the pool&rsquo;s overall mining power, used to generate each block. Should the pool operator&rsquo;s
system suffer downtime due to a cyber-attack, software malfunction, or similar issues, it will negatively impact our ability to
mine and receive revenue. Furthermore, we are dependent on the accuracy of the mining pool operator&rsquo;s recordkeeping to accurately
record the total processing power provided to the pool for a given Bitcoin mining application in order to assess the proportion
of that total processing power we provided. While we have internal methods of tracking both our power provided and the total used
by the pool, the mining pool operator uses its own recordkeeping to determine our proportion of a given reward. We have little
means of recourse against the mining pool operator if we determine that the proportion of the reward that the mining pool operator
pays out to us is incorrect, other than leaving the pool. If we are unable to consistently obtain accurate proportionate rewards
from our mining pool operator, we may experience reduced reward for our efforts, which would have an adverse effect on our results
of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 42 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Over time, incentives for
Bitcoin miners to continue to contribute processing power to the Bitcoin network may transition from a set reward to transaction
fees. If the incentives for Bitcoin mining are not sufficiently high, we may not have an adequate incentive to continue to mine.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, as the number of Bitcoin rewards
awarded for solving a block in a blockchain decreases, our ability to achieve profitability also decreases. Decreased use and
demand for Bitcoin rewards may adversely affect our incentive to expend processing power to solve blocks. If the Bitcoin rewards
for solving blocks and transaction fees are not sufficiently high, fewer Bitcoin miners will mine. At insufficiently attractive
rewards, our costs of operations in total may exceed our revenues from Bitcoin mining.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To incentivize Bitcoin miners to continue
to contribute processing power to the Bitcoin network, such network may either formally or informally transition from a set reward
to transaction fees earned upon solving a block. This transition could be accomplished either by Bitcoin miners independently
electing to record in the blocks they solve only those transactions that include payment of a transaction fee or by the Bitcoin
network adopting software upgrades that require the payment of a minimum transaction fee for all transactions. If as a result
transaction fees paid for Bitcoin transactions become too high, Bitcoin users may be reluctant to transfer Bitcoin or accept Bitcoin
as a means of payment, and existing users may be motivated to hold existing Bitcoin and switch from Bitcoin to another digital
asset or back to fiat currency for transactions, diminishing the aggregate amount of available transaction fees for Bitcoin miners.
Such reduction would adversely impact our results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Bitcoin reward for successfully
uncovering a block will halve several times in the future, and Bitcoin value may not adjust to compensate us for the reduction
in the rewards we receive from our Bitcoin mining efforts.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Halving is a process designed to control
the overall supply and reduce the risk of inflation in cryptocurrencies using a proof of work consensus algorithm. At a predetermined
block, the Bitcoin mining reward is cut in half, hence the term &ldquo;halving.&rdquo; For Bitcoin, the reward was initially set
at 50 Bitcoin currency rewards per block and this was cut in half to 25 on November 28, 2012 at block 210,000, then again to 12.5
on July 9, 2016 at block 420,000. The most recent halving for Bitcoin occurred on May 11, 2020 at block 630,000 and the reward
was reduced to 6.25. It is expected that the next halving will likely occur in 2024. This process will reoccur until the total
amount of Bitcoin currency rewards issued reaches 21 million, which is expected around the year 2140. While Bitcoin prices have
had a history of fluctuations around the halving of its rewards, there is no guarantee that the price change will be favorable
or would compensate for the reduction in mining reward. If a corresponding and proportionate increase in the trading prices of
Bitcoin or a proportionate decrease in mining difficulty does not follow these anticipated halving events, the revenue we earn
from our Bitcoin mining operations could see a corresponding decrease, which could have a material adverse effect on our business
and operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may not be able to realize the
benefits of forks, and forks in a digital asset network may occur in the future which may affect the value of the cryptocurrencies
that we mine held by us. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that a significant majority
of users and miners on a cryptocurrency network install software that changes the cryptocurrency network or properties of a cryptocurrency,
including the irreversibility of transactions and limitations on the mining of new cryptocurrency, the cryptocurrency network
would be subject to new protocols and software. If less than a significant majority of users and miners on the cryptocurrency
network consent to the proposed modification, however, and the modification is not compatible with the software prior to its modification,
a &ldquo;fork&rdquo; of the network would occur, with one prong of the network running the pre-modified software and the other
running the modified software. The effect of such a fork would be the existence of two versions of the cryptocurrency running
in parallel, yet lacking interchangeability and necessitating exchange-type transaction to convert currencies between the two
forks. After a fork, it may be unclear which fork represents the original asset and which is the new asset.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we hold a specific cryptocurrency at
the time of a hard fork into two cryptocurrencies, industry standards would dictate that we would be expected to hold an equivalent
amount of the old and new assets following the fork. We may not, however, be able to secure or realize the economic benefit of
the new asset. Our business may be adversely impacted by forks in an applicable cryptocurrency network.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, historically, speculation
over a new &ldquo;hard fork&rdquo; in the Bitcoin protocol has resulted in Bitcoin price volatility and future hard forks may
occur at any time. A hard fork can lead to a disruption of networks and our information technology systems could be affected by
cybersecurity attacks, replay attacks, or security weaknesses, any of which can further lead to temporary or even permanent loss
of its assets. Such disruption and loss could cause us to be exposed to liability, even in circumstances where we have no intention
of supporting an asset compromised by a hard fork. Additionally, a hard fork may result in a scenario where users running the
previous protocol will not recognize blocks created by those running the new protocol, and vice versa. This may render our cryptocurrency
mining hardware incompatible with the new protocol. Such changes may have a material effect on our operations, financial position,
and financial performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>As the aggregate amount of computing
power, or hash rate, in the Bitcoin network increases, the amount of Bitcoin earned per unit of hash rate decreases; as a result,
in order to maintain our market share, we may have to incur significant capital expenditures in order to expand our fleet of miners.
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate computing power of the global
Bitcoin network has generally grown over time and we expect it to continue to grow in the future. To the extent the global hash
rate continues to increase, the market share of and the amount of Bitcoin rewards paid to any fixed fleet of miners will decrease.
Therefore, in order to maintain our market share, we may be required to expand our mining fleet, which may require significant
capital expenditures. Such significant capital expenditures could have an adverse effect on our business operations, strategy,
and financial performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Climate change, and the regulatory
and legislative developments related to climate change, may materially adversely affect our business and financial condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The potential physical impacts of climate
change on our operations are highly uncertain and would be particular to the geographic circumstances in areas in which we operate
or in which our third-party providers operate. These may include changes in rainfall and storm patterns and intensities, water
shortages, changing sea levels, and changing temperatures. The impacts of climate change may materially and adversely impact the
cost, production, and financial performance of our operations. Further, any impacts to our business and financial condition as
a result of climate change are likely to occur over a sustained period of time and are therefore difficult to quantify with any
degree of specificity. For example, extreme weather events may result in adverse physical effects on portions of our infrastructure,
which could disrupt our supply chain and ultimately our business operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, a number of governments or
governmental bodies have introduced or are contemplating legislative and regulatory changes in response to the potential impact
of climate change. Given the very significant amount of electrical power required to operate cryptocurrency miners, as well as
the environmental impact of mining for the rare earth metals used in the production of mining servers, the cryptocurrency mining
industry may become a target for future environmental and energy regulation, and any such regulation may not distinguish between
cryptocurrency mining powered by renewable energy, as is SCI&rsquo;s business, and cryptocurrency mining using traditional (i.e.
fossil fuel) sources of energy. Legislation and increased regulation regarding climate change could impose significant costs on
us and our suppliers, including costs related to increased energy requirements, capital equipment, environmental monitoring, and
reporting, and other costs to comply with such regulations. Any future climate change regulations could also negatively impact
our ability to compete with companies situated in areas not subject to such limitations. Given the political significance and
uncertainty around the impact of climate change and how it should be addressed, we cannot predict how legislation and regulation
will affect our financial condition, operating performance, and ability to compete. Any of the foregoing could result in a material
adverse effect on our business, prospects, and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our business plan is heavily dependent
upon acquisitions and strategic alliances and our ability to identify, acquire or ally on appropriate terms, and successfully
integrate and manage any acquired companies or alliances will impact our financial condition and operating results. </I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Part of our strategy to grow our business
is dependent on the acquisition of other entities or businesses in the future that complement our current products, enhance our
market coverage or technical capabilities, or offer growth opportunities. We may also need to form strategic alliances or partnerships
in order to remain competitive in our market. We may not be able, however, to identify and successfully negotiate suitable acquisitions
alliances, obtain any financing necessary for such acquisitions on satisfactory terms, or otherwise complete any such acquisitions
or alliances. Further, any acquisition or alliance may require a significant amount of management&rsquo;s time and financial resources
to complete and acquisitions, strategic alliances or partnerships could be difficult to integrate, disrupt our business, and dilute
stockholder value.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For example, in January 2020,
the Company formed SCI as its wholly-owned subsidiary to pursue a new business line focused on cryptocurrency and the blockchain
ecosystem. In October 2021, Soluna Computing became a wholly-owned subsidiary of SCI pursuant to a merger. Prior to the merger,
Soluna Computing had assisted us in developing and operating the cryptocurrency mining facility through contractual arrangements.
In the future, we may acquire or form strategic alliances or partnerships with other businesses in order to remain competitive
or to acquire new technologies. Acquisitions, alliances, and investments involve numerous risks, including:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">the
                 potential failure to achieve the expected benefits of the combination, acquisition or alliance;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">difficulties
                 in and the cost of integrating operations, technologies, services and personnel;</P>
</TD>
</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">difficulty of assimilating geographically-dispersed operations and personnel of the companies
    we acquire or ally with;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">impairment of relationships with
        employees, customers, vendors, distributors, or business partners of either an acquired business or our own;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">unanticipated difficulties in
        conforming business practices, policies, procedures, internal controls, and financial records of acquisitions with our
        own;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify">the potential inability to successfully integrate acquired operations and products or to realize
    cost savings or other anticipated benefits from integration;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">diversion of financial and managerial resources from existing operations;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">risk of entering new markets in which we have little or no experience or where competitors
    may have stronger market positions;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">potential write-offs of acquired assets or investments, and potential financial and credit
    risks associated with acquired customers;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">inability to generate sufficient revenue to offset acquisition or investment costs;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify">the risk of cancellation or early termination of an alliance by either party;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">potential unknown liabilities associated with the acquired businesses;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">unanticipated expenses related to acquired technology and its integration
    into the existing businesses;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">negative impact to our results of operations because of the depreciation and amortization
    of amounts related to acquired intangible assets, fixed assets, and deferred compensation, and the loss of acquired deferred
    revenue and unbilled deferred revenue;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">loss of key employees or customers
        of acquired companies;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">potential disruption of our business
        or the acquired business;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify">inability to accurately forecast the performance of recently-acquired businesses, resulting
    in unforeseen adverse effects on our operating results;</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt">&#9679;</TD>
    <TD STYLE="text-align: justify">the tax effects of any acquisitions; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify">Adverse accounting impact to our results of operations.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our failure to successfully manage
our recent acquisition of Soluna Computing or other future acquisitions, strategic alliances, or partnerships could seriously
harm our operating results. In addition, our stockholders would be diluted if we finance the future acquisitions, strategic alliances,
or partnerships by incurring convertible debt or issuing equity securities.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We cannot offer any assurance that we
will be able to identify, complete, or successfully integrate any suitable acquisitions or suitable alliances. Even if successfully
negotiated and closed, any acquisitions or alliances may not yield expected synergies, may not advance our business strategy as
expected, may fall short of expected return-on-investment targets, or may otherwise fail to achieve their objectives or perform
as contemplated and not prove successful. Companies that we acquire may operate with different cost and margin structures, which
could further cause fluctuations in our operating results and adversely affect our business, financial condition, and results
of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>In connection with the ground leases
for our new cryptocurrency mining operations, we rely on the landlord to sell us the power required for our operations, and any
failure of the landlord to supply such power, whether as a result of its failure to pay the TVA or otherwise, would materially
impact our operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2021, EcoChain Block, a wholly-owned
subsidiary of SCI, entered into two ground leases (the &ldquo;Ground Leases&rdquo;) for a building located in the Southeast region
of the United States that will be SCI&rsquo;s second cryptocurrency mining facility, which includes surrounding land for potential
additional capacity. The Ground Leases will not be effective until certain conditions set forth therein are met. In addition,
EcoChain Block and the landlord entered into a power supply agreement whereby EcoChain Block will purchase the power for its cryptocurrency
mining operations from the landlord, who purchases power directly from the TVA. The rates payable by EcoChain Block to the landlord
will be at the same pre-negotiated rates paid by landlord, which are less than SCI could obtain directly from the TVA. The landlord&rsquo;s
failure to provide power to SCI, as a result of the termination of such power supply to the landlord by the TVA, as a result of
the landlord&rsquo;s failure to pay the TVA for such power, or otherwise, would, in all likelihood, result in our inability to
obtain the power we need for our cryptocurrency mining operations, unless and until we were able to obtain such power directly
from the TVA, which would result in a significant interruption to our business. We may also incur significant costs associated
with negotiating and entering into a new agreement with the TVA to supply power to EcoChain Block&rsquo;s cryptocurrency mining
facilities, and with setting up corresponding infrastructure to receive such power directly. Further, there can be no assurance
that EcoChain Block will be able to negotiate a power supply agreement with the TVA on equally favorable terms as the landlord,
if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The properties on which certain
of our ground leases are located are subject to possible forfeiture to the U.S. government, and, if seized, would, in all likelihood,
require us to spend significant funds to maintain our cryptocurrency mining rights. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020, the United States Department
of Justice&rsquo;s Money Laundering &amp; Asset Recovery Section (&ldquo;DOJ&rdquo;), together with the U.S. Attorney&rsquo;s
Office for the Southern District of Florida, filed civil asset forfeiture complaints against parties related to the landlord (the
&ldquo;Landlord Owners&rdquo;) in connection with certain real properties, including the real properties that are the subject
of the Ground Leases (the &ldquo;Subject Properties&rdquo;). The complaints, all of which are currently pending before a federal
judge, alleged that the funds used by Landlord Owners to purchase the Subject Properties were traceable to the proceeds of a bank
fraud purportedly committed internationally in Ukraine by the Landlord Owners. Though the DOJ has not filed a civil forfeiture
action against the Subject Properties, the complaint the government submitted in support of its asset forfeiture requests against
certain properties, including the Subject Properties, included a description of the Ukrainian bank fraud and the various properties
located in the United States that the DOJ believes were purchased with the proceeds of that international bank fraud, including
the Subject Properties.&nbsp;In the event that the Subject Properties are seized by the U.S. government, EcoChain Block may be
required to negotiate with the U.S. government for the supply of power that SCI was receiving from the landlord pursuant to the
Power Supply Agreement. Additionally, the U.S. government, in all likelihood, would place the Subject Properties for sale at an
auction, or otherwise, and we would likely be required to purchase the Subject Properties to assure the continuation of our cryptocurrency
mining operations at such facility, all of which would require our expenditure of significant funds and could have a material
adverse impact on our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If federal or state legislatures
or agencies initiate or release tax determinations that change the classification of cryptocurrencies as property for tax purposes
(in the context of when such cryptocurrencies are held as an investment), such determination could have a negative tax consequence
on us. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current Internal Revenue Service guidance
indicates that digital assets such as Bitcoin should be treated and taxed as property, and that transactions involving the payment
of bitcoin for goods and services should be treated as barter transactions. While this treatment creates a potential tax reporting
requirement for any circumstance where the ownership of a cryptocurrency passes from one person to another, it preserves the right
to apply capital gains treatment to those transactions which may adversely affect our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Risks Relating to our MTI
Instruments Business</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Our MTI Instruments business
depends on a small number of customers including the U.S. Air Force.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Historically, we have had a small
number of customers representing a large percentage of our total revenue. Although we endeavor to maintain and further expand
our customer base, we expect that sales to a limited number of customers will continue to account for a high percentage of our
revenues in any given period for the foreseeable future, and the loss of even just a couple of customers, or a significant reduction
in sales to our existing customer base, could have a material adverse effect on our business. In addition, our revenues are largely
dependent upon the ability of our customers to continue to grow or need services or to develop and sell products that incorporate
our services and products. We also depend on purchases by the U.S. Air Force for a significant portion of our revenues and the
loss of the U.S. Air Force as a customer or a delay or decline in funding of our existing or future contracts with them could
decrease our backlog or adversely affect our business and prospects, sales, cash flows, and our ability to fund our continued
product development and growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 43 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>We do not have long-term
purchase commitments from our customers, and our customers are also able to cancel, reduce, or delay orders for our products.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We generally do not obtain firm,
long-term purchase commitments from our customers, and frequently do not have visibility as to their future demand for our products
and services. Customers also cancel, change or delay design, production or aftermarket service quantities and schedules, or fail
to meet their forecasts for a number of reasons beyond our control. Customer expectations can also change rapidly, requiring us
to take on additional commitments or risks, and requiring that we provide rapid product turnaround and respond to short lead times.
A variety of conditions, both specific to individual customers and generally affecting the demand for original equipment manufacturers&rsquo;
products, may cause customers to cancel, reduce, or delay orders. Conversely, if our customers unexpectedly and significantly
increase product orders, we may be required to rapidly increase production, which could strain our resources and reduce our margins.
We typically plan production and inventory levels based on internal forecasts of customer demand, which can be highly unpredictable
and can fluctuate substantially, leading to excess inventory write-downs and resulting negative impacts on gross margin and net
income. Additionally, and as a result, our revenues may be volatile from period to period, we may not achieve the anticipated
revenues from these efforts, or these efforts may result in non-recoverable costs.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Our annual and quarterly
operating results may experience significant fluctuations, which could adversely impact our operations and financial results.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In addition to the variability
resulting from the short-term nature of our customers&rsquo; commitments, other factors contribute to significant periodic fluctuations
in our results of operations. These factors include:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">the
                 cyclicality of the markets we serve;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">the
                 timing and size of orders;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">the
                 volume of orders relative to our capacity;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">product
                 introductions and market acceptance of new products or new generations of products;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">evolution
                 in the life cycles of our customers&rsquo; products;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">timing
                 of expenses in anticipation of future orders;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">changes
                 in product mix;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">availability
                 of manufacturing and assembly services;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">changes
                 in cost and availability of labor and components;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">timely
                 delivery of product solutions to customers;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">pricing
                 and availability of competitive products;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">introduction
                 of new technologies into the markets we serve;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">pressures
                 on reducing selling prices;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">our
                 success in serving new markets; and</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">changes
                 in economic conditions.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The price of our securities could
decline substantially in the event that any of these risks result in our financial performance being below the expectations of
analysts and investors, which are based on historical and predictive models that are not necessarily accurate representations
of the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 44; Value: 1 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>We may not be able to keep
pace with technological innovations or develop new product solutions in a timely manner.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The electronic, semiconductor,
solar, automotive, and general industrial segments are subject to constant technological change. MTI Instruments&rsquo; future
success will depend on our ability to respond appropriately to changing technologies and changes in product function and quality.
If we rely on products and technologies that are not attractive to end users, we may not be successful in capturing or retaining
market share. Technological advances, the introduction of new products, and new design techniques could adversely affect our business
prospects unless we are able to adapt to the changing conditions. Technological advances could render our products obsolete, and
we may not be able to respond effectively to the technological requirements of evolving markets. As a result, we will be required
to expend substantial funds for and commit significant resources to:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">continue
                 research and development activities on all product lines;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">hire
                 additional engineering and other technical personnel; and</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">purchase
                 advanced design tools and test equipment.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our business could be harmed
if we are unable to develop and utilize new technologies that address the needs of our customers, or our competitors do so more
effectively than we do.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Our efforts to continue
to develop new products and technologies may not result in commercial success, which could cause a decline in our revenue and
otherwise harm our business.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our research and development
efforts with respect to our products and technologies may not result in customer or market acceptance. Some or all of such products
and technologies may not successfully make the transition from the research and development lab to cost-effective production as
a result of technology problems, competitive cost issues, yield problems, and other factors. Even when we successfully complete
a research and development effort with respect to a particular product or technology, our customers may decide not to introduce
or may discontinue products utilizing the product or technology for a variety of reasons, including the following:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">difficulties
                 with other suppliers of components for the products;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">superior
                 technologies developed by our competitors and unfavorable comparisons of our solutions with these technologies;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">price
                 considerations; and</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">lack
                 of anticipated or actual market demand for the products.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The nature of MTI Instruments&rsquo;
business will require us to make continuing investments to develop new products and technologies. Significant expenses relating
to one or more new products or technologies that ultimately prove to be unsuccessful for any reason could have a material adverse
effect on us. In addition, any investments or acquisitions made to enhance our products and technologies may prove to be unsuccessful.
If our efforts are unsuccessful, our business could be harmed. Moreover, when we announce our development of new products, sales
of current products may decrease as customers delay making purchases until such new products are available, which could adversely
affect our business, revenues, and results of operations.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>The cyclical nature of
the industries of many of MTI Instruments&rsquo; existing and target customers may result in fluctuations in our operating results.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Demand for our products and services
in our target markets is cyclical, and revenues from the sale of our products and services can vary significantly from one period
to the next as a result. We may sell a significant amount of our products to one or a few customers for various short term projects
in one period, and then have markedly decreased sales in following periods as these projects end or customers have the products
they require for the foreseeable future.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The electronics and military
industries in particular have experienced significant economic downturns at various times. These downturns are characterized by
diminished product demand, accelerated erosion of average selling prices, and production overcapacity. We may seek to reduce our
exposure to industry downturns by providing design and production services for leading companies in rapidly expanding industry
segments. We may, however, experience substantial period-to-period fluctuations in future operating results because of general
industry conditions or events occurring in the general economy.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 45; Value: 1 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>International sales risks
could adversely affect our operating results. Furthermore, our operating results could be adversely affected by changes to U.S.
policy and fluctuations in the value of the U.S. dollar against foreign currencies.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Sales outside of the United States
accounted for approximately 33.1% of our total revenue during the nine months ended September 30, 2021, 25.9% of our total revenue
in 2020, and 35.3% of our total revenue in 2019. Our international business may be adversely affected by changing political and
economic conditions in foreign countries. Having a worldwide distribution network for our products exposes us to various economic,
political, and other risks that could adversely affect our operations and operating results, including the following:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">export
                 restrictions and controls relating to technology;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">the
                 burdens and costs of compliance with a variety of existing and new foreign regulatory requirements and laws,
                 including the General Data Protection Regulation (GDPR) in the European Union and similar laws in other jurisdictions,
                 and unexpected changes in such regulatory requirements;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">laws
                 and business practices favoring local companies, including tariffs imposed by other countries on U.S. goods;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">timing
                 to meet regulatory requirements;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">developments
                 with respect to and any impact of tariffs and other trade barrier restrictions;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">longer
                 payment cycles and greater difficulty in enforcing agreements and collecting receivables through foreign legal
                 systems;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">potentially
                 reduced protection for, and difficulties in enforcing, intellectual property rights; and</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">political
                 or economic instability in certain parts of the world.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">These risks or any combination
of them could increase our costs, lengthen our sales cycle, and require significant management attention and could otherwise negatively
affect our business, operating results, financial condition, and results of operations.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In addition, we transact our
business in U.S. dollars and bill and collect our sales in U.S. dollars. It is possible that U.S. policy changes and uncertainty
about policy could increase market volatility and currency exchange rate fluctuations. Market volatility and currency exchange
rate fluctuations could impact our results of operations and financial condition related to transactions denominated in a foreign
currency. A weakening of the dollar could cause our overseas vendors to require renegotiation of either the prices or currency
we pay for their goods and services. Similarly, a strengthening of the dollar could cause our products to be more expensive for
our international customers, which could impact price and margins and/or cause the demand for our products, and thus our revenue,
to decline.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In the future, customers may
negotiate pricing and make payments in non-U.S. currencies. If our overseas vendors or customers require us to transact business
in non-U.S. currencies, fluctuations in foreign currency exchange rates could affect our cost of goods, operating expenses, and
operating margins and could result in exchange losses. In addition, currency devaluation can result in a loss to us if we hold
deposits of that currency. Hedging foreign currencies can be difficult, especially if the currency is not freely traded. We cannot
predict the impact that future exchange rate fluctuations may have on our operating results.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>MTI Instruments&rsquo; business
operations, financial performance, and liquidity are occasionally reliant on a single supplier or vendor or a limited group of
suppliers and vendors. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We depend on a limited number of suppliers
and vendors for products and services relating to our MTI Instruments business. Specifically, for the nine months ended September
30, 2021 and the year ended December 31, 2020, Spinnaker Contract Manufacturing, Inc. supplied 9% and 15%, respectively, of the
PC boards used by almost all MTI Instrument products, and SYNNEX Corporation supplied 2% and 26%, respectively, of the military
computers used by MTI Instruments. In the event it becomes necessary to seek alternative suppliers and vendors, we may be unable
to obtain satisfactory replacement supplies or services on economically attractive terms, on a timely basis, or at all, which
could increase costs or cause disruptions in the manufacturing of our products or delivery of our services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 46; Value: 1 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to our Company Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Our confidentiality agreements
with employees and others may not adequately prevent disclosure of our trade secrets and other proprietary information, which
could limit our ability to compete.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">While we are currently in the
process of applying for patents with respect to SCI&rsquo;s business, presently we rely on trade secrets to protect our proprietary
technology and processes. Despite such protection, however, it is possible that a third party may copy or otherwise obtain and
use our U.S. Patent and Trademark Office-registered or other proprietary information without our authorization, and trade secrets
can be difficult to protect. Policing unauthorized use of our intellectual property and trade secrets is difficult, particularly
in light of the global nature of the Internet and because the laws of other countries may afford us little or no effective protection
of our intellectual property. Potentially expensive litigation may be necessary in the future to enforce our intellectual property
rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others or to defend against
claims of infringement or invalidity. Additionally, we enter into confidentiality and intellectual property assignment agreements
with our employees, consultants, and other advisors. These agreements generally require that the other party keep confidential
and not disclose to third parties confidential information developed by the party under such agreements or made known to the party
by us during the course of the party&rsquo;s relationship with us. Our employees, consultants, and other advisors, however, may
not honor these agreements and enforcing a claim that a party illegally obtained and is using our trade secrets is difficult,
expensive and time-consuming, and the outcome is unpredictable. Our failure to obtain and maintain trade secret protection could
adversely affect our competitive position.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>We rely on highly-skilled
personnel and the continuing efforts of our executive officers and, if we are unable to retain, motivate, or hire qualified personnel,
our business may be severely disrupted. In addition, increased labor costs and the unavailability of skilled workers could hurt
our business, financial condition, and results of operations.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our performance largely depends
on the talents, knowledge, skills, know-how and efforts of highly skilled individuals and in particular, the expertise held by
our Chief Executive Officer, Michael Toporek. His absence, were it to occur, would materially and adversely impact development
and implementation of our projects and businesses. Our future success depends on our continuing ability to identify, hire, develop,
motivate and retain highly skilled personnel for all areas of our organization. Our continued ability to compete effectively depends
on our ability to attract, among others, new technology developers and to retain and motivate our existing contractors. If one
or more of our executive officers or other key personnel are unable or unwilling to continue in their present positions, we may
not be able to replace them readily, if at all. In such case, our business may be severely disrupted, and we may incur additional
expenses to recruit and retain new officers or other key personnel. In addition, if any of our executives or key personnel joins
a competitor or forms a competing company, we may lose customers.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we compete with other businesses
in our industries and other similar employers to attract and retain qualified&nbsp;personnel with the technical skills and experience
required to successfully operate our businesses. The demand for skilled workers is high and the supply is limited, and a shortage
in the labor pool of skilled workers or other general inflationary pressures or changes in applicable laws and regulations could
make it more difficult for us to attract and retain&nbsp;personnel and could require us to enhance our wage and benefits packages,
which could increase our operating costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 47; Value: 1 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Brookstone XXIV&rsquo;s
ownership of the outstanding shares of our Common Stock gives it a controlling interest in the Company.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">As of December 10, 2021, Brookstone
XXIV owned approximately 28.7% of the Company&rsquo;s outstanding shares of Common Stock, and has designated two directors that
sit on our ten-member Board. Accordingly, Brookstone XXIV has the ability to exert a significant degree of influence or actual
control over our management and affairs and, as a practical matter, will control corporate actions requiring stockholder approval,
irrespective of how our other stockholders may vote, including the election of directors, amendments to our Articles of Incorporation
and Bylaws, and the approval of mergers and other significant corporate transactions, including a sale of substantially all of
our assets, and Brookstone XXIV may vote its shares in a manner that is adverse to the interests of our minority stockholders.
This concentration of voting control could deprive holders of our Common Stock of an opportunity to receive a premium for their
shares of our Common Stock as part of a sale of the Company. Further, Brookstone XXIV&rsquo;s control position might adversely
affect the market price of our securities to the extent investors perceive disadvantages in owning shares of a company with a
controlling stockholder.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Brookstone XXIV and its
director designees may acquire interests and positions that could present potential conflicts with our and our stockholders&rsquo;
interests.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Brookstone XXIV and its director
designees may make investments in companies and may, from time to time, acquire and hold interests in businesses that compete
directly or indirectly with us. Brookstone XXIV and its director designees may also pursue, for their own accounts, acquisition
opportunities that may be complementary to our business, and as a result, those acquisition opportunities might not be available
to us. As part of our sale of 3,750,000 shares of our Common Stock to Brookstone XXIV in October 2016 and as required by Brookstone
XXIV as a condition to purchasing the shares, our Board renounced, to the extent permitted by applicable law, the Company&rsquo;s
expectancy with respect to being offered an opportunity to participate in any business opportunity that is discovered by or presented
to a director designee (a &ldquo;Business Opportunity&rdquo;), whether in such director designee&rsquo;s capacity as a director
of the Company or otherwise. Accordingly, the interests of Brookstone XXIV and the designated directors with respect to a Business
Opportunity may supersede ours, and Brookstone XXIV or its affiliates or the Brookstone XXIV-designated directors may be involved
with businesses that compete with us and may pursue opportunities for the sole benefit of Brookstone XXIV and its affiliates without
our involvement, for which we have limited recourse. Such actions on the part of Brookstone XXIV or its director designees could
have a material adverse effect on our business, financial condition, results of operations and cash flows.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 48 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In addition, Michael Toporek,
the Company&rsquo;s Chief Executive Officer, serves as the Managing General Partner of Brookstone XXIV. As a result of the potential
conflicts inherent in his serving in both roles, it is possible that Mr. Toporek could make decisions that benefit Brookstone
XXIV at the expense of the Company.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Insiders continue to have
substantial control over the Company.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">As of December 10, 2021, the
Company&rsquo;s directors and executive officers held the current right to vote approximately 34.6% of the Company&rsquo;s outstanding
voting stock. Of this total, 28.7% was owned or controlled by Brookstone XXIV, for which Michael Toporek, the Company&rsquo;s
Chief Executive Officer, also serves as Managing General Partner. In addition, the Company&rsquo;s directors and executive officers
have the right to acquire additional shares of our Common Stock by exercising their equity awards under our equity compensation
plans, which could increase their voting percentage significantly. As a result, Mr. Toporek acting alone, and/or many of the Company&rsquo;s
officers and directors acting together, may have the ability to exert significant control over the Company&rsquo;s decisions and
control the management and affairs of the Company, and also to determine the outcome of matters submitted to stockholders for
approval, including the election or removal of a director, and any merger, consolidation, or sale of all or substantially all
of the Company&rsquo;s assets. Accordingly, this concentration of ownership may harm the future market price of our securities
by:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">delaying,
                 deferring, or preventing a change in control of the Company;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">impeding
                 a merger, consolidation, takeover, or other business combination involving the Company; or</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9679;</P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">discouraging
                 a potential acquirer from making a tender offer or otherwise attempting to obtain control of the Company.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We are subject to complex environmental,
health, and safety laws and regulations that may expose us to significant liabilities for penalties, damages, or costs of remediation
or compliance.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to various federal, state,
local and foreign environmental, health, and safety laws and regulations. These laws and regulations govern matters such as: the
emission and discharge of hazardous materials into the ground, air, or water; the generation, use, storage, handling, treatment,
packaging, transportation, exposure to, and disposal of hazardous and biological materials, including recordkeeping, reporting,
and registration requirements; and the health and safety of our employees. We may incur significant additional costs beyond those
currently contemplated to comply with these regulatory requirements. Further, if we fail to comply with these requirements we
may be exposed to fines, penalties, and/or interruptions in our operations that could have a material adverse effect on our business,
operating results, and financial condition. Certain environmental laws may impose strict, joint, and several liability for costs
required to clean up and restore sites where hazardous substances have been disposed or otherwise released into the environment,
even under circumstances where the hazardous substances were released by prior owners or operators or the activities conducted
and from which a release emanated complied with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, existing regulations, particularly
in the environmental area, could be revised or reinterpreted, or new laws and regulations could be adopted or become applicable
to us or our facilities, and future changes in environmental laws and regulations could occur, including potential regulatory
and enforcement developments related to air emissions, any of which could result in significant additional costs. Any of the foregoing
could have a material adverse effect on our results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to the Recent Acquisition
of Soluna Computing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may fail to realize all of the
anticipated benefits of our recent acquisition of Soluna Computing.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The success of the recent Soluna Computing
acquisition will depend, in part, on the Company&rsquo;s and Soluna Computing&rsquo;s ability to realize the anticipated benefits
and cost savings from combining the businesses of Soluna Computing and SCI. To realize these anticipated benefits and cost savings,
however, we must successfully combine the businesses of Soluna Computing and SCI. If we are unable to successfully combine the
businesses of Soluna Computing and SCI, the anticipated benefits and cost savings of the transaction may not be realized fully
or at all or may take longer to realize than expected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until very recently, Soluna Computing
and SCI operated independently, and we have just begun to integrate the companies&rsquo; operations. It is possible that the integration
process could result in the loss of key employees and the disruption of the merged company&rsquo;s ongoing business, which could
have a negative impact on our ability to achieve the anticipated benefits of the merger. Integration efforts between the two companies
may, to some extent, also divert management&rsquo;s attention and resources. These integration matters could have an adverse effect
on each SHI and SCI during the current transition period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our operating results will suffer
if SHI and SCI do not effectively manage the increased scale of SCI&rsquo;s operations and the optimization and expansion opportunities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following its acquisition of Soluna Computing,
SCI is larger and more diverse than it was prior to the acquisition transaction. Its future success will depend, in part, upon
its ability to manage its optimization and expansion opportunities, which may pose substantial challenges for SCI to integrate
new operations into its existing business in an efficient and timely manner, and upon its ability to successfully monitor its
operations, costs, and regulatory compliance, and to maintain other necessary internal controls. There is no assurance that SCI&rsquo;s
optimization and expansion opportunities will be successful, or that it will realize its expected operating efficiencies, cost
savings, revenue enhancements, synergies, or other expected benefits of its acquisition of Soluna Computing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General Risk Factors </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We are heavily dependent on our
senior management, and a loss of a member of our senior management team could cause our stock price to suffer.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we lose the services of Michael Toporek,
our Chief Executive Officer and a member of our board of directors, Jessica L. Thomas, our Chief Financial Officer, David C. Michaels,
our Chairman of the Board, and/or certain key employees, we may not be able to find appropriate replacements on a timely basis,
and our business could be adversely affected. We do not currently maintain key life insurance policies on these officers or key
employees. Our existing operations and continued future development depend to a significant extent upon the performance and active
participation of these individuals and certain key employees. We may not be successful in retaining the services of these individuals,
and if we were to lose any of these individuals, we may not be able to find appropriate replacements on a timely basis and our
financial condition and results of operations could be materially adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>We may incur losses and
liabilities in the course of business that could prove costly to defend or resolve.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Companies that operate in one
or more of the businesses that we operate face significant legal risks. There is a risk that we could become involved in litigation
wherein an adverse result could have a material adverse effect on our business and our financial condition. There is a risk of
litigation generally in conducting a commercial business, and we are, at times, involved in commercial disputes with third parties,
such as customers, distributors, and vendors. These risks often may be difficult to assess or quantify and their existence and
magnitude often remain unknown for substantial periods of time. We may incur significant legal expenses in defending against litigation.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 49 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>We may become subject to
claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from selling
our products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial
monetary damages and injunctive relief.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We may receive notices from third
parties that the manufacture, use, or sale of any products we develop infringes upon one or more claims of their patents. Moreover,
because patent applications can take many years to issue, there may be currently pending applications, unknown to us, that may
later result in issued patents that materially and adversely affect our business. Third parties could also assert infringement
or misappropriation claims against us with respect to our future product offerings, if any. We cannot be certain that we have
not infringed the intellectual property rights of any third parties. Any infringement or misappropriation claim could result in
significant costs, substantial damages, and our inability to manufacture, market, or sell any of our product offerings that are
found to infringe another person&rsquo;s patent. Even if we were to prevail in any such action, the litigation could result in
substantial cost and diversion of resources that could materially and adversely affect our business. If a court determined, or
if we independently discovered, that our product offerings violated third-party proprietary rights, there can be no assurance
that we would be able to re-engineer our product offerings to avoid those rights or obtain a license under those rights on commercially
reasonable terms, if at all. As a result, we could be prohibited from selling products that are found to infringe upon the rights
of others. Even if obtaining a license were feasible, it may be costly and time-consuming. A court could also enter orders that
temporarily, preliminarily, or permanently enjoin us from making, using, selling, offering to sell, or importing our products
that are found to infringe on third parties&rsquo; intellectual property rights, or could enter orders mandating that we undertake
certain remedial actions. Further, a court could order us to pay compensatory damages for any such infringement, plus prejudgment
interest, and could in addition treble the compensatory damages and award attorneys&rsquo; fees. Any such payments could materially
and adversely affect our business and financial condition.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>If we are unable to protect
our information systems against service interruption or failure, misappropriation of data or breaches of security, our operations
could be disrupted, we could be subject to costly government enforcement actions and private litigation and our reputation may
be damaged.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our business involves the collection,
storage and transmission of personal, financial or other information that is entrusted to us by our customers and employees. Our
information systems also contain the Company&rsquo;s proprietary and other confidential information related to our business. Our
efforts to protect such information may be unsuccessful due to the actions of third parties, computer viruses, physical or electronic
break-ins, catastrophic events, employee error or malfeasance or other attempts to harm our systems. As the techniques used to
obtain unauthorized access, disable or degrade service, or sabotage systems, change frequently and often are not recognized until
launched against a target, we may be unable to anticipate these techniques or timely implement adequate preventative measures.
We could also experience a loss of critical data and delays or interruptions in our ability to manage inventories or process transactions.
Some of our commercial partners, such as those that help us maintain our website, may receive or store information provided by
us or our users through our website. If these third parties fail to adopt or adhere to adequate information security practices,
or fail to comply with our policies in this regard, or in the event of a breach of their networks, our customers&rsquo; or employees&rsquo;
information may be improperly accessed, used or disclosed.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 50 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If our systems are harmed or
fail to function properly, we may need to expend significant financial resources to repair or replace systems or to otherwise
protect against security breaches or to address problems caused by breaches. If we experience a significant security breach or
fail to detect and appropriately respond to a significant security breach, we could be exposed to costly legal actions against
us in connection with such incidents, which could result in orders or judgments forcing us to pay damages or fines or to take
certain actions with respect to our information systems. Any incidents involving unauthorized access to or improper use of user
information, or incidents that are a violation of our online privacy policies, could harm our brand reputation and diminish our
competitive position. Any of these events could have a material and adverse effect on our business, reputation or financial results.
Our insurance policies carry coverage limits, which may not be adequate to reimburse us for losses caused by security breaches.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 51 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Our risk management process
may not identify all risks that we are subject to and will not eliminate all risk.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our Enterprise Risk Management
(&ldquo;ERM&rdquo;) process seeks to identify and address significant risks. Our ERM process uses the most recent integrated risk
framework in <I>Internal Control &mdash; Integrated Framework (2013) </I>issued by the Committee of Sponsoring Organizations of
the Treadway Commission to assess, manage, and monitor risks. We believe that risk-taking is an inherent aspect of the pursuit
of our growth and performance strategy. Our goals are to proactively manage risks in a structured approach in conjunction with
strategic planning, with the intent to preserve and enhance shareowner value, and to manage prudently, rather than wholly avoiding,
risks. We can mitigate risks and their impact on the Company, however, only to a limited extent, and no ERM process can identify
all risks that we may face. Therefore, there may be risks that we are currently unaware of, that may develop in the future or
that we currently consider immaterial. Further, our management of risks may prove inadequate. The emergence of risks of which
we were unaware or are unable to manage could have a material adverse effect on our business, prospects, financial condition and
results of operations.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 52 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>The Company&rsquo;s officers
and directors are indemnified against certain conduct that may prove costly to defend.</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our Articles of Incorporation
and Bylaws generally provide broad indemnification to our officers and directors against judgments, fines, amounts paid in settlement,
and expenses, including attorneys&rsquo; fees actually incurred in connection with most actions or proceedings to which they are
or are threatened to be made a party that relates to their service as an officer or director, except as limited as set forth therein.
We are also obligated to advance expenses as they are incurred by a director or officer in defending an action or proceeding prior
to final disposition upon receipt of an undertaking by the applicable person to repay such advanced amount if the advancement
is ultimately found to not be permitted by law or otherwise.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 53 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In addition, the Nevada Revised
Statutes (the &ldquo;NRS&rdquo;) provides that no director or officer is individually liable for damages as a result of an act
or failure to act in his or her capacity as a director or officer except if (i) the presumption that such director or officer
acted in good faith, on an informed basis and with a view to the interests of the Company is rebutted, and (ii) it is proven that
such director&rsquo;s or officer&rsquo;s act or failure to act constituted a breach of his or her fiduciary duties as a director
or officer, and such breach involved intentional misconduct, fraud or a knowing violation of law.. Consequently, subject to the
applicable provisions of the NRS and to certain limited exceptions in the Articles of Incorporation and Bylaws, the Company&rsquo;s
officers and directors will not be liable to the Company or to its stockholders for monetary damages resulting from their conduct
as an officer or director. As a result, we may have to spend significant resources indemnifying our officers and directors or
paying for damages caused by their conduct.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 54 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><B>C</B><A NAME="a003_v1"></A><B>AUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This prospectus and the documents
incorporated by reference into this prospectus and any accompanying prospectus supplement, and the documents that we reference
herein and therein and have filed as exhibits to the registration statement, including the sections entitled &ldquo;Risk Factors,&rdquo;
contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 21(E) of the Exchange Act and Section 27A of the
Securities Act. These forward-looking statements include, without limitation: statements regarding proposed new products or services;
statements concerning litigation or other matters; statements concerning projections, predictions, expectations, estimates, or
forecasts for our business, financial and operating results and future economic performance; statements of management&rsquo;s
goals and objectives; statements concerning our competitive environment, availability of resources and regulation; trends affecting
our financial condition, results of operations or future prospects; our financing plans or growth strategies; and other similar
expressions concerning matters that are not historical facts. Words such as &ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;should&rdquo;,
&ldquo;could&rdquo;, &ldquo;would&rdquo;, &ldquo;predicts&rdquo;, &ldquo;potential&rdquo;, &ldquo;continue&rdquo;, &ldquo;expects&rdquo;,
&ldquo;anticipates&rdquo;, &ldquo;future&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;, &ldquo;believes&rdquo; and &ldquo;estimates,&rdquo;
and variations of such terms or similar expressions, are intended to identify such forward-looking statements.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; margin-bottom: 0pt; text-align: justify">Forward-looking
statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications
of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information
available at the time they are made and/or management&rsquo;s good faith belief as of that time with respect to future events
and are subject to risks and uncertainties that could cause actual performance or results to differ materially from what is expressed
in or suggested by the forward-looking statements. The section in this prospectus entitled &ldquo;Risk Factors&rdquo; and the
sections in our periodic reports, including the sections entitled &ldquo;Business&rdquo; in our recent Annual Report on Form 10-K
and &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; in our recent Annual
Report on Form 10-K and subsequent quarterly reports filed with the SEC, as well as other sections in this prospectus and the
documents or reports incorporated by reference into this prospectus, and any accompanying prospectus supplement and the documents
that we reference herein and therein and have filed as exhibits to the registration statement, discuss some of the factors that
could contribute to these differences.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; margin-bottom: 0pt; text-align: justify">Forward-looking
statements speak only as of the date they are made. You should not put undue reliance on any forward-looking statements. We assume
no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors
affecting forward-looking information, except to the extent required by applicable securities laws. If we do update one or more
forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking
statements. Investors should review our subsequent reports filed with the SEC described in the sections entitled &ldquo;Where
You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Information by Reference&rdquo; of this prospectus and
incorporated by reference into this prospectus and any accompanying prospectus supplement and the documents that we reference
herein and therein and have filed as exhibits to the registration statement, all of which are accessible on the SEC&rsquo;s website
at <I>www.sec.gov</I>.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 55 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><B>U</B><A NAME="a004_v1"></A><B>SE
OF PROCEEDS</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Except as otherwise provided
in the applicable prospectus supplement, we intend to use the net proceeds from the sale of the securities offered by this prospectus
for working capital and general corporate purposes.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The intended application of the
proceeds from the sale of any particular offering of securities using this prospectus will be described in the accompanying prospectus
supplement relating to such offering. The precise amount and timing of the application of these proceeds will depend on our funding
requirements and the availability and costs of other funds.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We will not receive any proceeds
from the sale by the selling stockholders of our Common Stock. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we will not receive any proceeds from the sale of the Shares by the Selling Stockholders described in this prospectus supplement,
we will receive $12.50 per share upon the cash exercise of each Class A Warrant, $15.00 per share upon the cash exercise of each
Class B Warrant and $18.00 per share upon the cash exercise of each Class C Warrant. We may be required to pay certain offering
fees and expenses in connection with the registration of the selling stockholders&rsquo; securities and to indemnify the selling
stockholders against certain liabilities.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 56 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><B>T</B><A NAME="a005_v1"></A><B>HE
SECURITIES THAT WE MAY OFFER</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The descriptions of
our securities contained in this prospectus, together with the applicable prospectus supplements, summarize all of the material
terms and provisions of the various types of securities that we may offer. We will describe in the applicable prospectus supplement
relating to any securities the particular terms of such securities offered by that prospectus supplement. If we indicate in the
applicable prospectus supplement, the terms of such securities may differ from the terms that we have summarized below. We will
also include in the prospectus supplement information, where applicable, about material United States federal income tax considerations
relating to such securities, and the securities exchange, if any, on which such securities will be listed.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We may sell from time
to time, in one or more offerings, either individually or in any combination:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">shares
                 of our Common Stock;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">shares
                 of our Preferred Stock;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">warrants
                 to purchase shares of our Common Stock or Preferred Stock;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">debt
                 securities;</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">subscription
                 rights; and/or</P>
</TD>
</TR>

</TABLE>
<TABLE BORDER="0" WIDTH="100%" CELLSPACING="0" CELLPADDING="0">

<TR>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
</TD>
<TD VALIGN="TOP" STYLE="width: 18pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></P>
</TD>
<TD VALIGN="TOP"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">units
                 consisting of shares of our Common Stock or Preferred Stock or warrants to purchase shares of our Common Stock
                 or Preferred Stock.</P>
</TD>
</TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The terms of any securities
that we offer will be determined at the time of sale. We may issue securities that are exercisable, exchangeable for or convertible
into Common Stock. When particular securities are offered, a supplement to this prospectus will be filed with the SEC, which will
describe the terms of the offering and sale of the offered securities.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 57 -->
<DIV STYLE="border-bottom: #000000 2pt solid; margin-top: 12pt; margin-bottom: 6pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-style: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P>
</DIV>
<DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
<!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>


<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a006_v1"></A><B>DESCRIPTION
OF CAPITAL STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The following description of our capital
stock and certain provisions of our articles of incorporation, as amended (&ldquo;Articles of Incorporation&rdquo;), and our bylaws
(&ldquo;Bylaws&rdquo;) are summaries and are qualified by reference to our Articles of Incorporation and Bylaws. Such summaries
do not purport to be complete and are qualified in their entirety by reference to Nevada law, including the NRS, as well as copies
of our Articles of Incorporation and Bylaws, which have been filed as exhibits to prior reports filed by us with the SEC and are
incorporated by reference as exhibits to the registration statement of which this prospectus forms a part. See &ldquo;Where You
Can Find More Information.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles of Incorporation authorizes
us to issue up to 85,000,000 shares of stock, consisting of 75,000,000 shares of Common Stock, par value $0.001 per share, and
10,000,000 shares of Preferred Stock, par value $0.001 per share, of which 840,000 shares were classified as shares of Series
A Preferred Stock as of December 10, 2021. See &ldquo;Description of the Series A Preferred Stock&rdquo; beginning on page 30.
As of December 10, 2021, we had 14,100,609 shares of Common Stock issued and 13,085,116 shares of Common Stock outstanding and
806,585 shares of Series A Preferred Stock issued and outstanding.</P>

<P STYLE="margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our Articles of Incorporation, the
Board, without stockholder approval, is authorized to provide for the issuance of shares of Preferred Stock in one or more classes
or series, to establish the number of shares in each class or series and to fix the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of some general
terms and provisions of our Common Stock. Because it is a summary, it does not contain all of the information that may be important
to you. If you want more information, you should read our Articles of Incorporation and Bylaws, copies of which have been filed
with the SEC. See &ldquo;Where You Can Find More Information.&rdquo; This summary is also subject to and qualified by reference
to the description of the particular terms of Common Stock described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise described in the applicable
prospectus supplement, and subject to the preferential rights of any other class or series of shares of capital stock then outstanding
or which may be issued holders of our Common Stock are entitled to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Voting Rights</I>.
The holders of the Common Stock are entitled to one vote per share held and have the right and power to vote on all matters on
which a vote of shareholders is taken. Shareholders do not have cumulative voting rights in the election of directors. The election
of directors of the Company is decided by plurality vote and all other questions are decided by majority vote of shareholders
present in person or by proxy, except as otherwise required by the NRS or our Articles of Incorporation. Our Articles of Incorporation
provide that notwithstanding any other provision of our Articles of Incorporation or the bylaws (and notwithstanding the fact
that some lesser percentage may be specified by law, the Articles of Incorporation or the bylaws), any director or the entire
Board may be removed at any time, but only for cause or after the affirmative vote of 75% or more of the outstanding shares of
capital stock entitled to vote for the election of directors at a meeting called for that purpose or after the affirmative vote
of 75% of the entire Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board is divided into three classes,
with each class consisting, as nearly as may be possible, of one-third of the total number of directors, with the terms of the
classes scheduled to expire in successive years. At each annual meeting of the shareholders of the Company, the shareholders elect
the members of a single class of directors for three-year terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Dividends</I>.
The holders of the Common Stock are entitled to receive dividends when, as, and if declared by the Board, out of funds legally
available therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 58; Options: NewSection; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Liquidation</I>.
Upon liquidation, dissolution, or the winding up of the Company, holder of Common Stock are entitled to receive any remaining
assets of the Company in proportion to the respective number of shares held after payment of and reservation for Company liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Preemptive Rights</I>.
The holders of shares of our Common Stock do not have any preemptive right to subscribe for or purchase any shares of any class
of stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Redemption Rights</I>.
The outstanding shares of Common Stock are not subject to redemption by the Company. To the extent that the Company issues additional
shares of Common Stock, the relative interest in the Company of existing shareholders will likely be diluted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Nonassessability</I>.
All outstanding shares of our Common Stock are fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Preferred Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of the general
terms and provisions of the Preferred Stock that we may offer by this prospectus. We may issue Preferred Stock in one or more
classes or series; each class or series of Preferred Stock will have its own rights and preferences. We will describe in a prospectus
supplement (1) the specific terms of the class or series of any Preferred Stock offered through that prospectus supplement and
(2) any general terms outlined in this section that will not apply to such Preferred Stock. Because this is a summary, it does
not contain all of the information that may be important to you. If you want more information, you should read our Articles of
Incorporation, including any applicable Certificates of Designations, and Bylaws, copies of which have been filed with the SEC.
See &ldquo;Where You Can Find More Information.&rdquo; This summary is also subject to and qualified by reference to the description
of the particular terms of our securities described in the applicable prospectus supplement. The prospectus supplement may add
to, update or change the terms of such securities from those described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>General</I>. Our
Articles of Incorporation authorize the Board, without obtaining stockholder approval, to issue up to 10,000,000 shares of Preferred
Stock, par value $0.001 per share, from time to time, in one or more series, and to fix the number of shares and determine for
each such series such voting powers, designations, preferences, and relative participating, optional, or other rights and such
qualifications, limitations, or restrictions thereof. The Board is also expressly authorized to increase or decrease (but not
below the number of such series then outstanding) the number of shares of any series subsequent to the issuance of shares of that
series. If the number of shares of any series is decreased, the shares no longer designated as shares of such series will resume
the status of &ldquo;blank check&rdquo; preferred stock and may be designated, again, as a new series of Preferred Stock by the
Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 10, 2021, 840,000 shares
of our Preferred Stock were classified as shares of Series A Preferred Stock and we had 806,585 shares of our Series A Preferred
Stock issued and outstanding. Unless the applicable prospectus supplement indicates otherwise, we will have the right to &ldquo;reopen&rdquo;
a previous issue of a series of Preferred Stock by issuing additional Preferred Stock of such series.</P>

<P STYLE="margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Preferred Stock will have the distribution,
liquidation, redemption, voting and conversion rights described in this section unless we state otherwise in the applicable prospectus
supplement. The liquidation preference is not indicative of the price at which the Preferred Stock will actually trade on or after
the date of issuance. You should read the prospectus supplement relating to the particular class or series of the Preferred Stock
for specific terms, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the distinctive designation
                                         of the applicable class or series of Preferred Stock and the number of shares that will
                                         constitute the class or series;&#8203;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the initial offering price
                                         of such Preferred Stock;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">relative ranking and preference
                                         of such Preferred Stock as to distribution rights and rights upon liquidation, dissolution
                                         or winding up of our affairs;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 59; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the distribution rate or
                                         rates (or method of calculation) on that class or series, the distribution periods, the
                                         date(s) on which distributions will be payable and whether the distributions will be
                                         cumulative, noncumulative or partially cumulative, and, if cumulative, the dates from
                                         which the distributions will start to cumulate;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any redemption or sinking
                                         fund provisions of that class or series;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any voting rights;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any conversion or exchange
                                         provisions;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other specific terms,
                                         preferences, rights, limitations or restrictions of such Preferred Stock;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any limitations on issuance
                                         of any class or series of Preferred Stock ranking senior to or on a parity with such
                                         Preferred Stock as to distribution rights and rights upon liquidation, dissolution or
                                         winding up of our affairs;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any procedures for any auction
                                         and remarketing; and</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any listing of such Preferred
                                         Stock on any securities exchange</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of our Preferred Stock have no
preemptive rights to subscribe for any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will describe in the applicable prospectus
supplement any material U.S. federal income tax considerations applicable to the Preferred Stock offered by such prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of shares of Preferred Stock,
the issuance of rights to purchase Preferred Stock or the possibility of the issuance of Preferred Stock or such rights could
have the effect of delaying or preventing a change in our control. In addition, the rights of holders of Common Stock will be
subject to, and may be adversely affected by, the rights of holders of any Preferred Stock that we have issued or may issue in
the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Rank</I>. Unless
our Board of Directors otherwise determines and we so specify in the applicable prospectus supplement, we expect that the shares
of Preferred Stock will, with respect to distribution rights and rights upon liquidation, dissolution or winding up of our affairs,
rank senior to all our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Distributions</I>.
Holders of Preferred Stock of each class or series will be entitled to receive cash and/or share distributions at the rates and
on the dates shown in the applicable prospectus supplement. We will pay each distribution to holders of record as they appear
on our stock transfer books on the record dates fixed by our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not authorize or pay any distributions
on a class or series of Preferred Stock or set aside funds for the payment of distributions if restricted or prohibited by law,
or if the terms of any of our agreements, including agreements relating to our indebtedness or our other classes or series of
Preferred Stock, prohibit that authorization, payment or setting aside of funds or provide that the authorization, payment or
setting aside of funds is a breach of or a default under that agreement. We are now, and may in the future become, a party to
agreements which restrict or prevent the payment of distributions on, or the purchase or redemption of, our shares of capital
stock, including Preferred Stock. These restrictions may be indirect, such as covenants which require us to maintain specified
levels of net worth or assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Distributions on any class or series of
Preferred Stock may be cumulative, noncumulative or partially cumulative, as specified in the applicable prospectus supplement.
Cumulative distributions will be cumulative from and after the date shown in the applicable prospectus supplement. If our Board
of Directors fails to authorize a distribution that is noncumulative, the holders of the applicable class or series will have
no right to receive, and we will have no obligation to pay, a distribution in respect of the applicable distribution period, whether
or not distributions on that class or series are declared payable in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 60; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We refer to our shares of Common shares
or other stock, now or hereafter issued, that rank junior to an applicable class or series of Preferred Stock with respect to
distribution rights as junior stock. To the extent that the applicable class or series is entitled to a cumulative distribution,
we may not declare or pay any distributions, or set aside any funds for the payment of distributions, on junior stock, or redeem
or otherwise acquire junior stock, unless we also have declared and either paid or set aside for payment the full cumulative distributions
on such class or series of Preferred Stock and on all our other class or series of Preferred Stock ranking senior to or on a parity
with such class or series of Preferred Stock for all past distribution periods. The preceding sentence does not prohibit:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">distributions payable in
                                         junior shares or options, warrants or rights to subscribe for or purchase junior stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">conversions into or exchanges
                                         for junior stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">pro rata offers to purchase
                                         or a concurrent redemption of all, or a pro rata portion of, the outstanding Preferred
                                         Stock of such class or series and any other class or series of shares ranking on a parity
                                         with such class or series of Preferred Stock with respect to distribution rights and
                                         rights upon our liquidation, dissolution or winding up; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">our redemption, purchase
                                         or other acquisition of shares under incentive, benefit or share purchase plans for Directors,
                                         officers or employees, or others performing or providing similar services, or our redemption
                                         or other acquisition of rights issued under any shareholder rights plan we may adopt.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8203;To the extent an applicable class
or series is noncumulative, we need only declare, and pay or set aside for payment, the distribution for the then current distribution
period, before making distributions on or acquiring junior shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless full cumulative distributions on
a class or series of Preferred Stock have been or are contemporaneously declared and either paid or set aside for payment for
all past distribution periods, no distributions (other than in junior shares) may be declared or paid or set aside for payment
on any other class or series of Preferred Stock ranking on a parity with such class or series with respect to distribution rights.
When distributions are not paid in full upon a class or series of Preferred Stock and any other class or series ranking on a parity
with such class or series with respect to distribution rights, all distributions declared upon such class or series and any class
or series ranking on a parity with such class or series with respect to distribution rights shall be allocated pro rata so that
the amount of distributions declared per share on such class or series and such other shares shall in all cases bear to each other
the same ratio that the accrued distributions per share on such class or series and such other shares bear to each other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the applicable
prospectus supplement, we will credit any distribution payment made on an applicable class or series, including any capital gain
distribution, first against the earliest accrued but unpaid distribution due with respect to the class or series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Redemption</I>.
We may have the right or may be required to redeem one or more classes or series of Preferred Stock, as a whole or in part, in
each case upon the terms, if any, and at the times and at the redemption prices shown in the applicable prospectus supplement.
If a class or series of Preferred Stock is subject to mandatory redemption, we will specify in the applicable prospectus supplement
the number of shares we are required to redeem, when those redemptions start, the redemption price and any other terms and conditions
affecting the redemption. The redemption price will include all accrued and unpaid distributions, except in the case of noncumulative
Preferred Stock. The redemption price may be payable in cash or other property, as specified in the applicable prospectus supplement.
If the redemption price for Preferred Stock of any class or series is payable only from the net proceeds of our issuance of shares
of capital stock, the terms of the Preferred Stock may provide that, if no shares of capital stock shall have been issued or to
the extent the net proceeds from any issuance are insufficient to pay in full the aggregate redemption price then due, the Preferred
Stock will automatically and mandatorily be converted into shares of Common Stock pursuant to conversion provisions specified
in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Liquidation Preference</I>.
The applicable prospectus supplement will specify the liquidation preference of the applicable class or series. Upon our voluntary
or involuntary liquidation, dissolution or winding up of our affairs, before any distribution may be made to the holders of our
common shares or any other shares of capital stock ranking junior in the distribution of assets upon any liquidation, dissolution
or winding up of our affairs, to the applicable class or series, the holders of that class or series will be entitled to receive,
out of our assets legally available for distribution to shareholders, liquidating distributions in the amount of the liquidation
preference, plus an amount equal to all distributions accrued and unpaid. In the case of a noncumulative applicable class or series,
accrued and unpaid distributions include only the then current distribution period. Unless otherwise specified in the applicable
prospectus supplement, if liquidating distributions have been made in full to all holders of Preferred Stock, our remaining assets
will be distributed among the holders of any other shares of capital stock ranking junior to the Preferred Stock upon liquidation,
according to their rights and preferences and in each case according to their number of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 61; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, upon any voluntary or involuntary
liquidation, dissolution or winding up of our affairs, our available assets are insufficient to pay the amount of the liquidating
distributions on all outstanding shares of that class or series and the corresponding amounts payable on all equally ranking shares
of capital stock upon any liquidation, dissolution or winding up of our affairs, then the holders of that class or series and
all other equally ranking shares of capital stock shall share ratably in the distribution in proportion to the full liquidating
distributions to which they would otherwise be entitled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the applicable
prospectus supplement, after payment of the full amount of the liquidating distribution to which they are entitled, the holders
of a class or series of Preferred Stock will have no right or claim to any of our remaining assets. Neither the sale, lease, transfer
or conveyance of all or substantially all of our property or business, nor the merger or consolidation of us into or with any
other entity or the merger or consolidation of any other entity into or with us or a statutory share exchange by us, shall be
deemed to constitute the dissolution, liquidation or winding up of our affairs. In determining whether a distribution (other than
upon voluntary or involuntary dissolution), by dividend, redemption or other acquisition of shares or otherwise, is permitted
under Nevada law, amounts that would be needed, if we were to be dissolved at the time of the distribution, to satisfy the preferential
rights upon dissolution of the holders of a class or series of Preferred Stock will not be added to our total liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Voting Rights</I>.
Holders of our Preferred Stock will not have any voting rights, except as set forth below or otherwise from time to time specified
in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise provided for in an applicable
class or series, so long as any Preferred Stock are outstanding, we may not, without the affirmative vote or consent of a majority
of the shares of each affected class or series of Preferred Stock outstanding at that time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">authorize, create or increase
                                         the authorized or issued amount of any class or series of shares of capital stock ranking
                                         senior to that class or series of Preferred Stock with respect to distribution and liquidation
                                         rights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reclassify any authorized
                                         shares of capital stock into a class or series of shares of capital stock ranking senior
                                         to that class or series of Preferred Stock with respect to distribution and liquidation
                                         rights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">create, authorize or issue
                                         any security or obligation convertible into or evidencing the right to purchase any shares
                                         of capital stock ranking senior to that class or series of Preferred Stock with respect
                                         to distribution and liquidation rights; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">amend, alter or repeal the
                                         provisions of our Articles of Incorporation or any Certificate of Designations relating
                                         to that class or series of Preferred Stock, whether by merger, consolidation or otherwise,
                                         in a manner that materially and adversely affects the class or series of Preferred Stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8203;The authorization, creation or
increase of the authorized or issued amount of any class or series of shares of capital stock ranking on parity or junior to a
class or series of Preferred Stock with respect to distribution and liquidation rights will not be deemed to materially and adversely
affect that class or series. Further, with respect to any merger, consolidation or similar event, so long as a class or series
of Preferred Stock remains outstanding with the terms thereof materially unchanged or the holders of shares of that class or series
receive shares of the successor with substantially identical rights, taking into account that, upon the occurrence of such event,
we may not be the surviving entity, the occurrence of such event will not be deemed to materially and adversely affect that class
or series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing voting provisions will not
apply if all of the outstanding shares of the class or series of Preferred Stock with the right to vote have been redeemed or
called for redemption and sufficient funds have been deposited in trust for the redemption either at or prior to the act triggering
these voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 62; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Conversion and
Exchange Rights</I>. We will describe in the applicable prospectus supplement the terms and conditions, if any, upon which you
may, or we may require you to, convert or exchange Preferred Stock of any class or series into shares of Common Stock or any other
class or series of shares of capital stock or debt securities or other property. The terms will include the number of shares of
Common Stock or other securities or property into which the Preferred Stock are convertible or exchangeable, the conversion or
exchange price (or the manner of determining it), the conversion or exchange period, provisions as to whether conversion or exchange
will be at the option of the holders of the class or series or at our option, the events requiring an adjustment of the conversion
or exchange price and provisions affecting conversion or exchange upon the redemption of shares of the class or series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Series A Preferred Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
summary of some general terms and provisions of our Series A Preferred Stock. Because it is a summary, it does not contain all
of the information that may be important to you. If you want more information, you should read our Articles of Incorporation and
Bylaws, copies of which have been filed with the SEC. See &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Voting Rights</I>.
Holders of the Series A Preferred Stock do not have any voting rights, except as described below or as otherwise required by law.
In any matter in which the Series A Preferred Stock may vote (as expressly provided herein or as may be required by law), each
share of Series A Preferred Stock will be entitled to one vote per $25.00 of liquidation preference; provided that if the Series
A Preferred Stock and any other stock ranking on parity to the Series A Preferred Stock as to dividend rights and rights as to
the distribution of assets upon the Company&rsquo;s liquidation, dissolution or winding up are entitled to vote together as a
single class on any matter, the holders of each will vote in proportion to their respective liquidation preferences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Dividends</I>.
Subject to the preferential rights, if any, of the holders of any class or series of capital stock of the Company ranking senior
to the Series A Preferred Stock as to dividends, the holders of the Series A Preferred Stock are entitled to receive, when, as
and if declared by the Board of Directors (or a duly authorized committee of the Board), only out of funds legally available for
the payment of dividends, cumulative cash dividends at the annual rate of&nbsp;9.0% of the $25.00 liquidation preference&nbsp;per
year (equivalent to $2.25 per year).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Liquidation</I>.
In the event of the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, holders of
shares of Series A Preferred Stock will be entitled to be paid out of the assets of the Company legally available for distribution
to its stockholders (<I>i.e.</I>, after satisfaction of all the Company&rsquo;s liabilities to creditors, if any) and, subject
to the rights of holders of any shares of each other class or series of capital stock ranking, as to rights to the distribution
of assets upon the Company&rsquo;s voluntary or involuntary liquidation, dissolution or winding up, senior to the Series A Preferred
Stock, a liquidation preference of $25.00 per share, plus an amount equal to any accumulated and unpaid dividends to the date
of payment (whether or not declared), before any distribution or payment may be made to holders of shares of the Common Stock
or any other class or series of the Company&rsquo;s capital stock ranking, as to rights to the distribution of assets upon any
voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Stock (the &ldquo;liquidation
preference&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, upon such voluntary or involuntary
liquidation, dissolution or winding up of the Company&rsquo;s affairs, the assets of the Company legally available for distribution
to the Company&rsquo;s stockholders are insufficient to pay the full amount of the liquidation preference on all outstanding shares
of Series A Preferred Stock and the corresponding amounts payable on all shares of each other class or series of capital stock
of the Company ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution
or winding up, on parity with the Series A Preferred Stock, then the holders of the Series A Preferred Stock and each such other
class or series of capital stock of the Company ranking, as to rights to the distribution of assets upon the Company&rsquo;s voluntary
or involuntary liquidation, dissolution or winding up, on parity with the Series A Preferred Stock will share ratably in any distribution
of assets in proportion to the full liquidation preference to which they would otherwise be respectively entitled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Preemptive Rights</I>.
No holders of Series A Preferred Stock will, as holders of Series A Preferred Stock, have any preemptive rights to purchase or
subscribe for the Common Stock or any other security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 63; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Redemption Rights</I>.
The Company is not required to redeem the Series A Preferred Stock at any time. Accordingly, the Series A Preferred Stock will
remain outstanding indefinitely, unless the Company decides, at its option, to exercise its redemption right or, under circumstances
as described in &ldquo;Conversion Rights,&rdquo; where the holders of Series A Preferred Stock have a conversion right, such holders
convert the Series A Preferred Stock into the Common Stock. The Series A Preferred Stock is not subject to any sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Conversion Rights</I>.
The shares of Series A Preferred Stock are not convertible into or exchangeable for any other property or securities of the Company
or any other entity, except upon the occurrence of a delisting event or change of control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Nonassessability</I>.
All outstanding shares of our Series A Preferred Stock are fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our shares of Common Stock and Series
A Preferred Stock are listed on Nasdaq under the symbols &ldquo;SLNH&rdquo; and &ldquo;SLNHP&rdquo;, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent and registrar for our
Common Stock and Series A Preferred Stock is American Stock Transfer &amp; Trust Company, LLC (&ldquo;Transfer Agent&rdquo;).
The Transfer Agent&rsquo;s address is 6201 15<SUP>th</SUP> Avenue, Brooklyn, NY 11219.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&#8203;</FONT><B>Outstanding
Stock Options and Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 10, 2021, there were options
to acquire a total of 992,300 shares of Common Stock at a weighted-average exercise price of $5.44, of which 355,800 shares of
our Common Stock are currently issuable upon exercise of outstanding stock options at a weighted-average exercise price of $4.37
per share; and <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding warrants to purchase up to
an aggregate of 2,385,141 shares of Common Stock at a weighted average exercise price of $13.37 (including the shares underlying
the warrants).</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certain Provisions of Our Articles
of Incorporation Bylaws</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles of Incorporation and Bylaws
contain provisions and terms that may delay, defer, or prevent a tender offer or change in control of the Company that a shareholder
might consider to be in his, her, or its best interests, including attempts that might result in a premium being paid over the
market price for our shares of Common Stock. The Company expects that such provisions and terms will operate to discourage extraordinary
corporate transactions with respect to the Company, such as takeover bids, and will instead encourage any potential acquiror of
the Company to first correspond with the Board. These provisions and terms include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Special meetings of shareholders may only be called by the Chief Executive
    Officer, President, or Secretary of the Company or otherwise by resolution of the Board; shareholders have no right to call
    special meetings thereof.</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">The Company maintains a classified Board that is divided into three classes
    serving for respective three-year terms. As a result, it would take at least two successive annual meetings of shareholders
    to replace a majority of our Board.</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Vacancies on the Board may be filled only by majority vote of remaining directors
    then in office, even if less than a quorum, with the individual elected to serve for the remainder of the unexpired term.</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Except in instances of removal for cause, a director of the Company may be
    removed from service as a director only after the affirmative vote of 75% or more of outstanding shares of stock or 75% of
    the entire Board.</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Our Articles of Incorporation authorize us to issue up to 75,000,000 shares
    of Common Stock. Under Nevada law, our Board is permitted, in its discretion, at any time, and from time to time, without
    any action by the shareholders of the Company, to issue shares of our Common Stock (except to the extent such issuance would
    be violative of fiduciary duties, so dilutive to existing holders that it would be the equivalent of a sale of the Company,
    or otherwise prohibited by select provisions of the NRS). The issuance of shares of authorized but unissued stock could, under
    certain circumstances, have an anti-takeover effect, for example, by diluting the stock ownership of a person seeking to effect
    a change in the composition of our Board or contemplating a tender offer or other transaction for the acquisition of the Company.</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 64; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Nevada Anti-Takeover
Statutes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to Sections 78.411 &ndash;
78.444 of the Nevada Revised Statutes, relating to combinations with interested stockholders. These provisions prohibit an &ldquo;interested
stockholder&rdquo; from entering into a &ldquo;combination&rdquo; with the Company unless certain conditions are met. An &ldquo;interested
stockholder&rdquo; is a person who, together with affiliates and associates, beneficially owns (or within the prior two years,
did beneficially own) 10% or more of the Company&rsquo;s capital stock entitled to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Section 78.416 of the Nevada Revised
Statutes defines &ldquo;combination&rdquo; to include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any merger or consolidation
                                         involving the Company (or its subsidiary) and (i) the interested stockholder or (ii)
                                         any other entity which is, or after and as a result of the merger or consolidation would
                                         be, an affiliate or associate of the interested stockholder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any sale, transfer, pledge
                                         or other disposition of the assets of the Company (or its subsidiary) involving the interested
                                         stockholder or its affiliate or associate where the assets transferred (i) have an aggregate
                                         market value equal to more than 5% of the aggregate market value of all of the Company&rsquo;s
                                         assets, on a consolidated basis; (ii) have an aggregate market value equal to more than
                                         5% of the aggregate market value of all outstanding voting shares of the Company; or
                                         (iii) represent more than 10% of the earning power or net income of the Company, on a
                                         consolidated basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">subject to certain exceptions,
                                         any transaction that results in the issuance or transfer by the Company of any stock
                                         of the Corporation with a market value of 5% or more of the value of the outstanding
                                         shares of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the adoption of any plan
                                         or proposal for the liquidation or dissolution of the Company under any agreement, arrangement
                                         or understanding with the interested stockholder, or its affiliate or associate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any transaction involving
                                         the Company that has the effect of increasing the proportionate share of the stock of
                                         any class or series of the Company beneficially owned by the interested stockholder,
                                         or its affiliate or associate; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the receipt by the interested
                                         stockholder, or its affiliate or associate of the benefit of any loans, advances, guarantees,
                                         pledges or other financial benefits provided by or through the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Sections 78.378 through 78.3793
of the Nevada Revised Statutes limit the voting rights of certain acquired shares in a Nevada corporation (an &ldquo;issuing corporation&rdquo;)
that (i) has 200 or more stockholders, at least 100 of which are Nevada residents and (ii) conducts business in Nevada. Specifically,
if the acquisition results in ownership of: (i) 20% or more but less than 33%; (ii) 33% percent or more but less than 50%; or
(iii) 50% or more, as applicable, of the issuing corporation&rsquo;s then outstanding voting power with respect to the election
of directors, then the securities acquired in such acquisition are denied voting rights unless the acquisition is approved by
(i) the holders of a majority of the issuing corporation&rsquo;s voting power; and (ii) the holders of a majority of each class
or series of stock if the acquisition would adversely affect or change any preference of any relative or other right given to
any such class or series. Unless an issuing corporation&rsquo;s articles of incorporation or bylaws then in effect provide otherwise:
(i) not less than all of the voting securities of the issuing corporation acquired by the acquiring person may be redeemable by
an issuing corporation at the average price paid for the securities within 30 days if (x) the acquiring person has not given a
timely offeror&rsquo;s statement to the issuing corporation in accordance with Section 78.3789 of the Nevada Revised Statutes
or (y) the issuing corporation&rsquo;s stockholders vote not to grant voting rights to the acquiring person&rsquo;s securities,
and (ii) if the issuing corporation&rsquo;s stockholders vote to accord voting rights to the securities acquired by acquiring
person, then any stockholder of the issuing corporation who voted against granting voting rights to the acquiring person may demand
the purchase from an issuing corporation, for fair value, all or any portion of his securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 65; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect the existence of these provisions
to have an anti-takeover effect with respect to transactions that our Board does not approve in advance and could result in making
it more difficult to accomplish transactions that our shareholders may see as beneficial such as (i) discouraging business combinations
that might result in a premium over the market price for the shares of our Common Stock; (ii) discouraging hostile takeovers which
could inhibit temporary fluctuations in the market price of our Common Stock that often result from actual or rumored hostile
takeover attempts; and (iii) preventing changes in our management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Disclosure of Commission Position on
Indemnification for Securities Act Liabilities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing
provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in
the Securities Act and is, therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 66; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a007_v1"></A><B>DESCRIPTION
OF WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following description, together with
the additional information that we may include in any applicable prospectus supplements, summarizes the material terms and provisions
of the warrants that we may offer under this prospectus and the related warrant agreements and warrant certificates. While the
terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any series
of warrants in more detail in the applicable prospectus supplement. If we indicate in the prospectus supplement, the terms of
any warrants offered under that prospectus supplement may differ from the terms described below. If there are differences between
that prospectus supplement and this prospectus, the prospectus supplement will control. Thus, the statements we make in this section
may not apply to a particular series of warrants. Specific warrant agreements will contain additional important terms and provisions
and will be incorporated by reference as an exhibit to the registration statement which includes this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue warrants for purchase of
Common Stock or Preferred Stock in one or more series. We may issue warrants independently or together with Common Stock or Preferred
Stock, and the warrants may be attached to or separate from the Common Stock or Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will evidence each series of warrants
by warrant certificates that we may issue under a separate agreement. We may enter into the warrant agreement with a warrant agent.
Each warrant agent may be a bank that we select which has its principal office in the United States and a combined capital and
surplus of at least $125,000,000. We may also choose to act as our own warrant agent. We will indicate the name and address of
any such warrant agent in the applicable prospectus supplement relating to a particular series of warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will describe in the applicable prospectus
supplement the terms of the series of warrants, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the offering price and aggregate
                                         number of warrants offered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the currency for which the
                                         warrants may be purchased;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">if applicable, the designation
                                         and terms of the securities with which the warrants are issued and the number of warrants
                                         issued with each such security or each principal amount of such security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">if applicable, the date on
                                         and after which the warrants and the related securities will be separately transferable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the number of shares of Common
                                         Stock or Preferred Stock purchasable upon the exercise of one warrant and the price at
                                         which such shares may be purchased upon such exercise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the warrant agreement under
                                         which the warrants will be issued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the effect of any merger,
                                         consolidation, sale or other disposition of our business on the warrant agreement and
                                         the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">anti-dilution provisions
                                         of the warrants, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the terms of any rights to
                                         redeem or call the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any provisions for changes
                                         to or adjustments in the exercise price or number of securities issuable upon exercising
                                         the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the manner in which the warrant
                                         agreement and warrants may be modified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the identities of the warrant
                                         agent and any calculation or other agent for the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">federal income taxes of holding
                                         or exercising the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the terms of the securities
                                         issuable upon exercise of the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any securities exchange or
                                         quotation system on which the warrants or any securities deliverable upon exercise of
                                         the warrants may be listed; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other specific terms,
                                         preferences, rights or limitations of or restrictions on the warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before exercising their warrants, holders
of warrants will not have any of the rights of holders of Common Stock or Preferred Stock purchasable upon such exercise, including
the right to receive dividends, if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 67; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exercise of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each warrant will entitle the holder to
purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the
applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants
may exercise the warrants at any time up to 5:00 p.m. Eastern Time on the expiration date that we set forth in the applicable
prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the warrants may exercise the
warrants by delivering the warrant certificate representing the warrants to be exercised together with the specified information,
and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement.
We will set forth on the reverse side of the warrant certificate, and in the applicable prospectus supplement, the information
that the holder of the warrant will be required to deliver to the warrant agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until the warrant is properly exercised,
no holder of any warrant will be entitled to any rights of a holder of the securities purchasable upon exercise of the warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon receipt of the required payment and
the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office
indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If
fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate
for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender
securities as all or part of the exercise price for warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Enforceability of Rights By Holders
of Warrants </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any warrant agent will act solely as our
agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder
of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will
have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty
or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may,
without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right
to exercise, and receive the securities purchasable upon exercise of, its warrants in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Calculation Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Calculations relating to warrants may
be made by a calculation agent, an institution that we appoint as our agent for this purpose. The prospectus supplement for a
particular warrant will name the institution that we have appointed to act as the calculation agent for that warrant as of the
original issue date for that warrant. We may appoint a different institution to serve as calculation agent from time to time after
the original issue date without the consent or notification of the holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The calculation agent&rsquo;s determination
of any amount of money payable or securities deliverable with respect to a warrant will be final and binding in the absence of
manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless we provide otherwise in the applicable
prospectus supplement, the warrants and warrant agreements, and any claim, controversy or dispute arising under or related to
the warrants or warrant agreements, will be governed by and construed in accordance with the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 68; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a008_v1"></A><B>DESCRIPTION
OF DEBT SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">References in this &ldquo;Description
of Debt Securities&rdquo; section to &ldquo;we,&rdquo; &ldquo;us&rdquo; &ldquo;our&rdquo; or &ldquo;SHI&rdquo; mean Soluna Holdings,
Inc. and not any of its consolidated subsidiaries, unless the context otherwise requires. The following is a summary of some general
terms of the debt securities that we may offer by this prospectus and any applicable prospectus supplement. Because it is a summary,
it does not contain all of the information that may be important to you. If you want more information, you should read the forms
of indentures or note purchase agreements which we will file in connection with a particular offering and will be incorporated
by reference into the registration statement of which this prospectus is a part. If we issue debt securities, we will file any
additional final indentures, and any supplemental indentures or officer&rsquo;s certificates or note purchase agreements related
to the particular series of debt securities issued, with the SEC, and you should read those documents for further information
about the terms and provisions of such debt securities. See &ldquo;Where You Can Find More Information.&rdquo; This summary is
also subject to and qualified by reference to the descriptions of the particular terms of our debt securities to be described
in the applicable prospectus supplement. The applicable prospectus supplement may add to, update or change the terms of such debt
securities from those described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The debt securities sold under this prospectus
will be direct obligations of SHI and, unless otherwise stated in a prospectus supplement, will not be obligations of any of our
subsidiaries. Such debt obligations may be secured or unsecured and may be senior or subordinated indebtedness. Our debt securities
will be issued under one or more indentures between us and a trustee or a note purchase agreement. Any indenture will be subject
to and governed by the Trust Indenture Act of 1939, as amended (the &ldquo;Trust Indenture Act&rdquo;). The statements made in
this prospectus relating to any future indentures, note purchase agreements and the debt securities to be issued under the indentures
or note purchase agreements are summaries of certain anticipated provisions of the indentures or note purchase agreements and
are not complete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue debt securities that rank
&ldquo;senior,&rdquo; &ldquo;senior subordinated&rdquo; or &ldquo;junior subordinated,&rdquo; and which may be convertible into
another security. The debt securities that we refer to as &ldquo;senior&rdquo; will be direct obligations of SHI and will rank
equally and ratably in right of payment with our other indebtedness that is not subordinated, without giving effect to collateral
arrangements. We may issue debt securities that will be subordinated in right of payment to the prior payment in full of our senior
debt, as defined in the applicable prospectus supplement, and may rank equally and ratably with our other senior subordinated
indebtedness, if any, without giving effect to collateral arrangements. We refer to these as &ldquo;senior subordinated&rdquo;
securities. We may also issue debt securities that may be subordinated in right of payment to the senior subordinated securities.
These would be &ldquo;junior subordinated&rdquo; securities. We will file as an amendment to the registration statement of which
this prospectus is a part &nbsp;or in connection with a particular offering and will be incorporated by reference into the registration
statement of which this prospectus is a part three separate forms of indenture, one for the senior securities, one for the senior
subordinated securities and one for the junior subordinated securities, and a form of note purchase agreement.</P>

<P STYLE="margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue debt securities without limit
as to aggregate principal amount, in or more series, in each case as we establish in one or more supplemental indentures or note
purchase agreements. We need not issue all debt securities of one series at the same time. Unless we otherwise provide, we may
reopen a series, without the consent of the holders of the series, for the issuance of additional securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We anticipate that each indenture will
provide that we may, but need not, designate more than one trustee under an indenture, each with respect to one or more series
of debt securities. Any trustee under any indenture may resign or be removed with respect to one or more series of debt securities,
and we may appoint a successor trustee to act with respect to any such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The applicable prospectus supplement will
describe the specific terms relating to the series of debt securities we will offer, including, where applicable, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the title and series designation
                                         and whether they are senior securities, senior subordinated securities or junior subordinated
                                         securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 69; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the aggregate principal amount
                                         of the debt securities offered and any limit on the aggregate principal amount of that
                                         series that may be authenticated and delivered;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the&nbsp;percentage of the
                                         principal amount at which we will issue the debt securities and, if other than the principal
                                         amount of the debt securities, the portion of the principal amount of the debt securities
                                         payable upon maturity of the debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">if convertible, the initial
                                         conversion price, the conversion period and any other terms governing such conversion;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the stated maturity date;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any fixed or variable interest
                                         rate or rates per annum;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether such interest will
                                         be payable in cash or additional debt securities of the same series or will accrue and
                                         increase the aggregate principal amount outstanding of such series;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the place where principal,
                                         premium, if any, and interest will be payable and where the debt securities can be surrendered
                                         for transfer, exchange or conversion;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the date from which interest
                                         may accrue and any interest payment dates and any related record dates;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the terms of any guarantee
                                         of the debt securities and the identity of any guarantor or guarantors of such debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any sinking fund requirements;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any provisions for redemption
                                         or repurchase, including the redemption or repurchase price;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the debt securities
                                         are denominated or payable in U.S. dollars, a foreign currency or&nbsp;units of two or
                                         more currencies;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the amount of payments
                                         of principal of or premium, if any, or interest on the debt securities may be determined
                                         with reference to an index, formula or other method and the manner in which such amounts
                                         shall be determined;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the events of default and
                                         covenants of the debt securities, to the extent different from or in addition to those
                                         described in this prospectus;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether we will issue the
                                         debt securities in certificated or book-entry form;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the debt securities
                                         will be in registered or bearer form and, if in registered form, the denominations, if
                                         other than $2,000 and integral multiples of $1,000 in excess thereof, or, if in bearer
                                         form, the denominations and terms and conditions relating thereto;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether we will issue any
                                         of the debt securities in permanent global form and, if so, the terms and conditions,
                                         if any, upon which interests in the global security may be exchanged, in whole or in
                                         part, for the individual debt securities represented by the global security;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any addition or change to
                                         the provisions relating to the defeasance or covenant defeasance provisions of, or the
                                         satisfaction and discharge of, the debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether we will pay additional
                                         amounts on the debt securities in respect of any tax, assessment or governmental charge
                                         and, if so, whether we will have the option to redeem the debt securities instead of
                                         making this payment;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the subordination provisions,
                                         if any, relating to the debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">if the debt securities are
                                         to be issued upon the exercise of warrants, the time, manner and place for such debt
                                         securities to be authenticated and delivered;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any restriction or condition
                                         on the transferability of debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any addition or change to
                                         the provisions related to compensation and reimbursement of the trustee which applies
                                         to the debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any addition or change to
                                         the provisions related to supplemental indentures both with and without the consent of
                                         the holders;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">provisions, if any, granting
                                         special rights to holders upon the occurrence of specified events;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any addition or change to
                                         the events of default which applies to any debt securities and any change in the right
                                         of the trustee or the requisite holders of such debt securities to declare the principal
                                         amount thereof due and payable pursuant to the indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 70; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any addition or change to
                                         the covenants set forth in the indenture, or described in this prospectus or any prospectus
                                         supplement with respect to such series of debt securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other terms of debt securities
                                         of such series (which terms will not be inconsistent with the provisions of the Trust
                                         Indenture Act, but may modify, amend, supplement or delete any of the terms of the indenture,
                                         including those described in this prospectus or any prospectus supplement, with respect
                                         to such series).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will describe in the applicable prospectus
supplement any material U.S. federal income tax considerations applicable to the debt securities offered by such prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue debt securities at less than
the principal amount payable at maturity. We refer to these securities as &ldquo;original issue discount&rdquo; securities. If
material or applicable, we will describe in the applicable prospectus supplement special U.S. federal income tax considerations
applicable to original issue discount securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as may be described in any prospectus
supplement, any future indenture or note purchase agreement will not contain any other provisions that would limit our ability
to incur indebtedness or that would afford holders of the debt securities protection in the event of a highly leveraged or similar
transaction involving us or in the event of a change in control. You should review carefully the applicable prospectus supplement
for information with respect to events of default and covenants applicable to the debt securities being offered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Denominations, Interest, Registration
and Transfer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise described in the applicable
prospectus supplement, we will issue debt securities of any series that are registered securities in minimum denominations of
$2,000 and integral multiples of $1,000 in excess thereof, other than global securities, which may be of any denomination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in the applicable
prospectus supplement, we will pay the interest, principal and any premium at the corporate trust office of the trustee or at
the location specified in a note purchase agreement or, at our option, we may make payment of interest by check mailed to the
address of the person entitled to the payment as it appears in the applicable register or by wire transfer of funds to that person
at an account maintained within the United States or, in the case of global securities, in accordance with the procedures of the
depositary for such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not punctually pay or otherwise
provide for interest on any interest payment date, the defaulted interest will be paid either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to the person in whose name
                                         the debt security is registered at the close of business on a special record date the
                                         trustee will fix; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">in any other lawful manner,
                                         all as the applicable indenture or note purchase agreement describes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may have your debt securities divided
into more debt securities of smaller authorized denominations or combined into fewer debt securities of larger authorized denominations,
as long as the total principal amount is not changed. We call this an &ldquo;exchange.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may exchange or transfer debt securities
at the office of the applicable trustee. The trustee acts as our agent for registering debt securities in the names of holders
and transferring debt securities. We may change this appointment to another entity or perform this role ourselves. The entity
performing the role of maintaining the list of registered holders is called the &ldquo;registrar.&rdquo; The registrar will also
perform transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will not be required to pay a service
charge to transfer or exchange debt securities, but you may be required to pay for any tax or other governmental charge associated
with the exchange or transfer. The registrar will make the transfer or exchange only if it is satisfied with your proof of ownership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 71; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Merger, Consolidation or Sale of Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not consolidate with or merge into
any other person or convey, transfer or lease all or substantially all of our properties and assets to any other person (other
than one of our direct or indirect wholly owned subsidiaries), and we may not permit any other person (other than one of our direct
or indirect wholly owned subsidiaries) to consolidate with or merge into us, unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we are the surviving entity
                                         or, in case we consolidate with or merge into another person, the person formed by such
                                         consolidation or merger is, or in case we convey, transfer or lease all or substantially
                                         all of our properties and assets to any person, such acquiring person is, an entity organized
                                         and validly existing under the laws of the United States, any state thereof or the District
                                         of Columbia and expressly assumes, by a supplemental indenture executed and delivered
                                         to the trustee, in form satisfactory to the trustee, the due and punctual payment of
                                         the principal of and any premium and interest on all applicable debt securities issued
                                         under the applicable indenture and the performance or observance of every covenant of
                                         the applicable indenture on our part to be performed or observed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">immediately after giving
                                         effect to such transaction, and treating any indebtedness which becomes an obligation
                                         of us or any of our subsidiaries as a result of such transaction as having been incurred
                                         by us or such subsidiary at the time of such transaction, no event of default, and no
                                         event which, after notice or lapse of time or both, would become an event of default,
                                         in each case under the applicable indenture, has happened and is continuing; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we have delivered to the
                                         trustee an officer&rsquo;s certificate and an opinion of counsel, each stating that such
                                         consolidation, merger, conveyance, transfer or lease and, if a supplemental indenture
                                         is required in connection with such transaction, such supplemental indenture complies
                                         with the applicable indenture provisions described in this paragraph and that all conditions
                                         precedent provided for in the applicable indenture relating to such transaction have
                                         been complied with.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Events of Default and Related Matters
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Events of Default</I>. Unless otherwise
described in a prospectus supplement, the term &ldquo;event of default&rdquo; for any series of debt securities means any of the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we do not pay the principal
                                         of or any premium on a debt security of that series when due;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we do not pay interest on
                                         a debt security of that series within 30&nbsp;days after its due date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we do not deposit any sinking
                                         fund payment for that series within 30&nbsp;days after its due date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we remain in breach of any
                                         other covenant of the applicable indenture (other than a covenant added to the indenture
                                         solely for the benefit of another series) for 60&nbsp;days after we receive a notice
                                         of default specifying the breach and requiring that it be remedied. Only the trustee
                                         or holders of at least a majority in principal amount of outstanding debt securities
                                         of the affected series may send the notice;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we experience specified events
                                         of bankruptcy, insolvency or reorganization; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other event of default
                                         described in the applicable prospectus supplement occurs.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Remedies if an Event of Default Occurs.
</I>If an event of default has occurred and has not been cured, the trustee or the holders of not less than a majority in principal
amount of the outstanding debt securities of the affected series may declare the entire principal amount of all the debt securities
of that series to be due and payable immediately. If an event of default occurs because we experience specified events of bankruptcy,
insolvency or reorganization, the principal amount of all the debt securities of that series will be automatically accelerated
and become immediately due and payable, without any action by the trustee or any holder. At any time after the trustee or the
holders have accelerated any series of debt securities, but before a judgment or decree for payment of the money due has been
obtained, the holders of a majority in principal amount of the outstanding debt securities of the affected series may, under certain
circumstances, rescind and annul such acceleration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except in cases of default where the trustee
has some special duties, the trustee is not required to take any action under the applicable indenture at the request of any holders
unless the holders offer the trustee reasonable protection from expenses and liability. We refer to this as an &ldquo;indemnity.&rdquo;
If reasonable indemnity is provided, the holders of not less than a majority in principal amount of the outstanding debt securities
of the relevant series may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any
remedy available to the trustee. These majority holders may also direct the trustee in performing any other action under the applicable
indenture, subject to certain limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 72; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before you bypass the trustee and bring
your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to
the applicable indenture or debt securities issued under such indenture, the following must occur:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">you must give the trustee
                                         written notice that an event of default has occurred and is continuing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the holders of at least a
                                         majority in principal amount of all outstanding debt securities of the relevant series
                                         must make a written request that the trustee take action because of the default and must
                                         offer reasonable indemnity to the trustee against the cost and other liabilities of taking
                                         that action; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the trustee must have not
                                         taken action for 60&nbsp;days after receipt of the notice, request and offer of indemnity
                                         and must have not received from the holders of a majority in principal amount of all
                                         outstanding debt securities of the relevant series other conflicting directions within
                                         such 60 day period.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, you are entitled at any time
to bring a lawsuit for the payment of money due on your debt security after its due date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Every year we will furnish to the trustee
a written statement by certain of our officers certifying that, to their best knowledge, we are in compliance with the applicable
indenture and the debt securities, or else specifying any default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Modification of an Indenture or Note
Purchase Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise described in a prospectus
supplement, there are three types of changes we can make to the indentures, note purchase agreements and our debt securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Changes Requiring Your Approval</I>.
First, we cannot make certain changes to the indentures, note purchase agreements and our debt securities without the approval
of each holder of debt securities affected by the change. The following is a list of those types of changes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">change the stated maturity
                                         of the principal of, or interest on, a debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reduce the principal of,
                                         or the rate of interest on, a debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reduce the amount of any
                                         premium due upon redemption;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reduce the amount of principal
                                         of an original issue discount security payable upon acceleration of its maturity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">change the currency or place
                                         of payment on a debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">impair a holder&rsquo;s right
                                         to sue for payment on or after the stated maturity of a debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">in the case of a subordinated
                                         debt security, modify the subordination provisions of such debt security in a manner
                                         that is adverse to the holders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reduce the&nbsp;percentage
                                         of holders of debt securities whose consent is needed to modify or amend an indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reduce the&nbsp;percentage
                                         of holders of debt securities whose consent is needed to waive compliance with certain
                                         provisions of an indenture or certain defaults and their consequences;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">waive past defaults in the
                                         payment of principal of or premium, if any, or interest on the debt securities or in
                                         respect of any covenant or provision that cannot be modified or amended without the approval
                                         of each holder of the debt securities; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">modify any of the foregoing
                                         provisions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Changes Requiring Majority Approval</I>.
Second, certain changes require the approval of holders of not less than a majority in principal amount of the outstanding debt
securities of the affected series. We require the same majority vote to obtain a waiver of a past default. However, we cannot
obtain a waiver of a payment default or any other aspect of an indenture or the debt securities listed in the first category described
above under &ldquo;&mdash; Changes Requiring Your Approval&rdquo; without the consent of each holder of debt securities affected
by the waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 73; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Changes Not Requiring Approval</I>.
Third, certain changes do not require any approval of holders of debt securities. These include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to evidence the assumption
                                         by a successor obligor of our obligations;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to add to our covenants for
                                         the benefit of holders of debt securities of all or any series or to surrender any right
                                         or power conferred upon us;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to add any additional events
                                         of default for the benefit of holders of all or any series of debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to add to or change any provisions
                                         necessary to permit or facilitate the issuance of debt securities in bearer form, registrable
                                         or not registrable as to principal, and with or without interest coupons, or to permit
                                         or facilitate the issuance of debt securities in uncertificated form;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to add to, change or eliminate
                                         any of the provisions, so long as such addition, change or elimination does not apply
                                         to any debt security of any existing series of debt security entitled to the benefit
                                         of such provision or modify the rights of the holder of any such debt security with respect
                                         to such provision or such addition, change or elimination only becomes effective when
                                         there is no such security outstanding;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to add guarantees of or to
                                         secure all or any series of the debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to establish the forms or
                                         terms of debt securities of any series;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to evidence and provide for
                                         the acceptance of appointment of a successor trustee;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to cure any ambiguity, to
                                         correct or supplement any provision in the applicable indenture or note purchase agreement
                                         which may be defective or inconsistent with any other provision contained therein or
                                         to conform the terms of the indenture or note purchase agreement that are applicable
                                         to a series of debt securities to the description of the terms of such debt securities
                                         in the offering memorandum, prospectus supplement or other offering document applicable
                                         to such debt securities at the time of initial sale thereof;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to permit or facilitate the
                                         defeasance or satisfaction and discharge of debt securities of any series; provided that
                                         such action does not adversely affect the interests of any holder of debt securities
                                         in any material respect;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to prohibit the authentication
                                         and delivery of additional series of debt securities;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to add to or change or eliminate
                                         any provision as shall be necessary or desirable in accordance with any amendments to
                                         the Trust Indenture Act;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to comply with the rules
                                         of any applicable depositary; or</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">to change anything that does
                                         not adversely affect the interests of the holders of debt securities of any series in
                                         any material respect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Further Details Concerning Approval</I>.
Debt securities are not considered outstanding, and therefore the holders thereof are not eligible to vote or consent or give
their approval or take other action under the applicable indenture or note purchase agreement, if we have deposited or set aside
in trust for you money for their payment or redemption or if we or one of our affiliates own them. Debt securities are also not
considered to be outstanding and therefore the holders thereof are not eligible to vote or consent or give their approval or take
other action under the applicable indenture or note purchase agreement if they have been fully defeased or discharged, as described
below under &ldquo;&mdash;&nbsp;Discharge, Defeasance and Covenant Defeasance&thinsp;&mdash;&thinsp;Discharge&rdquo; or &ldquo;&mdash;
Full Defeasance.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Discharge, Defeasance and Covenant
Defeasance </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Discharge</I>. Unless otherwise described
in a prospectus supplement, we may discharge our obligations to holders of any series of debt securities that have become due
and payable or will become due and payable at their stated maturity within one year, or are to be called for redemption within
one year, by depositing or causing to be deposited with the trustee, in trust, funds in the applicable currency in an amount sufficient
to pay the debt securities of such series, including any premium and interest to the date of such deposit (in the case of debt
securities which have become due and payable) or to such stated maturity or redemption date, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 74; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Full Defeasance.</I>&nbsp;Unless otherwise
described in a prospectus supplement, we can, under particular circumstances, effect a full defeasance of any series of debt securities.
By this we mean we can legally release ourselves from any payment or other obligations on the debt securities if, among other
things, we put in place the arrangements described below to pay those debt securities and deliver certain certificates and opinions
to the trustee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we must irrevocably deposit
                                         (or cause to be deposited), in trust, for the benefit of all direct holders of the debt
                                         securities of such series money or government obligations (or, in some circumstances,
                                         depository receipts representing such government obligations), or a combination thereof,
                                         that will provide funds in an amount sufficient to pay the debt securities of such series,
                                         including any premium and interest on the debt securities of such series at their stated
                                         maturity or applicable redemption date (a &ldquo;government obligation&rdquo; for these
                                         purposes means, with respect to any series of debt securities, securities that are not
                                         callable or redeemable at the option of the issuer thereof and are (1)&nbsp;direct obligations
                                         of the government that issued the currency in which such series is denominated (or, if
                                         such series is denominated in euros, the direct obligations of any government that is
                                         a member of the European Monetary Union) for the payment of which its full faith and
                                         credit is pledged or (2)&nbsp;obligations of a person controlled or supervised by and
                                         acting as an agency or instrumentality of such government the payment of which is unconditionally
                                         guaranteed as a full faith and credit obligation by such government); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">we must deliver to the trustee
                                         a legal opinion stating that the current U.S. federal income tax law has changed or an
                                         Internal Revenue Service, or IRS, ruling has been issued, in each case to the effect
                                         that holders of the outstanding debt securities of such series will not recognize gain
                                         or loss for federal income tax purposes as a result of such full defeasance and will
                                         be subject to federal income tax on the same amounts and in the same manner and at the
                                         same times as would have been the case if such full defeasance had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, the following
rights and obligations will survive full defeasance:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">your right to receive payments
                                         from the trust when payments are due;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">our obligations relating
                                         to registration and transfer of debt securities and lost or mutilated certificates; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">our obligations to maintain
                                         a payment office and to hold moneys for payment in trust.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Covenant Defeasance</I>. Under current
U.S. federal income tax law, we can make the same type of deposit described above with respect to a series of debt securities
and be released from the obligations imposed by most of the covenants with respect to such series and provisions of the applicable
indenture or note purchase agreement with respect to such series, and we may omit to comply with those covenants and provisions
without creating an event of default. This is called &ldquo;covenant defeasance.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we accomplish covenant defeasance,
the following provisions of an indenture or a note purchase agreement and the debt securities of such series would no longer apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">most of the covenants applicable
                                         to such series of debt securities and any events of default for failure to comply with
                                         those covenants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any subordination provisions;
                                         and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">certain other events of default
                                         as set forth in any prospectus supplement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Conversion and Exchange Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms and conditions, if any, upon
which the debt securities are convertible into or exchangeable for Common Stock or Preferred Stock, other debt securities or other
property will be set forth in the applicable prospectus supplement. Such terms will include whether the debt securities are convertible
into or exchangeable for Common Stock or Preferred Stock, other debt securities or other property, the conversion or exchange
price (or manner of calculation thereof), the conversion or exchange period, whether conversion or exchange will be at the option
of the holders, the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or
exchange in the event of the redemption of such debt securities and any restrictions on conversion or exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 75; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Subordination</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will describe in the applicable prospectus
supplement the terms and conditions, if any, upon which any series of senior subordinated securities or junior subordinated securities
is subordinated to debt securities of another series or to our other indebtedness. The terms will include a description of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the indebtedness ranking
                                         senior to the debt securities being offered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the restrictions, if any,
                                         on payments to the holders of the debt securities being offered while a default with
                                         respect to the senior indebtedness is continuing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the restrictions, if any,
                                         on payments to the holders of the debt securities being offered following an event of
                                         default with respect to such debt securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">provisions requiring holders
                                         of the debt securities being offered and any related guarantees to remit payments to
                                         holders of senior indebtedness.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Global Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue the debt securities of a
series in whole or in part in the form of one or more registered global securities that we will deposit with a depositary or with
a nominee for a depositary identified in the applicable prospectus supplement and registered in the name of such depositary or
nominee. In such case, we will issue one or more registered global securities denominated in an amount equal to the aggregate
principal amount of all of the debt securities of the series to be issued and represented by such registered global security or
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless and until it is exchanged in whole
or in part for debt securities in definitive registered form, a registered global security may not be transferred except as a
whole:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">by the depositary for such
                                         registered global security to its nominee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">by a nominee of the depositary
                                         to the depositary or another nominee of the depositary; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">by the depositary or its
                                         nominee to a successor of the depositary or a nominee of the successor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The prospectus supplement relating to
a series of debt securities will describe the specific terms of the depositary arrangement with respect to any portion of such
series represented by a registered global security. We currently anticipate that the following provisions will apply to all depositary
arrangements for debt securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">ownership of beneficial interests
                                         in a registered global security will be limited to persons that have accounts with the
                                         depositary for the registered global security, those persons being referred to as &ldquo;participants,&rdquo;
                                         or persons that may hold interests through participants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">upon the issuance of a registered
                                         global security, the depositary for the registered global security will credit, on its
                                         book-entry registration and transfer system, the participants&rsquo; accounts with the
                                         respective principal amounts of the debt securities represented by the registered global
                                         security beneficially owned by the participants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any dealers, underwriters
                                         or agents participating in the distribution of the debt securities will designate the
                                         accounts to be credited; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">ownership of any beneficial
                                         interest in the registered global security will be shown on, and the transfer of any
                                         ownership interest will be effected only through, records maintained by the depositary
                                         for the registered global security (with respect to interests of participants) and on
                                         the records of participants (with respect to interests of persons holding through participants).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 76; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The laws of some states may require that
certain purchasers of securities take physical delivery of the securities in definitive form. These laws may limit the ability
of those persons to own, transfer or pledge beneficial interests in registered global securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So long as the depositary for a registered
global security, or its nominee, is the registered owner of the registered global security, the depositary or the nominee, as
the case may be, will be considered the sole owner or holder of the debt securities represented by the registered global security
for all purposes under the applicable indenture. Except as set forth below, owners of beneficial interests in a registered global
security:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">will not be entitled to have
                                         the debt securities represented by a registered global security registered in their names;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">will not receive or be entitled
                                         to receive physical delivery of the debt securities in the definitive form; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">will not be considered the
                                         owners or holders of the debt securities under the applicable indenture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, each person owning a beneficial
interest in a registered global security must rely on the procedures of the depositary for the registered global security and,
if the person is not a participant, on the procedures of a participant through which the person owns its interest, to exercise
any rights of a holder under the applicable indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We understand that under currently existing
industry practices, if we request any action of holders or if an owner of a beneficial interest in a registered global security
desires to give or take any action that a holder is entitled to give or take under an indenture, the depositary for the registered
global security would authorize the participants holding the relevant beneficial interests to give or take the action, and those
participants would authorize beneficial owners owning through those participants to give or take the action or would otherwise
act upon the instructions of beneficial owners holding through them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will make payments of principal of and premium, if any,
and interest, if any, on debt securities represented by a registered global security registered in the name of a depositary or
its nominee to the depositary or its nominee, as the case may be, as the registered owners of the registered global security.
Neither we nor any trustee or any other agent of us or a trustee will be responsible or liable for any aspect of the records relating
to, or payments made on account of, beneficial ownership interests in the registered global security or for maintaining, supervising
or reviewing any records relating to the beneficial ownership interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect that the depositary for any
debt securities represented by a registered global security, upon receipt of any payments of principal and premium, if any, and
interest, if any, in respect of the registered global security, will immediately credit participants&rsquo; accounts with payments
in amounts proportionate to their respective beneficial interests in the registered global security as shown on the records of
the depositary. We also expect that standing customer instructions and customary practices will govern payments by participants
to owners of beneficial interests in the registered global security held through the participants, as is now the case with the
securities held for the accounts of customers in bearer form or registered in &ldquo;street&nbsp;name.&rdquo; We also expect that
any of these payments will be the responsibility of the participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No registered global security may be exchanged
in whole or in part for debt securities registered, and no transfer of a registered global security in whole or in part may be
registered, in the name of any person other than the depositary for such registered global security, unless (1)&nbsp;such depositary
notifies us that it is unwilling or unable to continue as depositary for such registered global security or has ceased to be a
clearing agency registered under the Exchange Act and we fail to appoint an eligible successor depositary within 90&nbsp;days,
(2)&nbsp;an event of default shall have occurred and be continuing with respect to such debt securities, or (3)&nbsp;circumstances,
if any, exist in addition to or in lieu of the foregoing as have been specified for that purpose in an applicable prospectus supplement.
In any such case, the affected registered global security may be exchanged in whole or in part for debt securities in definitive
form and the applicable trustee will register any such debt securities in such name or names as such depositary directs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 77; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently anticipate that certain registered
global securities will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, or DTC, and will
be registered in the name of Cede &amp; Co., as the nominee of DTC. DTC has advised us that DTC is a limited-purpose trust company
organized under the New York Banking Law, a &ldquo;banking organization&rdquo; within the meaning of the New York Banking Law,
a member of the Federal Reserve System, a &ldquo;clearing corporation&rdquo; within the meaning of the New York Uniform Commercial
Code and a &ldquo;clearing agency&rdquo; registered pursuant to the provisions of Section 17A of the Exchange Act. DTC holds securities
that its participants, or direct participants, deposit with DTC. DTC also facilitates the post-trade settlement among direct participants
of sales and other securities transactions in deposited securities, through electronic computerized book-entry transfers and pledges
between direct participants&rsquo; accounts. This eliminates the need for physical movement of securities certificates. Direct
participants include both U.S. and non-U.S. securities brokers and dealers, banks, trust companies, clearing corporations and
certain other organizations. DTC is a wholly owned subsidiary of The Depository Trust &amp; Clearing Corporation, or DTCC. DTCC
is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are
registered clearing agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also available
to others such as both U.S. and non-U.S. securities brokers and dealers, banks, trust companies and clearing corporations that
clear through or maintain a custodial relationship with a direct participant, either directly or indirectly. The rules applicable
to DTC and its direct participants are on file with the SEC. The information in this paragraph concerning DTC and DTC&rsquo;s
book-entry system has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy
thereof. In the event registered global securities are deposited with, or on behalf of, a depositary other than DTC, we will describe
additional or differing terms of the depositary arrangements in the applicable prospectus supplement relating to that particular
series of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may also issue bearer debt securities
of a series in the form of one or more global securities, referred to as &ldquo;bearer global securities.&rdquo; We currently
anticipate that we will deposit these bearer global securities with a common depositary for Euroclear Bank SA/NV and Clearstream
Banking, soci&eacute;t&eacute; anonyme, or with a nominee for the depositary identified in the prospectus supplement relating
to that series. The prospectus supplement relating to a series of debt securities represented by a bearer global security will
describe the specific terms and procedures, including the specific terms of the depositary arrangement and any specific procedures
for the issuance of debt securities in definitive form in exchange for a bearer global security, with respect to the portion of
the series represented by a bearer global security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither we nor any trustee assumes any
responsibility for the performance by DTC or any other depositary or its participants of their respective obligations, including
obligations that they have under the rules and procedures that govern their operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any future indentures or note purchase
agreements and our debt securities issued thereunder will be governed by and construed in accordance with the laws of the State
of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a009_v1"></A><B>DESCRIPTION
OF SUBSCRIPTION RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue subscription rights to purchase
our Common Stock, Preferred Stock or debt securities. These subscription rights may be offered independently or together with
any other security offered hereby and may or may not be transferable by the stockholder receiving the subscription rights in such
offering. In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more underwriters
or other purchasers pursuant to which the underwriter or other purchasers may be required to purchase any securities remaining
unsubscribed for after such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The prospectus supplement relating to
any subscription rights we offer, if any, will, to the extent applicable, include specific terms relating to the offering, including
some or all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the price, if any, for the
                                         subscription rights;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the exercise price payable
                                         for our Common Stock, Preferred Stock or debt securities upon the exercise of the subscription
                                         rights;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the number of subscription
                                         rights to be issued to each stockholder;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the number and terms of our
                                         Common Stock, Preferred Stock or debt securities which may be purchased per each subscription
                                         right;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the extent to which subscription
                                         rights are transferable;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other terms of the subscription
                                         rights, including the terms, procedures and limitations relating to the exchange and
                                         exercise of the subscription rights;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the date on which the right
                                         to exercise the subscription rights shall commence, and the date on which the subscription
                                         rights shall expire;</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the extent to which the subscription
                                         rights may include an over-subscription privilege with respect to unsubscribed securities
                                         or an over-allotment privilege to the extent the securities are fully subscribed; and</TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">if applicable, the material
                                         terms of any standby underwriting or purchase arrangement which may be entered into by
                                         the Company in connection with the offering of subscription rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 79; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a010_v1"></A><B>DESCRIPTION
OF UNITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue units comprising shares of
Common Stock or Preferred Stock and warrants to purchase shares of Common Stock, Preferred Stock or other securities. Each unit
will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a
unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued
may provide that the securities included in such unit may not be held or transferred separately, at any time or at any time before
a specified date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The applicable prospectus supplement will
describe:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the designation and terms
                                         of the units and of the securities comprising the units, including whether and under
                                         what circumstances those securities may be held or transferred separately;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any unit agreement under
                                         which the units will be issued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any provisions for the issuance,
                                         payment, settlement, transfer or exchange of the units or of the securities comprising
                                         the units; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">whether the units will be
                                         issued in fully registered or global form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The applicable prospectus supplement will
describe the terms of any units. The preceding description and any description of units in the applicable prospectus supplement
does not purport to be complete and is subject to and is qualified in its entirety by reference to the unit agreement and, if
applicable, collateral arrangements and depositary arrangements relating to such units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 80; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a011_v1"></A><B>SELLING
STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus also relates to the possible
resale by the selling stockholders to be named in a prospectus supplement, who we refer to in this prospectus as the &ldquo;selling
stockholders,&rdquo; of up to 3,552,146 shares of our Common Stock underlying the Selling Stockholders Notes and Selling Stockholders
Warrants (each as defined below) which were issued in a transaction exempt from registration under the Securities Act pursuant
to a Securities Purchase Agreement (the &ldquo;SPA&rdquo;) among the Company and the selling stockholders dated October 25, 2021
pursuant to which such stockholders received (i) secured convertible notes in the aggregate principal amount of $16,304,348 for
an aggregate purchase price of $15 million (collectively, the &ldquo;Selling Stockholders Notes&rdquo;), which are, subject to
certain conditions, convertible at any time by the selling stockholders, into an aggregate of 1,776,073 shares of Common Stock
(the &ldquo;Conversion Shares&rdquo;), at a price per share of $9.18, and (ii) Class A, Class B and Class C common stock purchase
warrants (collectively, the &ldquo;Selling Stockholders Warrants&rdquo;) to purchase up to an aggregate of 1,776,073 shares of
Common Stock (the &ldquo;Warrant Shares&rdquo;), at an exercise price of $12.50, $15.00 and $18.00 per share, respectively. The
Selling Stockholders Warrants are immediately exercisable for five years upon issuance, subject to applicable Nasdaq rules.</P>

<P STYLE="margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Common Stock to be offered by the selling stockholders are &ldquo;restricted securities&rdquo; under applicable federal
and state securities laws and are being registered under the Securities Act to give those selling stockholders the opportunity
to publicly sell these shares, if they elect to do so following exercise of the Selling Stockholders Warrants or conversion of
the Selling Stockholders Notes. The registration of these shares does not require that the selling stockholders exercise any of
the Selling Stockholders Warrants, convert any of the Selling Stockholders Notes or sell any of the Conversion Shares or Warrant
Shares. The selling stockholders may sell all, some or none of the shares of Common Stock they receive pursuant to this prospectus
and the applicable prospectus supplement. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further information regarding the selling
stockholders will be set forth in a prospectus supplement or in filings we make with the SEC under the Exchange Act which are
incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To our knowledge, none of the selling
stockholders had any position, office, or other material relationship with us or any of our affiliates within the past three years.<BR STYLE="clear: both"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 81; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a012_v1"></A><B>PLAN
OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and/or the selling stockholders may
sell the securities being offered pursuant to this prospectus through underwriters or dealers, through agents, or directly to
one or more purchasers or through a combination of these methods. The applicable prospectus supplement will describe the terms
of the offering of the securities, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the name or names of any
                                         underwriters, if any, and if required, any dealers or agents;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the purchase price of the
                                         securities and the proceeds that we will receive from the sale;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any underwriting discounts
                                         and other items constituting underwriters&rsquo; compensation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any discounts or concessions
                                         allowed or reallowed or paid to dealers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any securities exchange or
                                         market on which the securities may be listed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and/or the selling stockholders may
distribute the securities from time to time in one or more transactions at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">a fixed price or prices,
                                         which may be changed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">market prices prevailing
                                         at the time of sale;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">prices related to such prevailing
                                         market prices; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">negotiated prices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only underwriters named in the prospectus
supplement are underwriters of the securities offered by the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If underwriters are used in an offering,
we and/or the selling stockholders will execute an underwriting agreement with such underwriters and will specify the name of
each underwriter and the terms of the transaction (including any underwriting discounts and other terms constituting compensation
of the underwriters and any dealers) in a prospectus supplement. The securities may be offered to the public either through underwriting
syndicates represented by managing underwriters or directly by one or more investment banking firms or others, as designated.
If an underwriting syndicate is used, the managing underwriter(s) will be specified on the cover of the prospectus supplement.
If underwriters are used in the sale, the offered securities will be acquired by the underwriters for their own accounts and may
be resold from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or
at varying prices determined at the time of sale. Any public offering price and any discounts or concessions allowed or reallowed
or paid to dealers may be changed from time to time. Unless otherwise set forth in the prospectus supplement, the obligations
of the underwriters to purchase the offered securities will be subject to conditions precedent and the underwriters will be obligated
to purchase all of the offered securities if any are purchased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and/or the selling stockholders may
grant to the underwriters options to purchase additional securities to cover over-allotments, if any, at the public offering price,
with additional underwriting commissions or discounts, as may be set forth in a related prospectus supplement. The terms of any
over-allotment option will be set forth in the prospectus supplement for those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we and/or the selling stockholders
use a dealer in the sale of the securities being offered pursuant to this prospectus or any prospectus supplement, we and/or the
selling stockholders will sell the securities to the dealer, as principal. The dealer may then resell the securities to the public
at varying prices to be determined by the dealer at the time of resale. The names of the dealers and the terms of the transaction
will be specified in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and/or the selling stockholders may
sell the securities directly or through agents we and/or the selling stockholders designate from time to time. We will name any
agent involved in the offering and sale of securities and we will describe any commissions we will pay the agent in the prospectus
supplement. Unless the prospectus supplement states otherwise, any agent will act on a best-efforts basis for the period of its
appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and/or the selling stockholders may
authorize agents or underwriters to solicit offers by institutional investors to purchase securities from us at the public offering
price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified
date in the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these
contracts in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 82; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and/or the selling stockholders may
also sell equity securities covered by this registration statement in an &ldquo;at the market&rdquo; offering as defined in Rule
415(a)(4) under the Securities Act. Such offering may be made into an existing trading market for such securities in transactions
at other than a fixed price on or through the facilities of Nasdaq or any other securities exchange or quotation or trading service
on which such securities may be listed, quoted or traded at the time of sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such at the market offerings, if any,
may be conducted by underwriters acting as principal or agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the sale of the securities,
underwriters, dealers or agents may receive compensation from us and/or the selling stockholders or from purchasers of the securities
for whom they act as agents in the form of discounts, concessions or commissions. Underwriters may sell the securities to or through
dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters
or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution
of the securities, and any institutional investors or others that purchase securities directly and then resell the securities,
may be deemed to be underwriters, and any discounts or commissions received by them from us and any profit on the resale of the
securities by them may be deemed to be underwriting discounts and commissions under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may provide agents and underwriters
with indemnification against particular civil liabilities, including liabilities under the Securities Act, or contribution with
respect to payments that the agents or underwriters may make with respect to such liabilities. Agents and underwriters may engage
in transactions with, or perform services for, us in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we and/or the selling stockholders
may enter into derivative transactions with third parties (including the writing of options) in privately negotiated transactions.
If the applicable prospectus supplement indicates, in connection with such a transaction, the third parties may, pursuant to this
prospectus and the applicable prospectus supplement, sell securities covered by this prospectus and the applicable prospectus
supplement. If so, the third party may use securities borrowed from us or others to settle such sales and may use securities received
from us to close out any related short positions. We and/or the selling stockholders may also loan or pledge securities covered
by this prospectus and the applicable prospectus supplement to third parties, who may sell the loaned securities or, in an event
of default in the case of a pledge, sell the pledged securities pursuant to this prospectus and the applicable prospectus supplement.
The third party in such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement
or in a post-effective amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To facilitate an offering of a series
of securities, persons participating in the offering may engage in transactions that stabilize, maintain, or otherwise affect
the market price of the securities. This may include over-allotments or short sales of the securities, which involve the sale
by persons participating in the offering of more securities than have been sold to them by us. In those circumstances, such persons
would cover such over-allotments or short positions by purchasing in the open market or by exercising the over-allotment option
granted to those persons. In addition, those persons may stabilize or maintain the price of the securities by bidding for or purchasing
securities in the open market or by imposing penalty bids, whereby selling concessions allowed to underwriters or dealers participating
in any such offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions.
The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which
might otherwise prevail in the open market. Such transactions, if commenced, may be discontinued at any time. We make no representation
or prediction as to the direction or magnitude of any effect that the transactions described above, if implemented, may have on
the price of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 83; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All securities we may offer, other than
our Common Stock and Series A Preferred Stock, will be new issues of securities with no established trading market. Any agents
or underwriters may make a market in these securities, but will not be obligated to do so and may discontinue any market making
at any time without notice. We cannot guarantee the liquidity of the trading markets for any securities. There is currently no
market for any of the securities being registered hereby, other than our Common Stock and Series A Preferred Stock which are listed
on Nasdaq. We have no current plans for listing of debt securities, warrants, units or subscription rights on any securities exchange
or quotation system; any such listing with respect to any particular debt securities, warrants, units or subscription rights will
be described in the applicable prospectus supplement or other offering materials, as the case may be. Any underwriters to whom
securities are sold by us for public offering and sale may make a market in the securities, but such underwriters will not be
obligated to do so and may discontinue any market making at any time without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to comply with the securities
laws of some states, if applicable, the securities offered pursuant to this prospectus will be sold in those states only through
registered or licensed brokers or dealers. In addition, in some states securities may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available
and complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 84; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a013_v1"></A><B>LEGAL
MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise specified in connection
with the particular offering of any securities, the validity of the issuance of the securities offered hereby will be passed upon
for us by Sullivan &amp; Worcester LLP, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a014_v1"></A><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements
of Soluna Holdings, Inc. as of and for the two years ended December 31, 2020 incorporated into this prospectus by reference to
our Annual Report on Form 10-K for the year ended December 31, 2020 have been audited by Wojeski &amp; Company, CPAs, P.C., an
independent registered public accounting firm, as stated in their report thereon, which are incorporated by reference herein in
reliance upon such report and upon the authority of such firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a015_v1"></A><B>WHERE
YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus constitutes a part of
a Registration Statement on Form S-3 filed under the Securities Act. As permitted by the SEC&rsquo;s rules, this prospectus and
any prospectus supplement, which form a part of the registration statement, do not contain all of the information that is included
in the registration statement. You will find additional information about us in the registration statement. Any statements made
in this prospectus or any prospectus supplement concerning legal documents are not necessarily complete and you should read the
documents that are filed as exhibits to the registration statement or otherwise filed with the SEC for a more complete understanding
of the document or matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We file annual, quarterly and current
reports, proxy statements and other information with the SEC. Our SEC filings are available to the public at no cost from the
SEC&rsquo;s website at http://www.sec.gov. Our corporate website is www.solunacomputing.com. The information on our corporate
website is not incorporated by reference in this prospectus, any prospectus supplement or the registration statement of which
they form a part, and the documents incorporated by reference herein and therein, and you should not consider it a part of this
prospectus, any prospectus supplement, the registration statement or such documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a016_v1"></A><B>INCORPORATION
OF DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have filed a Registration Statement
on Form S-3 with the SEC under the Securities Act. This prospectus is part of the registration statement, but the registration
statement includes and incorporates by reference additional information and exhibits. The SEC permits us to &ldquo;incorporate
by reference&rdquo; the information contained in documents that we file with the SEC, which means that we can disclose important
information to you by referring you to those documents rather than by including them in this prospectus. Information that is incorporated
by reference is considered to be part of this prospectus and you should read it with the same care that you read this prospectus.
Information that we file later with the SEC will automatically update and supersede the information that is either contained,
or incorporated by reference, in this prospectus, and will be considered to be a part of this prospectus from the date those documents
are filed. We have filed with the SEC, and incorporate by reference in this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 97%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on Form 10-K for the fiscal year ended </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000039/mti10kv3.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2020</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, filed with the SEC on March
    31, 2021, as amended by our Form 10-K/A, filed with the SEC on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000043/mti10ka.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    29, 2021;</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Quarterly Reports on Form 10-Q for the quarters ended </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000061/mti10q1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000321/g082290_10q.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000679/g082396_10q.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, filed with the SEC on May 17,
    2021, August 10, 2021 and November 12, 2021, respectively;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1%"></TD><TD STYLE="width: 2%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; width: 97%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         Current Reports on Form 8-K filed with the SEC on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000007/mti8k012121.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
                                         21, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000014/mkty8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
                                         24, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000016/mti8k022621.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
                                         26, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000018/mkty8k022621.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000025/mti8k030221.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
                                         8, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000033/mkty8k03222021.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
                                         22, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000095/g082131_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
                                         12, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000116/g082165_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
                                         29, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000047/mti8k043021.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
                                         30, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000124/g082184_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
                                         4, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000160/g082207_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
                                         19, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000172/g082210_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
                                         27, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000187/g082214_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
                                         10, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000192/g082217_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
                                         15, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000208/g082243_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
                                         24, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000340/g082297_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
                                         12, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000398/g082320_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
                                         23, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000408/g082330_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
                                         31, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000461/g082347_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
                                         22, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000505/g082363_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
                                         30, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000568/g082388_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
                                         12, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000582/g082394_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
                                         25, 2021</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
                                         </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000632/g082430_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
                                         4, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;
                                         </FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 85; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1%"></TD><TD STYLE="width: 2%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; width: 97%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         Definitive Proxy Statement on Schedule 14A for our annual meeting of stockholders held
                                         on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000062/mtidef14a.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
                                         9, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         filed with the SEC on May 18, 2021 and our Definitive Proxy Statement on Schedule 14A
                                         for a special meeting of stockholders held on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000548/g082379_def14a.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
                                         29, 2021</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                         filed with the SEC on October 7, 2021; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
&nbsp; &nbsp; &nbsp; &nbsp;</FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 97%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    registration statement on Form 8-A filed with the SEC on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000100329721000034/mkty8a12b.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    22, 2021</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with respect to the Common Stock
    and our registration statement on Form 8-A filed with the SEC on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/64463/000175392621000384/g082310_8a.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    19, 2021</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with respect to our Series A
    Preferred Stock.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also incorporate by reference all additional
documents that we file with the SEC under the terms of Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that are made after
the initial filing of the registration statement of which this prospectus forms a part and prior to effectiveness of the registration
statement and after the initial filing date of the registration statement of which this prospectus is a part until the offering
of the particular securities covered by a prospectus supplement or term sheet has been completed. We are not, however, incorporating,
in each case, any documents or information that we are deemed to furnish and not file in accordance with SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will provide, without charge, to each
person to whom a copy of this prospectus or any prospectus supplement forming a part of the registration statement is delivered,
including any beneficial owner, upon the written or oral request of such person, a copy of any or all of the documents incorporated
by reference herein, including exhibits. Requests should be directed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">Soluna
Holdings, Inc. </FONT><BR>
<FONT STYLE="font-weight: normal">325 Washington Avenue Extension</FONT><BR>
<FONT STYLE="font-weight: normal">Albany, NY 12205</FONT><BR>
<FONT STYLE="font-weight: normal">hello@soluna.io</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Copies of these filings are also available on our website at
www.solunacomputing.com<I>.</I> For other ways to obtain a copy of these filings, please refer to &ldquo;Where You Can Find More
Information&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 86; Value: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SOLUNA
HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares
of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>PROSPECTUS
SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Book-Running
Manager</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Univest</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 329.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 87; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form424b5_001.jpg
<TEXT>
begin 644 form424b5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" != /X# 2(  A$! Q$!_\0
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M8*ODG$>:9;#*<=6G5XBPT'4PV)P5*/M(/V=:%?\ VJE*-1*)^?'[<?AKQ/\
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MF%#/\LH\$SG%1C6JY9DE."XBP%3&\B]O37M:=.4G.'(TD_P_^.O[-'@/X?>
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MW>O)XF^*.F65P(%MMEO?M;W$:PM[9^P+^T#\5OCE\=_VWO#FI?%"W^+WP)^
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;>:#NO275@&=GZFB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
